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Chapter 1 
GENERAL INTRODUCTION 
This thesis addresses a number of aspects of chronic renal failure (CRF) and 
dialysis treatment in children and its implications for a child's development and 
family functioning. 
Until twenty years ago, chronic renal failure in children which led to end 
stage renal disease (ESRD) could not be treated. Since then, life-saving techni-
ques - haemodialysis (HD) and transplantation - became also suitable for 
children, at first in the U.S.A., later in western Europe. Right from the start, 
particularly paediatricians paid a great deal of attention to the psychosocial 
implications of these far-reaching forms of treatment [1], mainly as a result of 
experience with adult dialysis patients and study findings of especially Abram 
and Kaplan-De Nour [2,3]. A number of publications appeared in the early 
nineteen seventies which aimed to evaluate the heavy emotional burden for the 
child and his/her family, and the psychological processes resulting from 
adaptation to haemodialysis and transplantation [4-10]. Further progress in the 
medical-technical field and the development of new techniques, such as 
continuous ambulatory peritoneal dialysis (CAPD) and continuous cycling 
peritoneal dialysis (CCPD), meant that the accent shifted from research on 
behavioural and emotional aspects, to the effects of chronic renal failure on the 
development of the child and improvement of the quality of life, also in the 
longer-term [11-18]. 
The first part of this thesis (Chapters 1, 2, and 3) forms the introduction to the 
research section that is described in Chapters 4 to 9. Chapter 2 deals with the 
medical aspects of chronic renal failure and renal-replacement techniques in as 
far as they are relevant to a good understanding of the study. Chapter 3 
provides an overview of the implications of a chronic disease in general, as well 
as the specific consequences of renal disease, for both the child and the family. 
The majority of psychological aspects of chronic renal disease in childhood, as 
far as mentioned in the literature, are dealt with in this chapter, so that together 
these chapters form the theoretical framework of the two types of studies which 
were performed. 
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The background of the studies described were generated by the application of 
CAPD/CCPD techniques at the beginning of the nineteen eighties at paediatric 
dialysis centres where children younger than five year of age could receive 
long-term dialysis treatment [19,20]. In view of the lower age limit for dialysis 
treatment and the consequential increase in life expectancy, it appeared to be 
necessary to perform a systematic investigation on the influence of renal 
function disorders and dialysis treatment on the psycho-motor growth and 
development of children with CRF. 
The general overview by Biasioli et al. [21], and other publications on 
children with renal disease [16-18], brought forward the alarming fact that 
young renal patients could suffer from developmental disorders and progressive 
encephalopathy in the pre-dialysis phase. These findings partly agreed with our 
experience with young renal patients. Psychological examination performed on a 
small number of patients with developmental retardation showed that their 
development improved significantly after the start of CAPD. This resulted in the 
question as to whether the early application of renal replacement therapy would 
offer this group of children better developmental chances. Chapters 4, 5, and 6 
present the results of prospective research into the neurological, motor, and 
cognitive development of young patients with ESRD in both the pre-dialysis 
phase and the dialysis phase. Also the effect of starting dialysis treatment and 
the influence of other medical and psychological factors were evaluated. 
Chapter 7 describes the effects of transplantation on the cognitive functioning of 
older children. 
During the first few years of applying CAPD treatment to young children at our 
centre, we found that the shift from haemodialysis (centre dialysis) to CAPD 
treatment (home dialysis) and the delegation of medical responsibility to the 
parents, also had implications for family functioning [22]. Particularly the 
parents of young patients appeared to be burdened heavily. Evaluation of the 
most optimal time to start CAPD treatment in young children should therefore 
not only consider the importance of an early start of renal replacement therapy 
in order to prevent developmental disorders, but also whether a family and the 
parents can sustain the treatment. 
To be able to make reliable and systematic assessments of the amount of 
burden dialysis treatment has on a family and to monitor risk factors in relation 
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to family functioning, it was necessary to develop specific measurement 
instruments [23,24]. Chapters 8 and 9 describe the development of these 
instruments and the results of a study on family burden in relation to HD and 
CAPD treatment. 
The research findings are discussed and summarized with a number of 
recommendations in Chapter 10. 
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Chapter 2 
MEDICAL ASPECTS OF CHRONIC RENAL FAILURE 
IN CHILDREN 
2.1. Function of the kidneys and the consequences of renal failure 
The kidneys are two organs localized retroperitoneally in the upper abdomen. 
Their main function is the control of the fluid and electrolyte homeostasis in the 
body, as well as the elimination of metabolites from the body. Other functional 
contributions relate to the control of blood pressure (renin), bone metabolism 
(vitamin D), and red blood cell formation (erythropoietin). For these functions, 
each kidney contains about 1,000,000 glomeruli (Figure 2.1). 
A glomerulus is a small filter unit which filters water and electrolytes from 
the blood. Most of the filtrate is re-absorbed in the tubules, where under the 
control of hormones, the fluid and electrolyte balance is maintained. Finally, the 
urine leaves the tubular system by the collecting ducts and flows into the renal 
pelvis. 
The excretory function of the kidneys is commonly calculated as clearance, 
i.e., the amount of bloodplasma which is fully cleared of a metabolite within a 
certain period of time. A number of substances are suitable for clearance 
studies. In clinical practice, the most widely used marker is creatinine. Creatini-
ne clearance is expressed as ml/min/1.73m2 body surface and can be calculated 
from data obtained by the collection of a 24-hour urinary specimen and a blood 
sample. If no 24-hour urinary collection is available, creatinine clearance can be 
estimated from the serum creatinine concentration and the height of the patient 
[1]. Normal values beyond two years are 100-156ml/min/1.73m2. 
Renal function has a great reserve. A loss of up to 50% of functional renal 
tissue will have no consequences on the patient. If less than 50% of functioning 
renal tissue is present, therapeutic measures (see below) are indicated. A patient 
can survive, however, with a renal function as low as 10%, without renal 
replacement therapy. If the renal function drops below 10% (end stage renal 
disease) dialysis therapy or renal transplantation will be necessary. 
Symptoms of renal failure generally occur if renal function drops to below 
25%. Initial symptoms are decreased growth and poor weight gain [2]. 
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Figure 2.1. Schematic drawing of the anatomy of the functional unit of the kidney, 
the nephron, (from Junquiera LD, Corneiro J, Kelly RO. Functionele 
Histologie. Utrecht, Wet. uitg. Bunge, 1990. With permission). 
At a later stage acidosis, renal osteodystrophy, hypertension, and anaemia are 
common. In the absence of therapy, the combination of anaemia, acidosis, and 
azotemia leads to increasing clinical disability and establishes the multisymptom 
complex known as uraemia. In this phase avitality, loss of appetite, nausea, and 
vomiting are common symptoms. In this phase also the so-called uraemic 
encephalopathy may occur. 
Uraemic encephalopathy is one of the most serious complications of chronic 
renal failure. Several excellent reviews have been published on this topic [3-8]. 
Uraemia has damaging effects on cerebral function, although all neurotoxic sub-
stances responsible have not yet been fully identified. Uraemic encephalopathy 
is characterized by mental status abnormalities, headaches, disturbances of sleep 
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and vegetative functions, and polyneuropathy. Lethargy, general malaise, and 
easy fatigue of mental activity are common in adult dialysis patients. In children 
disturbances of brain maturation have been reported using spectral 
electroencephalography [9]. The use of aluminium as a phosphate binding agent 
contributes to the occurrence of toxic encephalopathic symptoms [10]. 
2.2. Incidence and aetiology of chronic renal failure in childhood 
End-stage renal disease in childhood is a rare condition. Frequency rates vary 
regionally. The most recent data from the European Dialysis and Transplanta-
tion Association (EDTA) show a mean number of 3 new paediatric cases per 
million child population (0-15 years) in Europe in 1991, with a variation of <1 
(Algeria, Malta, Romania, Turkey) to 14 (Iceland) [11]. For the United States 
similar figures have been reported. The incidence was 11 per million child 
population (0-19 years) in the period 1989-1991 [12]. It should, however, be 
noted that the incidence in the older age group (15-19 years) was relatively high 
in this population. In the Dutch population of 3,027,573 children younger than 
15 years (mean value for 1979 to 1986) 18 new patients per year were admitted 
to one of the four paediatric dialysis programmes [13]. In 1994, 22 patients 
below the age of 15 years were admitted to a paediatric dialysis programme. 
The total number of paediatric dialysis patients treated at the four centres was 
61 on January 1, 1995 [14]. 
The aetiology of end-stage renal disease in the Dutch paediatric population is 
given in Table 2.1. Comparisons between the findings of different studies are 
complicated by the use of different classification systems and different upper-
age limits. It is clear, however, that in paediatric programmes hereditary and 
urological causes of end-stage renal disease are relatively frequent, compared to 
adult programmes, whereas diabetes mellitus is almost completely absent. 
2.3. Comorbidity and mortality 
Recent publications draw attention to the remarkable high proportion of other 
and multiple disorders in children with chronic renal failure (one third of the 
patients) [15,16]. 
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Table 2.1. Causes of ESRD in 167 children in the Netherlands, 1979-1986 (modified 
from [13]). 
Diagnosis 
Glomerulonephritis 
focal segmental glomerulosclerosis 
other 
Hereditary diseases 
nephronophtisis 
other 
Pyelonephritis 
urological pathology 
other 
Congenital hypoplasia/dysplasia 
Systemic disorders 
haemolytic uraemic syndrome 
other 
Other 
Unknown 
Number 
43 
22 
21 
33 
11 
22 
32 
26 
6 
23 
20 
16 
4 
8 
8 
% 
25.7 
19.8 
19.2 
13.8 
12.0 
4.8 
4.8 
This is over thirty times the incidence in the normal population [15]. Twenty 
percent of the patients has one other abnormality, while twelve percent has two 
or more [17,18]. 
Comorbidity may be related to the original disease (for example in syndro-
mal diseases), or may be acquired during the period of chronic renal failure or 
dialysis treatment. According to the data of the EDTA registry (1992) the 
severity of the abnormalities generally was considered to be mild [11]; the 
abnormalities varied from motor disturbances, visual, and auditory impairment 
to mental handicaps. Visual and auditory pathology was generally irreversible, 
but motor abnormalities showed amelioration after successful transplantation in 
only 39% of the patients [18]. In 18% of the study population mental handicaps 
were noted at the beginning of treatment, but in the opinion of the dialysis 
physician, an improvement occurred during renal replacement therapy in 38% of 
the children [18]. Comorbidity and its severity did not correlate with the 
duration of renal replacement therapy. 
With respect to mortality again the EDTA data can be used. Five-year patient 
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survival after start of renal replacement therapy is 85% [11]. Similar rates are 
derived from the American Medicare data [12]. These studies report that the 
youngest children have the poorest survival. 
2.4. Renal replacement therapy 
Dialysis and renal transplantation are generally considered to be acceptable 
treatment modalities for children with end-stage renal disease. Selection criteria, 
that have been applied in the past - mainly with respect to the exclusion of 
children with severe mental retardation -, are no longer valid at almost all 
centres [13]. Especially in the youngest age group, - the newborns and young 
infants -, the opinion of the parents plays an important role in the decision of 
whether to treat the child or not. It is not an obvious choice to dialyse a 
newborn, because major medical complications may occur, particularly in this 
age group. Complications can have an important impact on quality of life and 
even lead to death. It can not be the goal of renal replacement therapy to extend 
the suffering of a patient. However, also newborns have good chances for 
survival if the parents and the dialysis team are highly motivated and have a 
positive attitude towards dialysis treatment. Excellent results have been reported 
for peritoneal dialysis in children younger than two years [19-21]. Even renal 
transplantation is feasible in this age group, although a high mortality (about 
25%) has to be accepted [22-24]. 
Dialysis treatment in childhood should always be considered as a temporary 
measure to bridge the gap between end-stage renal disease and renal transplan-
tation. This period may be relatively long (several years) for a number of 
reasons: 
- shortage of donor kidneys [14] 
- technical problems with transplantation in infants and toddlers 
- presence of HLA-antibodies in some patients, especially after a previous 
transplantation. 
So-called pre-emptive transplantation also deserves attention. This is a trans-
plantation which is performed before end-stage renal disease has been reached, 
just before dialysis therapy needs to be started. Mostly, this form of transplanta-
tion is applied using a kidney donated by one of the parents. There is no 
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unanimous opinion whether it is desirable to promote this kind of transplanta-
tion. 
An important advantage of pre-emptive transplantation is that negative conse-
quences such as malnutrition, a decrease in growth, renal osteodystrophy, 
anaemia, hypertension, avitality, and long-term dialytic therapy, can be avoided. 
Psychosocial benefits for the patient and the family are: alleviation of the fear 
of death, of feelings of powerlessness, and of loss of control. Also the concept 
of body-image and self-esteem can improve because suffering from profound 
illness with concomitant physical symptoms, deterioration of school performan-
ce, cognitive impairment, and social isolation are prevented. Family life 
improves as well if dialysis treatment is not necessary: less frequent visits to the 
doctor and hospitalization resulting in less absenteeism from work and less 
financial strain, more equal care for the siblings, more time for leisure activities 
and holidays. 
A major disadvantage of pre-emptive transplantation is that, if the transplant 
fails, the patient and the family are inadequately prepared for dialysis treatment. 
No assessments will have been made of coping skills, motivation, and the 
support system [25]. 
It is commonly considered to be an injustice to put a patient on the waiting-
list for a pre-emptive transplantation, while there is still a shortage of donor 
kidneys. Therefore at most paediatric centres, a pre-emptive transplantation is 
only performed if there are strong medical or psychosocial indications or if a 
kidney is donated by a family member. 
2.4.1. Conservative treatment 
In the early phases of chronic renal insufficiency (renal function between 25 
and 50%) vitamin D metabolism will be impaired, necessitating the administra-
tion of active vitamin D metabolites to prevent renal osteodystrophy. 
With progression of renal disease, the patient's dietary protein intake will 
have to be restricted to prevent uraemic symptoms. Whereas in adult patients a 
protein intake of 0.6g/kg body weight/day can maintain adequate nutrition as 
well as neutral nitrogen balance, children require a higher protein intake. The 
theory that early protein restriction in the diet would conserve renal function for 
a longer period, has - although proven in the rat - not been confirmed in human 
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studies [26,27]. 
As a consequence of the relatively high protein intake in children with renal 
failure, especially in infants, hyperphosphataemia is a common finding. The 
administration of phosphate-binding agents such as Calciumcarbonate or 
Calciumacetate is therefore generally necessary. Aluminium-containing phos-
phate-binding agents were used in former days on a regular basis, but these are 
now avoided because of the risk of aluminium encephalopathy [28]. 
As renal function deteriorates, it is generally indicated to restrict potassium 
in the diet and to administer potassium-binding resins, such as calciumpoly-
styrenesulphonate. These drugs are very unpleasant to use, but sometimes pre-
treatment of drinks with these drugs can significantly lower the potassium con-
tent [29]. 
If diuresis decreases, dietary fluid restriction will be necessary. Sodium-
restriction is not generally required. In the case of acidosis, additional sodium 
bicarbonate must be administered. 
In summary, a child who is approaching end-stage renal disease will be 
treated with a complicated and very restrictive diet, as well as with a large 
number of medications, which impairs the quality of life considerably. 
Two methods of dialysis can be applied: haemodialysis and peritoneal 
dialysis. Generally, also dietary restrictions (potassium, protein, fluid) and a 
strict medication regimen are required with both treatment modalities. 
In the Netherlands chronic paediatric dialysis is always performed at one of 
the four paediatric dialysis centres which form part of a university hospital 
(Amsterdam, Nijmegen, Rotterdam, and Utrecht). 
2.4.2. Haemodialysis 
Intermittent chronic haemodialysis in childhood is performed thrice weekly for 
an average duration of 4 hours per session; it is always performed at a hospital. 
The blood is purified by an artificial dialyser, which is placed in a dialysis 
machine. The treatment is based on the principle of the filter properties of a 
semi-permeable membrane: the blood flows on one side of this membrane while 
dialysis fluid flows on the other side (Figure 2.2). 
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Figure 2.2. A diagram of a dialyser. The vertical arrows represent waste products 
diffusing, and water ultrafiltrating from blood. (From Gabriel R. 
A patient's guide to dialysis and transplantation. Dordrecht, Kluwer 
Academic Publishers, 1990. With permission). 
This dialysis fluid removes toxic metabolites by diffusion and excessive fluid 
from the body by ultrafiltration. Blood is circulated through the dialyser using a 
pump. The blood is obtained from an arteriovenous fistula (Figure 2.3), which 
is surgically created 6-8 weeks before dialysis is started. During this operation a 
connection is made between an artery and a superficial vein, generally in the 
forearm. For each dialysis session it is necessary to puncture this fistula with 
one or two needles. During dialysis and sometimes shortly afterwards, altera-
tions in fluid and electrolytes, as well as a rapid decrease in the blood urea 
concentration, may cause symptoms of low blood pressure, nausea, and head-
aches ("dialysis disequilibrium"). Recent developments in dialysis fluid compo-
sition (bicarbonate- instead of acetate-dialysis) have decreased the incidence of 
these complications. 
Contra-indications for haemodialysis generally have a medical-technical 
background. Especially in young children it may be difficult to create a suitable 
arteriovenous fistula, which allows sufficient blood flow. Psychosocial factors 
may also form contra-indications for haemodialysis: extreme fear of injections 
and needles, geographic distance between home and the dialysis centre, as well 
as the absence of specific teaching facilities (particularly for vocational training) 
at the hospital school. 
2.4.3. Peritoneal dialysis 
The technique of continuous ambulatory peritoneal dialysis (CAPD) was 
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artery 
supplying 
blood 
to hand 
(radial 
artery) 
Figure 2.3. A Cimino fistula. The hand receives an adequate amount of blood 
because another artery runs down the opposite side of the arm to the 
radial artery. From Gabriel R. A patient's guide to dialysis and trans­
plantation. Dordrecht, Kluwer Academic Publishers, 1990 (With permis­
sion). 
developed in the second half of the seventies and has been applied to children 
in the Netherlands since 1980 [30]. This treatment modality is particularly 
suitable for children under the age of six years. EDTA data over the period 
1980-1986 show a gradual increase in the application of С APD as a renal 
replacement therapy, but there are large regional differences between European 
countries [31]. Treatment is performed on an ambulatory basis i.e., the parents 
perform the treatment at home. If the child is old enough (12-14 yrs.), and has 
sufficient knowledge, self-reliance, and responsibility, he/she can perform the 
treatment him/herself. Not only chronological age, but also developmental and 
emotional maturity and stability are determining factors. 
The principle of peritoneal dialysis is based on the usage of the peritoneal 
membrane as a semi-permeable membrane. After a catheter is surgically 
inserted into the abdominal cavity, sterile dialysis fluid is infused. Because of 
the membrane properties of the peritoneum toxic metabolites are withdrawn 
from the peritoneal blood vessels into the dialysate. Excessive fluid can be 
removed from the body by increasing the osmolarity of the dialysis fluid. 
Osmolality can be increased by adding extra glucose to the dialysis fluid. 
The dialysate is exchanged four times a day; it drains by gravity (Figure 2.4). 
Because of an open connection with the abdominal cavity there is a risk of 
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Figure 2.4. Principle of CAPD-technique. From Khanna R, Nolph KD, Oreopoulos 
DG. The essentials of peritoneal dialysis. Dordrecht, Kluwer Academic 
Publishers, 1993. (With permission). 
bacterial contamination from outside. This can lead to one of the most feared 
complications of peritoneal dialysis: peritonitis. To prevent this complication, 
many efforts have been made to improve the safety of the exchange procedure. 
Innovations in the equipment have considerably reduced the incidence of 
peritonitis in recent years [32]. At the paediatric dialysis centre in Nijmegen 
exchanges are performed using the ultraviolet (UV) light method. During the 
exchange procedure, the connecting parts of the dialysis system are irradiated 
and sterilized by UV light [33-35]. Unfortunately, the semi-closed, so-called 
twin-bag system, is not suitable for paediatric patients [36]. 
It is common practice at Dutch paediatric centres that both parents (or other 
care-providers) are trained and prepared to perform the dialysis treatment in the 
home situation. They have to perform the dialysate exchange itself and properly 
record and interpret the fluid balance, body weight, and blood pressure. Perito-
neal dialysis patients have monthly check-ups at the hospital on an outpatient 
basis. 
There are other, "automated", forms of peritoneal dialysis. Continuous 
cycling peritoneal dialysis (CCPD), based on the same principle, is the most 
widely-applied method. Dialysis is not performed manually, but automatically 
by a machine (cycler), several times during the night. If the abdomen is left 
empty during the daytime, this method is called nightly intermittent peritoneal 
dialysis (NIPD), a preferred treatment modality in children. An important 
advantage is that the child has more freedom of movement during the daytime 
and theoretically will have better motor development. A disadvantage is that the 
dialysis equipment may produce alarms at night if the child is restless during 
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sleep. This can lead to sleeping disturbances in the child and/or parents. NIPD 
is particularly indicated in children with serious feeding complications, caused 
by the sensation of a filled abdomen and the high glucose content of the dialy­
sis fluid and in children with a limited ultrafiltration capacity [37]. 
For children, peritoneal dialysis has a number of medical and psychosocial 
advantages over haemodialysis. As peritoneal dialysis is a long-term process 
(i.e., 24 hours per day for С APD and CCPD, 8-12 hours at night for NIPD) 
body fluid composition and volume will change slowly and result in a near 
steady state. Children on peritoneal dialysis do not suffer from the disequili­
brium syndrome, as some children do during haemodialysis. The psychosocial 
advantages of peritoneal dialysis largely relate to less dependence on the hospi­
tal, better school attendance, continuity in the parent-child and family rela­
tionship, and less need for invasive procedures [38]. There are, however, 
obvious medical and psychosocial contra-indications for peritoneal dialysis, such 
as severe adhesions in the peritoneal cavity due to previous operative proce­
dures or infections, negative psychosocial circumstances like other diseases in 
the family, parental mental and/or emotional restrictions, and a pathological 
family structure (see Chapter 3). Furthermore, peritoneal dialysis may be contra-
indicated in adolescents, because of the risk of noncompliance and the risk of 
developing negative self-esteem because of the unsightly appearance of the 
catheter in the abdomen and a strong dependency on the parents (see Chapter 
3). 
The final choice between the two treatment modalities is generally made in 
close cooperation with the parents and the child. On January 1 1994, 20 chil­
dren (30.5%) below the age of 15 years were being treated with haemodialysis, 
and 41 (69.5%) with peritoneal dialysis in the Netherlands [39]. 
2.4.4. Renal transplantation 
Renal transplantation is the therapy of choice for patients with end-stage renal 
failure. All the physical signs of a disturbed renal function disappear after a 
successful transplantation. This is accompanied in most cases by psychosocial 
rehabilitation, predominantly with respect to motor and cognitive functioning 
[16,38,40,41]. 
Preparation for transplantation includes tissue typing. Data are collected by 
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the Eurotransplant Foundation (Leiden), which coordinates cadaveric transplan-
tation for a number of Western European countries. The large majority (over 
90%) of transplantations in the Netherlands are performed with kidneys obtain-
ed postmortally. Only a small proportion (8.4% in 1991 [14]) of transplantations 
are performed with a living donor kidney. In children, the living donor will 
mostly be one of the parents, because law prescribes a minimum donor age of 
18 years, so the sibs will generally be too young. Living donor transplantation 
is not promoted on a large scale in Western Europe. A parent-child transplanta-
tion can increase the vulnerability of a family with mostly young children. 
Psychological and ethical arguments may also impair a more positive attitude 
towards family transplantations. 
Psychological contraindications for (especially) a parent-child transplantation 
are a pathological family structure, e.g., serious marital conflicts or a symbiotic 
relationship between one of the parents and child. Also, psychological instabil-
ity or psychiatric illness of the donor are considered to be negative factors in 
the decision of using a kidney from a living donor. Unfavourable consequences 
of a living kidney donor include an increased pressure on the parent and child, 
and dependency between them. Problems can also arise if the transplant fails, 
and the removal of the graft is necessary. Irrealistic expectations and fantasies 
that the incorporation of a physical organ will result in the transfer of personal 
characteristics of the donor can form a psychological obstacle for a parent-child 
transplantation. Particularly in adolescents, strong identification with the donor 
may impair the development of autonomy which can be an unfavourable 
outcome [42]. 
Ethical conflicts can arise in consideration of the interests of the donor 
against those of the recipient. It is complicated to prevent moral or emotional 
pressure on the potential donor because any information given or even withheld 
is always selective and, moreover, is not always identical to previously received 
information. Wolff [42] has argued in favour of the obligation to inform 
families about all treatment modalities at an early stage, so that more time is 
available to reflect on donation. The physician has to respect the donor's dignity 
and autonomy in his/her decision. 
Experience has shown, that using a kidney from a living donor leads to better 
medical results than cadaveric transplantation [14,43]. Three-year graft survival 
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is 65% after cadaveric transplantation and 80% after living donor transplanta­
tion [11]. Moreover the majority of kidney donors and patients show satisfac­
tory physical and psychological rehabilitation and remain positive, even after 
transplant failure [42,44]. 
After renal transplantation, immunosuppressive medication is necessary to 
prevent rejection of the allograft. Nevertheless, rejection episodes arise fre­
quently, sometimes leading to loss of the allograft. In a large number of cases, 
hypertension occurs after renal transplantation; this may be difficult to regulate. 
Some renal diseases tend to recur in the allograft (e.g., focal glomerulosclero­
sis), and lead to graft loss. 
Most paediatric centres do not perform transplantation on infants for techni­
cal reasons, but prefer to postpone the transplantation until a minimum body 
size (generally 10-12 kg) has been reached. It is known that a young age of the 
recipient as well as a young age of the donor have negative influence on the 
transplantation results [45,46]. Surgical complications (thrombosis) occur more 
frequently. 
2.5. Specific non-psychological problems related to end-stage renal disease 
2.5.1. Growth Γ471 
Formerly, it had to be accepted that children with chronic renal failure (CRF) 
would suffer from (severe) growth retardation. Successful treatment of long­
standing end-stage renal disease (ESRD) led to an acceptable renal function 
after transplantation, but also resulted in small stature of most of our patients 
also in adulthood. In the early years of continuous ambulatory peritoneal 
dialysis (CAPD) there were a few optimistic reports about a better growth in 
children on CAPD than those on haemodialysis [48]. More recent studies, 
however, could not find any support for this optimism: growth was equally 
disappointing in both groups of patients [49]. Renal transplantation allowed 
subsequent normal growth, as long as the graft was functioning well, but catch­
up growth rarely occurred [50-53]. 
The severity of growth retardation depends on several factors. The most 
important is the age of onset of CRF. A child who develops renal failure at an 
older age will have had more opportunity for normal growth than a child who 
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has had renal failure from birth. 
Small adult stature is an important cause for concern in adolescents and 
young adults who have been treated for ESRD in childhood. Several studies 
have been performed on the outcome of treatment for ESRD in children [54-
56]. Items that rank high in papers on psychosocial aspects of this treatment are 
unemployment, dependence on others, fear of graft loss, fear of cancer, sexual 
problems, and small stature. Concern about height was reported with average 
frequency among these items. It should be emphasized, however, that these 
studies were performed on the whole group of persons, regardless of the sever-
ity of growth retardation. In this context it is more worthwhile to refer to the 
numerous studies on adult patients with growth hormone deficiency, which have 
indicated that it is a great concern to be too short. These people had low scores 
for positive well-being and high scores for anxiety and depressed mood. They 
felt socially isolated, slept poorly, and had difficulty with physical mobility. The 
group was also characterized by having few hobbies, an impaired sex life, high 
unemployment, and a tendency to live at home with their parents [57]. 
For a few years it has been possible to treat growth-retarded children with 
ESRD with rhGH. Growth hormone is not new as a medication. Growth 
hormone deficiency, mentioned above, is a well-known disease entity in 
paediatrics. Children with this deficiency have been treated successfully with 
human growth hormone which was extracted in small amounts from human 
hypophyses at obduction. Using modem DNA techniques it is now possible to 
produce recombinant human growth hormone - rhGH - in relatively large 
quantities. It has proven to be effective not only in growth hormone deficient 
children, but also in normal children and in children suffering from Turner 
syndrome. In normal small children, a growth velocity increase of up to 4 times 
that in a control group was observed [58]. This means that the growth rate of 
children with normal endogenous growth hormone production can be stimulated 
by the administration of additional growth hormone. As this became evident, it 
was clear that a therapeutic effect was likely in children with renal failure. 
Presently, studies on the effects of rhGH on children in all stages of renal 
failure are in progress in many hospitals. In children in the pre-dialysis phase it 
has been found that mean growth velocity increased from 5.0 to 8.5 cm per 
year in the first year of treatment and remained that high in the second and 
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Table 2.2. Influence of treatment with recombinant human growth hormone in 9 
children with chronic renal failure (pre-dialysis) [59]. 
mean 
SD 
Growth velocity (cm/year) 
before 
treatment 
5.0 
1.4 
after 
1 year 
8.5 
1.3 
after 
2 years 
8.2 
1.6 
after 
3 years 
8.1 
1.8 
third years of the study (Table 2.2) [59]. 
In children treated with dialysis, a 3-4 fold increase in growth velocity was 
observed during the treatment period [60]. Finally, in transplanted children who 
had acceptable graft function but nevertheless poor growth, growth velocity 
doubled in the year of therapy (Table 2.3) [61]. 
These data show clearly that the results of rhGH therapy in ESRD are very 
encouraging. Although the results of treatment have not yet been recorded over 
a very long period, it should be emphasized that every centimetre won is of 
great importance to the patients, with a potentially great impact on their (future) 
psychosocial functioning. 
2.5.2. Anaemia [47] 
Anaemia is a common complication of end-stage renal disease. It is mainly 
caused by a deficiency of erythropoietin (EPO), a hormone stimulating red 
blood cell formation, and which is produced by the normal kidney. Until 
recently, frequent blood transfusions were common practice at all dialysis units. 
The development of recombinant DNA techniques has enabled the production 
of biosynthetic erythropoietin on a large scale. Nowadays, all patients with renal 
anaemia in the Netherlands are treated with erythropoietin. 
A number of excellent reviews have been published on the positive therapeu-
tic effects and the side-effects of EPO [59-64]. It is generally known that EPO 
is the optimal treatment for renal anaemia in all patients with CRF, by improv-
ing their general condition and well-being. Most of the side-effects, such as 
hypertension and thrombosis of the arteriovenous fistula, are directly related to 
this therapeutic effect. 
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Table 2.3. Influence of treatment with recombinant human growth hormone in 9 
children after renal transplantation [61]. 
mean 
SD 
Growth velocity (cm/year) 
before 
treatment 
2.5 
2.1 
after 
1 year 
5.7 
2.7 
A major disadvantage of this drug is the fact that it has to be administered by 
the parenteral route. Subcutaneous and intravenous application are the best 
known; subcutaneous administration has proven to be the most cost-effective, 
which is important, because EPO is a very expensive drug. To children, 
especially the younger ones, these modes of administration are unattractive. The 
threat of a needle can cause considerable distress in these children and lead to 
conflicts between the patient and the person who has to administer the drug. In 
CAPD patients parents generally perform the treatment, which may cause 
unacceptable situations. Therefore, other modalities to administer EPO to 
children have been evaluated. In those treated with haemodialysis intravenous 
application three times a week at the end of dialysis is the preferred method, 
although a somewhat higher (approximately 25%) dose is required. In children 
treated with CAPD, we studied the resorption of EPO from the peritoneal cavity 
[65]. Until now over 30 CAPD patients have been treated with EPO intraper-
itoneally. Similar therapeutic effects were observed as those obtained with intra-
venous or subcutaneous administration. The dosage, however, was about 25-
50% higher than that needed for subcutaneous application, which was a real 
disadvantage cost-wise. Nevertheless, the reduction in family stress and the 
prevention of bum-out outweigh the higher cost, in our opinion. Intraperitoneal 
administration does not necessarily lead to a higher frequency of peritonitis if 
the parents are trained carefully [66]. 
Some large multi-centre studies have been performed, in which the quality of 
life was measured in large groups of adult patients using multiple scoring 
systems [67,68]. Patients treated with EPO had significantly higher scores than 
those not treated with EPO in all categories. Using treadmill studies, EPO 
improved the exercise tolerance of both adults and children [69,70]. An impor-
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tant improvement of quality of life has been reported [71]. The results with 
respect to the cognitive functioning are more conflicting. In a group of adult 
haemodialysis patients intelligence test scores improved by about 10 points after 
treatment with EPO [72-74]. In one study on children, correction of anaemia 
with EPO was also associated with an improvement in cognitive performance 
[75]; in our own patient group, however, we did not observe any significant 
improvement (Chapter 5; this dissertation). 
2.5.3. Renal osteodystrophy 
Bone abnormalities in renal osteodystrophy are determined by hyperparathy-
roidism and disturbed bone mineralization [76-78]. In advanced renal failure, 
phosphate retention occurs due to a decrease in phosphate excretion. This 
phenomenon leads to hypocalcaemia, which in tum may cause hyperparathy-
roidism. The kidney also plays an important role in the activation of vitamin D. 
In renal failure, activation is impaired. If this condition is not treated, clinical 
signs of osteodystrophy will appear. Major symptoms are bone pain and 
fractures, but extra-osseous calcifications, muscle weakness, and pruritus may 
also occur. In children, skeletal deformities and growth disturbances are promi-
nent. 
Therapy is based on the lowering of the blood phosphate concentration and 
the administration of sufficient amounts of active vitamin D metabolites. Blood 
phosphate concentration can be lowered by administration of phosphate binding 
agents orally. Nowadays, mostly calcium salts such as Calciumcarbonate or 
Calciumacetate are prescribed. These drugs did not become available until a few 
years ago. Prior to this, phosphate was bound in the gut by aluminium salts, but 
major absorption of aluminium often gave rise to aluminium encephalopathy. 
Nowadays, compounds containing aluminium have almost completely been 
abandoned. 
The combined use of calcium containing phosphate binding agents and active 
vitamin D metabolites has meant that severe renal osteodystrophy is seldom 
encountered in modern dialysis clinics. Only in rare cases autonomous therapy-
resistant hyperparathyroidism occurs, requiring surgical treatment (parathyroi-
dectomy) [79,80]. 
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Chapter 3 
PSYCHOLOGICAL ASPECTS OF CHRONIC 
RENAL FAILURE IN CHILDREN 
3.1. Implications of a chronic disease for the child and the family 
A child is more vulnerable to the physical, psychological, and social consequen-
ces of a chronic disease than an adult, since a child is in development and 
dependant on adults in material, emotional, and social respects. The family in 
which a child grows up plays a central role, and as Eiser [1] put it, chronic 
disease in a child is a diagnosis that affects and influences the whole family. 
Optimal development requires accomplishing age-specific developmental tasks 
within a safe and stable upbringing climate [2,3]. Long-term physical limitations 
and psychological burden resulting from chronic disease can cause stagnation or 
retardation in development and have negative influences on completing develop-
mental tasks [4-7]. 
Over the past twenty-five years, many studies have been performed on the 
relationship between chronic disease or physical handicap and psychopathology 
in the child or family. The results vary strongly and depend on the nature, 
stage, and severity of the disease [8-12]. For example, in children with asthma, 
diabetes, epilepsy, and cystic fibrosis, a high percentage of psychological 
problems were detected, also in the parents, particularly if the child was 
mentally retarded or had a cerebral dysfunction [8,13-15]. Other studies, 
however, conducted on children with cystic fibrosis, could not demonstrate an 
increased risk of psychological disturbances [16,17]. Stein and Jessop [18] 
stated that psychological adaptation is determined just as much by demographic 
factors as by disease-specific factors. 
A growing number of reports, mainly published over the past ten years, have 
indicated that a chronic disease can have a positive and growth-stimulating 
influence on the child and his/her family [19-24]. If the demands made by the 
chronic disease can be met, and the problems associated with the disease can be 
overcome, then this can enhance the self-respect, self-esteem, and mutual 
solidarity of the child and other family members. 
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Table 3.1. Factors that determine how and to what extent the disease interferes with 
development and family functioning. 
Disease-specific factors 
Intrapersonal factors 
Environmental factors 
- severity, chronicity, life-threatening character 
- demands, limitations resulting from the disease 
- abnormal appearance, iatrogenic effects 
- past medical history 
- age, developmental level of the child 
- socio-adaptive capacities 
- personality characteristics 
- attitude, coping behaviour of the parents 
- social support 
- other factors that form a burden 
- brothers and sisters 
Therefore the question remains: what factors, besides the disease, are (jointly) 
responsible for the problems, and how can these problems be prevented? [25]. 
Variables that determine how and to what extent the disease interferes with 
development and family functioning, can be divided into three categories 
[1,26,27] (Table 3.1). 
Disease-specific factors, such as the severity of the disease, the chronicity, 
and prognosis are of great importance in the adaptation process: whether or not 
the disease has a life-threatening character, uncertainty about the course of the 
disease, and whether or not the disease has a congenital origin [12,18-23,28,29]. 
Other specific consequences that also play a role include the limitations caused 
by the disease, the demands made by the treatment, possible iatrogenic effects, 
and the visibility of the disease [1,23,24,27]. The medical anamnesis in terms of 
frequency and duration of hospitalization is also of importance [29,30]. 
Intrapersonal factors include the age of the child and his/her developmental 
level, the age at which the diagnosis was made, the intellectual and social-
adaptive capacities of the child, and personality characteristics. 
Environmental factors also determine the way in which a chronic disease 
influences the development of a child. In the literature, besides the well-known 
factors such as the socio-economic status of the family, the educational level of 
the parents, family structure, the geographical living situation [29], a number of 
other relevant variables are also mentioned [1,20,23,24,26,27,30]. 
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Attitude of the parents 
The attitude of the parents, the way in which they accept and cope with the 
disease, to a large extent determines the upbringing behaviour and consequently 
the interaction between the parents and child [27]. This attitude can vary from a 
positive accepting, over-involved, indulgent, and over-protective attitude at one 
end of the scale, to a negative, hostile, rejecting attitude at the other end of the 
scale [1,31]. In general, an over-protective attitude of the parents is considered 
to be a risk factor with regard to optimal development. However, recent 
research by Veldhuizen & Meyer has shown that an over-protective upbringing 
attitude, as long as it is combined with warmth and care, can have a positive 
and protective effect on the emotional adaptation of children with cancer in 
certain stressful phases of the disease [32]. 
Social support 
Another important environmental factor is the extent to which social support is 
available and accepted [23,33-36]. The quality of the medical and psychological 
care forms an essential part of the support, not only in a practical and informa-
tive respect, but also in an emotional one [23,24,35,37-39]. Parents, but in 
particular the mothers of children with a severe illness, often feel socially 
isolated because friends and family are unable to understand the full extent of 
the burden and consequences of the illness. A study by Morrow et al. [36] 
showed that support and understanding from professionals - particularly from 
the treating physician - offer compensation for feelings of loneliness and 
isolation. 
Other factors which affect the burden 
Besides a chronic disease of a child, other pre-existing factors in a family can 
influence the development of a child. Serious life events, such as illness and 
bereavement among other (close) family members, dismissal and unemploy-
ment, financial problems, serious relational problems and divorce, determine the 
weight of the burden that a family can carry and its flexibility. 
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Brothers and sisters 
The role of brothers and sisters in a family with a sick child deserves special 
attention. Brothers and sisters of a sick child often miss actual and emotional 
care from their parents, but also from grandparents and other family members. 
Parents, particularly mothers, mention that they often have the feeling that they 
give inadequate attention and love to their healthy children; school and behav-
ioural problems can be attributed to this. Data in the literature on this subject 
are not univocal. A number of authors observed an increased risk of learning, 
emotional, and behavioural problems [40-43], while others found that healthy 
brothers and sisters were functioning reasonably well [17,24,44,45]. Brothers, 
particularly younger brothers, were found to be more vulnerable to behavioural 
disturbances than sisters [24,44,45]. Moreover, it is of importance whether the 
illness is visible externally: people often react differently to a "visibly" sick 
child than to healthy brothers and sisters. In addition, more emotional problems, 
such as feelings of guilt and suicidal fantasies, have been observed in the 
brothers and sisters of children with a life-threatening disease [1,27]. In younger 
children, extreme feelings of jealousy and over-demanding behaviour can be 
displayed [40], while in older children over-adaptation or withdrawal can 
indicate the wish to spare and protect the parents from any further distress [46]. 
Research has also shown that siblings not only suffer from or react to receiving 
inadequate attention from their parents, but also suffer from or react to the 
sometimes disrupting, demanding, and dominant behaviour of their sick brother 
or sister [40]. 
Before dealing with the specific consequences of chronic renal failure in the 
next section, this paragraph will summarize the problems which can arise (also 
on the grounds of the above-mentioned risk factors) in a chronically sick child 
and in its family [1,6,7,9,11,13,20,24-27,30,36-38,40,41,47]. Most frequently 
discussed in the literature are: 
- Disorders or retardation in psychomotor and cognitive development resulting 
directly from the effects of the disease (e.g., cerebral disorders), the limita-
tions these impose (e.g., pain, physical, or sensory handicaps), and the treat-
ment (e.g., side-effects of medication) [48]; 
- Learning and school problems as a secondary effect of cognitive defects, 
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concentration, and tempo problems, lack of vitality, school absenteeism; 
- Emotional problems resulting from anxiety and uncertainty about mutilating 
interventions, death and the effects of medication, admissions to hospital and 
frequent separation from the parents; 
- Social problems resulting from feelings of isolation, not being able to join in, 
having a different appearance and inferiority complex; 
- Behavioural problems resulting from pedagogical deprivation, over-indulgence, 
and over-protection; 
- Specifically in the adolescent phase: problems with coping and accepting an 
abnormal appearance, worries about the longterm perspectives, being accepted 
by peers and difficulties starting relationships and friendships, acquiring 
independence and autonomy, doubts about school and career choice, problems 
with intimacy and sexuality [24]; 
- Family problems resulting from fixation on the disease and the extra burden 
imposed by the treatment, manifesting itself in: tension and conflicts between 
the parents, social isolation, limitation of leisure-time activities and relaxation, 
extra financial burden, problems at work owing to hospital visits, check-ups, 
problems with the healthy brothers and sisters and worries about the future of 
the sick child. If the child has a life-threatening disease, anxiety about losing 
the child and anticipated grief can put heavy pressure on the parents [28,29-
49]. 
3.2. Specific consequences of chronic renal failure on the psychosocial 
functioning of the child 
3.2.1. Neurological, motor, and cognitive development 
In 1986, Biasioli et al. [50] published an overview of the neurological compli-
cations of uraemia by listing the clinical symptoms, the difficulties involved 
with various diagnosis techniques and the pathophysiology of uraemic encepha-
lopathy. The article is based on studies performed since the early nineteen 
sixties on adult patients with progressive renal failure [51-53]. Even in the very 
early stages of renal insufficiency, there can be changes in mental functions, the 
level of consciousness, and hormone balance, as well as neurological and motor 
disturbances. Various diagnostic techniques can be used to evaluate uraemic 
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encephalopathy and its consequences: EEG, evoked potentials, neuropsycholog-
ical tests, cerebrospinal fluid (CSF) examination, brain density (CT) scanning, 
and nuclear magnetic resonance (NMR). 
Cerebral maturation occurs mainly in the first twelve months of life. 
Therefore children with congenital renal failure are vulnerable to the 
consequences of uraemic toxicity. Rotundo et al. [55] published alarming results 
on 23 infants with renal disease up to the age of one year. In 20 out of the 23 
cases, serious neurological abnormalities were found, which manifested 
themselves in developmental retardation, microcephaly, hypotonia, convulsions, 
dyskinesia, and EEG abnormalities. None of the children were on dialysis 
treatment. It should be mentioned that this was a retrospective study, so it is 
possible that infants with less severe anomalies had been excluded from the 
sample. One year later, Schnaper et al. [56] published a study on 15 children 
with ESRD; using CT scanning, 8 of them were found to have cerebral cortical 
atrophy and 2 ventricular dilatation. The age of these patients ranged between 
3.5 and 20 years. A multifactorial explanation was given for the findings: high 
doses of steroids combined with specific biochemical and hormonal 
abnormalities resulting from uraemia, as well as the duration of haemodialysis 
(HD). In 1985 another report was published by McGraw et al. [57] on the 
neurological, motor, and cognitive development of 12 children who had been 
suffering from severe renal failure since infancy. These children were found to 
have neurological abnormalities: 7 of them had first been on dialysis and later 
received a kidney transplant; 9 of them had convulsions, and 8 had mild to 
moderate cortical atrophy. Eight out of the 10 children showed a retarded fine 
motor and cognitive development; in 5 cases retardation was reported to be 
mild. Improvement after the start of renal-replacement therapy 
(dialysis/transplantation) was only seen in one of these patients. The authors 
also gave a multifactorial explanation for their findings: long-term hospital-
ization, sensory deprivation, malnutrition, in some cases renal osteodystrophy 
resulting from hyperparathyroidism and the use of aluminium containing 
phosphate binders. However, in young patients with other serious abnormalities, 
such as congenital cardiac malfunction or malabsorption disturbances, who also 
had a history of malnutrition and frequent admissions to hospital, no irreversible 
motor or mental retardation was observed. Therefore, particularly the toxic 
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effects of uraemia during the first 12 months of life seem to have a decisive 
influence on both motor and cognitive development. Some authors have drawn 
attention to abnormal plasma amino acid concentrations in patients with uraemia 
[50,58] which can influence the development of the CNS. These notions are 
shared by a number of other authors who published studies on infants with 
severe renal insufficiency during the same period [58-62]. However, the study 
designs were heterogeneous with regard to selection and the number of patients, 
the clinical condition, the severity of renal disease, medication, and diagnostic 
techniques. Consequently, Geary et al. [63] performed a prospective longitudinal 
study on a fairly large group of patients (n=33) who had been suffering from 
mild to severe renal failure since infancy (GFR 31 ± 29ml/min/1.73m2). 
Seventeen young patients developed ESRD during the course of the study. At 
the last measurement, 10 children had mild to moderate developmental 
retardation; 7 of them had ESRD. Of the 16 children with moderate renal 
function, only three were mildly retarded. The conclusion drawn from this study 
and from the studies by Kleinknecht et al. [64] and Elzouki et al. [65] was that 
the developmental chances of children who had been suffering from chronic 
renal failure (CRF) since infancy were more favourable than had been reported 
previously. This was thought to be the result of changed insights regarding 
treatment, discontinuation of the use of aluminium containing phosphate binders 
and a stringent, aggressive regimen (by means of tube feeding) to improve 
nutritional state. 
This conclusion led to accentuated controversy about the optimal time for 
kidney transplantation. To prevent the negative toxic effects of renal failure 
during the critical period of cerebral maturation, a number of (mainly Ameri-
can) authors argued in favour of performing a kidney transplant at a very young 
age with, if possible, a kidney from a living donor [55,66-69]. A more reluctant 
policy was recommended by authors of the opinion that it is justified to 
postpone transplantation until the child is older owing to the increased risk of 
technical complications during renal transplantation in infants, improvements in 
treatment techniques, and a more favourable developmental prognosis [58,63-
66,70-72]. 
Therefore the question remains - a question which dominates recent litera-
ture -: can developmental disorders resulting from chronic renal failure be pre-
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vented and what are the determining factors? Although a few authors have 
suggested that starting dialysis at an early stage can contribute to the optimal 
growth and development of young children, little is known about the conse-
quences of this policy on the ultimate developmental course [72,73]. Moreover, 
it has not always been possible to demonstrate a direct relationship between 
changes in biochemical parameters, such as creatinine clearance and blood urea 
nitrogen (BUN), and developmental parameters [63,74,75]. In addition, children 
with existing CNS disturbances were excluded from some samples, while it was 
not always clear whether or not these disturbances had been caused by chronic 
renal failure [63,69]. And finally, no longitudinal data are available on the 
effects of treatment modalities [62,63,69]. 
The effects of the dialysis modality and transplantation 
Little research has been conducted into the effects of the dialysis modality on 
the cognitive function of children. CAPD/CCPD appear to be more favourable 
for young as well as older children than HD [62,76-78]. These findings have 
been confirmed in studies on adolescents and adults [79-81]. The explanation 
for the improvement in cognitive performance particularly in the fields of 
attention, vigilance, and rate of information processing, can partly be found in 
the so-called dialysis disequilibrium that does occur during HD but not during 
PD. 
After successful transplantation, various publications have reported consider-
able improvement in growth, development, physical well-being, quality of life, 
and cognitive functioning [66,70,74,82-85]. There appears to be a certain 
amount of "catching up" of cognitive development, particularly on a number of 
non-verbal skills that can be measured using so-called performal subtests of an 
intelligence test [74,82,83]. Interesting results were published by Davis et al. 
[69] and Fennell et al. [83] who showed that the increase in IQ and intelligence 
profile after transplantation was significantly correlated with the IQ and profile 
before transplantation. In addition, children who still demonstrated mental 
retardation after transplantation had been suffering from CRF since birth. 
Rasbury et al. [74] therefore concluded that CRF during infancy reduces the 
cognitive potential significantly and permanently. In a longitudinal study, 
Fennell et al. [83] observed that one month after transplantation there was a 
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significant improvement in IQ, but this effect had disappeared one year later. It 
was concluded that the effect of ESRD on cognitive functioning could not be 
compensated for by a transplantation, but further deterioration was prevented. 
This discussion is interesting in the light of conflicting findings regarding the 
cognitive status of older children with CRF in general and of young dialysis 
patients in particular. Various studies have demonstrated that the cognitive 
performance of children with ESRD was not significantly different from that of 
healthy children [86-88], whereas other studies have reported that a number of 
cognitive functions were affected. The latter included poorer problem-solving 
capacity, arithmetic, memory, concentration, verbal reasoning, and visual-motor 
coordination [74,83,89,90]. In these non-transplanted patients, once again those 
who had been suffering from CRF since birth were the most vulnerable. 
Generally, factors such as socio-economic status, primary renal disease, and the 
effects of chronic illness, were found to be of little importance [86,88,89,91]. 
In a recent longitudinal and carefully executed neuropsychological study, 
Fennell et al. postulated that as opposed to the case in adults, the consequences 
of CRF are not so-called state-like effects (i.e., dependent on the state of the 
patient) and thus reversible, but that young children with ESRD have a predis-
position towards permanent CNS dysfunction [86,92]. According to Fennell et 
al. [92] state-like effects can be defined as direct effects of renal function on 
test performance (c.q. cognitive tasks). In other words, after the start of dialysis 
treatment or after a transplantation, the scores obtained by patients with ESRD 
on neuropsychological tests improve because of the reduction in uraemic 
toxicity. These state-like effects could not be demonstrated using global 
intelligence tests [75], contrary to the results of more refined neuropsychologi-
cal methods. 
Although in most studies, if not all, conducted over the past 10 years, the 
emphasis was focused on possible cognitive defects in children with CRF, it 
ultimately appeared that the majority of these patients were functioning on a 
normal cognitive level. This can be derived indirectly from a number of follow-
up studies conducted over the past few years on adolescents and young adults 
who had been on dialysis or had undergone transplantation in childhood 
[79,93,94]. A considerable percentage of these patients had completed primary, 
and a minor percentage secondary, education. The educational outcome of the 
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patients with a successful transplant was more favourable than that of the 
patients on dialysis. In a next paragraph the long-term effects of CRF will be 
discussed extensively. 
Summarizing 
The neurological, motor, and cognitive development of young children who had 
renal insufficiency in infancy has found to be more retarded than that of 
children with other chronic diseases [55-62]. A distinction should be made 
between children with ESRD (who need RRT) and children with less serious 
renal failure who can be treated conservatively. The latter group has a better 
developmental perspective [63,64]. Although the detrimental influence of 
uraemic neurotoxicity on the development of the maturing CNS is recognised as 
being the most important determining factor, other factors also appear to exert 
an influence: nutritional state, negative effects of anaemia, phosphate binders 
containing aluminium, hyperparathyroidism, long-term hospitalization, and 
psychosocial factors [57,63-65,95]. 
There is no consensus about the reversibility of developmental disturbances. 
According to some authors [66-68] (primary) transplantation in infancy will 
prevent mental retardation in the long-term. Other studies have demonstrated 
that even after transplantation, developmental disturbances, and mental retarda-
tion were irreversible in children who had been suffering from ESRD since 
infancy [55,58-63,83,92]. 
The effects of CRF on the cognitive functioning of older children generally 
seem to be less negative and even reversible after transplantation [74,82,83,86-
88]. Specific problems can occur, particularly in HD patients on tasks related to 
attention, concentration, problem-solving capacity, short-term auditory memory, 
and visual-motor coordination. The implications for on psychosocial adaptation 
are discussed in the next paragraphs. 
3.2.2. Psychological adaptation of children and adolescents on dialysis treat-
ment and after transplantation 
The way in which children and adolescents adapt themselves psychologically 
and socially to chronic renal disease chiefly depends on a number of non-
disease-specific factors, such as age, developmental phase, personality, and 
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family variables, as was mentioned above. In addition, a number of factors 
specifically related to renal disease play a role in the adaptation process. 
A child with renal disease, who requires dialysis and transplantation, is 
confronted with acute phases in the disease which are associated with invasive 
interventions, hospitalization, stress, pain, and great uncertainty. These phases 
alternate with periods of comparative rest and stability. This has implications 
for the evaluation of the psychological adaptation of young kidney patients 
[8,15]. Study results can be seriously distorted if insufficient attention is paid to 
the phase of disease or treatment of an individual patient. Over the past few 
years, there has been growing interest in the long-term consequences of dialysis 
and transplantation in childhood [79,93,94,96]. 
A characteristic of chronic renal disease even after a successful transplanta-
tion, is the life-long dependence on medical check-ups, medication associated 
with anxiety and uncertainty about possible rejection of the kidney. 
Although the mortality rate of kidney patients is higher than that associated 
with a number of other chronic diseases, the life-threatening character of the 
disease has gradually been losing significance over the past twenty years. 
However, not only older patients, but also younger ones are aware of life-long 
dependence on dialysis or on a well-functioning transplant [1,87]. Nevertheless, 
despite the drastic medical treatment, the majority of young kidney patients 
adapt reasonably well psychosocial^ and do not distinguish themselves from 
children with other chronic diseases [91,97-99]. Severe psychological problems 
and psychopathology, which occur during the acute phase of the disease, are 
generally reversible [8,97]. However, this global conclusion does require some 
amount of nuancing. 
A number of factors can have a negative influence on ultimate psychosocial 
rehabilitation, such as dialysis treatment during early childhood, the duration of 
the disease, the complexity of the medical history, as well as the above-men-
tioned factors, such as lack of social support, premorbid personality problems, 
and negative family circumstances [98,100]. Moreover, adolescence has proven 
to be a critical period [91,97,100]. In addition there has also been increasing 
interest in the influence of the treatment modality (HD-CAPD) and transplanta-
tion. Research has shown that kidney transplantation is the most favourable 
mode of treatment also in relation to psychosocial adaptation [70,79,93,97-102]. 
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Not only the patients' physical condition improves after transplantation, but also 
self-confidence, social contacts, and mood. However, Reynolds et al. [97] 
reported an increase in slight behavioural problems after transplantation. They 
attributed this to the need for a patient to learn to deal with the transition from 
being ill to a situation of being healthy. 
In the more recent literature, CAPD treatment has taken preference over HD 
treatment. PD patients showed more self-confidence [99], were more socially 
competent, had fewer practical problems with the treatment, had lower depres-
sion scores and displayed fewer behavioural disorders [84]. A major explanation 
for this is the fact that with CAPD, the patient makes a more active contribu-
tion, has more control and command (internal locus of control) of the treatment 
and consequently of the disease process, which, in general, is considered to be a 
positive factor for adequate coping behaviour [84,99]. Although no systematic 
research has been conducted, there is some clinical evidence that HD takes 
preference for adolescents: physical growth and psycho-sexual maturation can 
interfere with a negative body image resulting from the abdominal CAPD 
catheter which is sometimes regarded as mutilating to the appearance, as well as 
the feeling of being "too fat" because of the dialysis fluid in the abdomen [103]. 
Comparative studies on adults, on the contrary, have generally shown positive 
results with regard to the psychological well-being of CAPD patients in 
comparison with HD patients [80]. 
A number of authors have shown greater reservation regarding the psycho-
social adaptation of chronic kidney patients and have argued in favour of 
structural psychosocial counselling, even after successful transplantation, to 
prevent social dysfunctioning and the onset of mental disorders [101,104-107]. 
Garralda et al. [8] concluded that the children with more severe renal failure (on 
HD) tended to have more psychiatric disturbance than the children who had 
been treated conservatively. 
The combined ill group (HD and non-dialysis patients) showed disorders in 
23% of the cases against 13% in the healthy controls. Korsch et al. [85] also 
found a comparable percentage of emotional problems and psychopathology 
(22%) in children who had been on HD or had undergone transplantation. 
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Table 3.2. Renal-disease-specific factors that influence psychosocial adaptation. 
- feeding and nutritional problems during infancy 
- tiredness, lack of vitality 
- diet, medication, fluid restriction 
- abnormal appearance, growth retardation, retarded sexual maturation 
- frequent and/or long-term hospitalization 
- invasive interventions, frequent (vena) puncture 
- unsuccessful transplantation 
Table 3.2 gives an overview of the specific factors of renal disease which can 
influence psychosocial adaptation. These effects are described separately below. 
Nutritional problems 
Nutritional problems in infants with congenital renal anomalies are caused by 
metabolic disturbances, the strict diet, lack of vitality, lack of "normal" taste 
patterns, not feeling hungry, nausea from the urea and, if CAPD is being 
applied, the continuous impression of "feeling full" owing to the dialysis fluid 
in the abdomen. Gastro-oesophageal reflux is a frequent complaint in CAPD 
patients [108]. The result is often refusal of food, vomiting, and consequently, 
malnutrition. This together with the possible need for naso-gastric tube feeding, 
can lead to so many aversion stimuli in relation to food that serious and 
sometimes permanent eating disorders arise. Another serious consequence is that 
the mother-child interaction can be charged with so much tension that the 
formation of biological regulation, basic safety, and an effective bonding 
relationship, essential to accomplishing developmental tasks in the first few 
years of life, are difficult or impossible [109,110]. 
Effects of tiredness and lack of vitality 
The physical complaints associated with chronic renal failure, such as tiredness, 
lack of appetite, lack of vitality, and general malaise, differ strongly in severity 
and duration from one patient to another. Tiredness is very common in HD 
patients, especially after dialysis. This can have serious effects on development 
and behaviour, such as decreasing or completely suppressing an infant's or pre-
school child's initiative to explore and experiment in his/her environment. The 
result will be stagnation in cognitive development, impairment of the child's 
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growth to independence, and disruption of contact with other children 
[110,111]. In children of school age and during adolescence, particularly aspects 
such as education, identity formation, and social contact with children of the 
same age, weigh heavily. Not only more frequent absenteeism from school, but 
also defects in cognitive functions, such as attention, concentration, and memory 
in dialysis patients, can cause problems at school [76,89,92,112]. Although there 
are hospital schools in the Netherlands which can partly compensate for regular 
absenteeism, studies have shown that dialysis patients cannot always keep up 
with the tempo of classmates (93,112). 
School problems often lead to social problems. Through the lack of vitality 
and regular absenteeism from school, it will be difficult to develop social skills 
and experiment with them. Moreover, owing to their specific circumstances, i.e., 
learning to cope with uncertainty, illness, limitations, and painful interventions, 
young kidney patients appear to be more emotionally mature than their peers, 
but on the other hand this can also form the reason why they have difficulty 
making adequate contact. 
Diet, medication, fluid restriction, and compliance 
A strict diet with low protein and low potassium (e.g., no or very small quanti-
ties of dairy products, meat, meat products, bread, fruit, vegetables, crisps, 
chocolate, etc.) isolates both younger and older ESRD children from daily 
social reality: they form an exception in the family, at school and at birthday 
parties. Large quantities of various types of medication in addition to strict fluid 
limitation (in some cases 1 litre or less per day) have sometimes been found to 
lead to serious ritual and obsessive behaviour. Irreversible compulsive, neurotic 
disturbances can result from very long-term dialysis. 
Compliance with the prescribed regimen has been a frequent study subject 
among children and adults with ESRD. Korsch & Fine [113] reported that non-
compliance, particularly with taking immune-suppressive agents after transplan-
tation, is an important causative factor of morbidity and mortality. This finding 
could not be confirmed by other authors, but in an overview paper, Wolcott et 
al. [114] mentioned a non-compliance rate of between 20% and 78% in adult 
HD patients. Psychological variables chiefly determine non-compliance. These 
include lack of knowledge and understanding of the purpose and effect of the 
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various types of medication, negative family factors such as lack of support, 
poor doctor-patient relationship, an external locus of control, low frustration 
tolerance, anxiety about side-effects and changes in physical appearance, 
depression, or anger/hostility regarding the illness and problems with coping 
after a failed transplant [114,115]. Reichwald-Klugger et al. [105] concluded 
that the main cause of non-compliance was the double controversial role of the 
parents. They are responsible for the child's upbringing and the continuity of 
the dialysis treatment, which can be conflicting for both the parent and the 
child, particularly if there is strict fluid limitation. A recent study on 32 
transplanted children aged between 6 and 21 years, focused on the influence of 
social support and family factors on compliance [99]. The conclusion was that 
no clear relation was found with parental support or family factors. The authors 
could not confirm the notion that adolescents are more at risk for non-complian-
ce [113,114]. However, from the point of view of developmental theories, it is 
obvious that adolescents are likely to display more non-compliance behaviour, 
because they are at the stage of experimenting with limits in a tension field of 
dependence-independence and oriented towards body image and physical 
appearance. Wolff [116] justifiably focused attention on the paradox of expec-
ting even a child with CRF to develop as normally and psychologically autono-
mously as possible, while at the same time demanding that the child - as a 
patient - behaves with as much compliance as possible. This dilemma should 
not only form a problem for the child and parents, but also for the health care 
workers treating the patient. 
In the case of non-compliance, particularly in adolescents, it is important to 
evaluate whether this is due to "normal" adolescent behaviour: protest against 
having to obey rules, overstepping margins, or whether non-compliance is a 
symptom of underlying psychological problems: of (masked) depression to the 
conscious or unconscious wish to commit suicide. 
Abnormal physical appearance, growth retardation (short stature), and retarded 
sexual maturation 
Sooner or later, all children with renal disease will be confronted by temporary 
or permanent physical changes and an abnormal physical appearance. These can 
arise as a direct effect of the renal disease, or owing to side-effects of medica-
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tion, such as a "Cushing" face after large doses of prednisone, hirsutism due to 
cyclosporin, obesity, and scarring from drains, fistulae, and operations. Possible 
psychological consequences include a negative body-image and self-esteem, 
lack of self-confidence with social contacts and social isolation [97,101, 
111,113]. Reynolds et al. [97,98] found, however, that after a successful 
transplant, children were aware of "looking different" but did not suffer as a 
result, or experienced it as a handicap. 
The psychological consequences of growth retardation have been described 
extensively in various groups of patients, such as children with growth hormone 
deficiency, Turner's syndrome, and idiopathic short stature. An overview article 
by Kelnar [117] deals with the biological, social, psychological, and societal 
effects. One of the conclusions is that the emotional and social environment 
(parents, school) determine the way in which a child with short stature sees and 
feels about himself. This interaction effect, or so-called silhouette effect, in 
which a person is addressed, treated or regarded according to his/her stature, 
can be responsible for retardation in social-emotional development (too childish 
behaviour), lack of independence, and a sombre view of the future. Growth 
retardation in combination with retarded sexual maturation is a major stress 
factor, particularly for adolescents. Being small and remaining small, not having 
secondary sexual characteristics (development of breasts, fat deposits, and body 
hair) have also appeared to inhibit stable friendships and sexual relationships, 
even in the long-term and after transplantation [93,97,98,101,111,116]. 
Through the development and administration of growth hormone (GH) 
treatment, which has already proved successful [118], it can be expected that 
the negative psychological consequences of short stature will disappear. An - as 
yet short - follow-up study on the psychological effects of GH treatment in 
adolescents, has offered leads for positive changes in self-confidence, anxiety, 
and depression [119]. 
The influence of frequent and long admissions to hospital 
In 1976, Quinton & Rutten [120] clearly demonstrated a correlation between 
admissions to hospital at a young age and behavioural disturbances later in life. 
However, the majority of more recent studies on the cognitive and socio-
emotional development of children with CRF were unable to establish an 
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influence of hospital admission [18,90,121]. Improvements in the care of sick 
children and the opportunity for parental participation form positive and 
important explanations for these changes [8]. In clinical practice, however, 
young children, particularly between 6 months and 4 years of age, show a 
negative reaction to frequent admissions to hospital. This is manifested in 
clinging behaviour, separation anxiety, eating and sleeping disturbances, protest 
and crying fits, apathy, withdrawal, and shyness. 
The influence of invasive interventions and frequent (vena) puncture 
Throughout the literature, invasive interventions and frequent (vena) punctures, 
such as those associated with HD in particular, are considered to have a 
negative influence on the psychological development of a child. Especially 
young children are vulnerable, and they are inclined to relate (vena) puncture 
and interventions with punishment and guilt [1]. The more positive outcomes in 
relation to the psycho-social adaptation of young CAPD patients, can be 
ascribed in part to relatively infrequent exposure to painful and threatening 
procedures. As yet, little is known about the psychological effects of daily 
injections of GH, although in recent Dutch studies, compliance was found to be 
satisfactory [119], while Smith et al. mentioned that 50% of the 118 patients 
had problems with the treatment [122]. 
The influence of a failed transplant 
A failed transplant, especially if the organ was from a living donor, is a very 
drastic event, which, as is the case with other comparable life events, evokes 
reactions of anger, rebellion, disbelief, and sadness from both the child and the 
parents [123-128]. Some studies have reported that particularly denial of, for 
instance, sadness and disappointment, is a frequent reaction pattern after a failed 
transplant [99,123,124,127]. Sinnema [24] emphasized that denial as a defense 
mechanism in stressful situations should not always be viewed as inadequate 
coping behaviour, but that it may have adaptive and functional value to minimi-
ze and control the stress and intimidation. Although a failed transplant is 
generally regarded as a stressful factor in the treatment of renal patients and is 
referred to as such in the literature, no systematic research has been conducted 
into its effects on psychosocial development in the long-term [97]. 
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3.3. Specific consequences of chronic renal failure on the family 
Section 3.1. describes the implication of chronic disease in general on family 
functioning. In the case of a chronic renal disease, the above-mentioned 
variables: disease-specific factors, intrapersonal factors, and environmental 
factors, are of importance for the way in which parents and other family 
members deal with renal disease in a child. According to Reynolds et al. [107] 
the effects of renal disease on a family can be divided into problems which are 
directly related to the physical condition of the child, practical problems, and 
the psychological burden. Moreover, specific problems also arise in the various 
phases in the course of renal disease, i.e., the pre-dialysis phase in which renal 
function gradually deteriorates, the dialysis phase, the transplantation phase, 
and the post-transplantation phase [70,79,84,85,91,93,97,98,105,111,124,129-
133). 
In the pre-dialysis phase, particularly deterioration of the physical condition of 
the child, expressed as tiredness, lack of vitality, and eating disturbances, form 
a considerable burden for the child, the parents and brothers and sisters. As this 
phase of chronic renal failure can encompass many years, continual confronta-
tion with a sick child can lead to strong fixation of the family on the disease 
and consequently on illness-related behaviour. Healthy aspects in the behaviour 
of the sick child (such as a young child's need to explore, an older child's 
pleasure in going to school, and an adolescent's growth towards independence) 
are ignored or neglected. The result is pedagogical deprivation, behavioural 
problems, and often the child develops an egocentric attitude. 
Practical problems in this phase are mainly concerned with supervising the 
(strict) diet and administering (many different) medications. Eating disturbances 
and problems with toilet training are also common in this phase. These factors 
cause an increase in the psychological burden of the parents, which is rein-
forced by uncertainty about future dialysis treatment and transplantation. 
In the dialysis phase, besides care for the child in relation to the necessary 
surgical interventions (creating a fistula or inserting a CAPD catheter), practical 
problems place a particularly heavy burden on the family. In relation to HD, 
these problems can include a long distance between home and the dialysis 
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centre, organising transport by taxi, arranging baby-sitters for the other children 
if the parents have to accompany the sick child. In the case of CAPD/CCPD, 
the parents carry great medical responsibility for the dialysis procedure, taking 
care of the catheter, recording the child's weight and fluid balance, measuring 
the blood pressure, and administering medication. An ambivalent attitude is 
often the result (being a parent and doctor at the same time), in addition to 
fixation on the ever-returning need to perform the dialysis procedure [105,124,-
132]. Studies have shown that 77% of the parents of dialysis patients, as 
opposed to 31% of the parents of pre-dialysis patients [124], report that the 
daily programme and life-style of the whole family, including work and leisure-
time activities, often have to be adapted to the intensive treatment of the 
CAPD/CCPD patient [129]. Particularly the parents of young children who 
require a great deal of care and are not yet ready for a transplant because they 
have not reached the target weight, experience a heavy burden [132,134]. 
Owing to the considerable time investment in PD treatment, the other 
children in the family, unintentionally, receive too little attention. As was 
mentioned above [46,107], this can be expressed as over-adaptive behaviour 
and/or withdrawal behaviour to spare the parents, or as acting-out behaviour, 
particularly at school, or as jealousy from brothers and sisters [124]. The 
mother's and/or father's job(s) also suffer under the treatment of the child: 
absenteeism, lack of concentration, impossibility of combining work with the 
care of a sick child (especially for mothers), lack of understanding from the 
employer and colleagues, are often mentioned by parents [107]. Financial 
problems are also common in this period [107,124,129]. The study by Reynolds 
et al. [124] showed that 65% of dialysis parents reported that the treatment was 
having a negative influence on their marriage, as opposed to 27% of pre-
dialysis parents. They also found that this did not always lead to an increase in 
divorce and this finding was confirmed by Brownbridge et al. [84]. Psychologi-
cal problems were found to be particularly common in the parents of HD 
patients, more than in the parents of PD patients [84]. But similar observations 
were reported in relation to episodes of peritonitis by the parents of PD patients 
[134]. 
The time-consuming treatment as well as mental preoccupation of the parents 
with their sick child sometimes results in social isolation. Relationships with 
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friends and acquaintances trail off, family members show too little understand-
ing for the parent's burden. It often appears difficult to accept support and help, 
but it contributes to an adequate way of coping with the disease [26,34,121]. 
Besides negative consequences of dialysis treatment on the family, the 
literature also mentions positive aspects. After an anxious period during 
deterioration of renal function and the adaptation period to dialysis treatment, 
the daily structure of HD or PD offers the parents and family a certain grip on 
life and more certainty. It is often found that after the start of dialysis treatment, 
there is a "honeymoon" period of 3 to 6 months duration [131,134]. Keeping up 
the treatment after this period is a heavy task and uncertainty returns about a 
future transplantation. Symptoms of burn-out arise after a long period of 
treatment [134]. 
Being able to carry out PD treatment adequately on their child leads to more 
self-respect and a more positive self-image in a number of parents, even in 
those who did not meet criteria such as normal cognitive function and econ-
omic, psychological, and social stability [132]. Moreover, home treatment offers 
the parents more control and the feeling of being independent of the hospital. 
In the transplantation phase and the period directly afterwards, there are always 
many worries. Except in the case of family organ donation, a new kidney 
generally comes unexpectedly, even after the family members have been 
waiting months for that "special" telephone call. It means that a number of 
practical measures have to be taken care of quickly, concerning work, baby-
sitters for the other children, admission to hospital and particularly support and 
care for the sick child. The psychological burden, however, is even heavier: 
uncertainty about how the operation will go, possible vascular complications 
and rejection sometimes prevail over happiness and relief. In an overview 
article on the psychological aspects of organ transplantation, Gold et al. [123] 
described this phase as a "cease-fire period". In addition, some parents might 
feel saddened by the thought that the kidney came from another child or adult 
who died. Although parents are generally well-prepared for possible complicati-
ons, they experience symptoms of rejection or infection as unexpected disap-
pointments. Loss of control of the disease and feelings of powerlessness often 
cause more stress than the dialysis phase [84,97,106,113,123]. Nevertheless, 
after a successful transplant, improvements are seen in the parent's mood, social 
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life, health, and in family functioning in general [84,97]. It is also common for 
the majority of parents and the other children to maintain their fixation on the 
health of the kidney patient, all the more if he or she is displaying behavioural 
problems in the post-transplant period. Temporary or permanent changes in 
appearance (Cushing face, hirsutism, and short stature) contribute to this 
situation [97,101,113,128]. Reynolds et al. [97] have therefore argued in favour 
of providing support and counselling for parents in the period after transplanta-
tion. 
The effect of a failed transplant on family functioning has never been studied 
systematically [97]. Streltzer et al. [127] and Gold et al. [123] described the 
process of denial and grief that follows a failed transplant in psychological 
terms. On the other hand, as was mentioned above, denial can be an adequate 
form of coping behaviour that protects the child and parents from the reality of 
having to restart dialysis treatment, which might have to be continued for many 
months or even years [24]. Lack of short-term perspective and loss of faith in 
medical technology are the heaviest burdens. 
Conclusion: the way in which parents and family experience and contend 
with all phases of the disease, depend strongly on personality characteristics, 
coping abilities of the parents, family structure, and external factors, such as 
those described in Section 3.1. 
3.4. Long-term effects of dialysis treatment and renal transplantation on 
psychosocial functioning 
Over the past ten years, great progress has been made with renal replacement 
therapy, even for very young children: dialysis techniques have improved, 
erythropoietin and growth hormone became available, and transplant results 
have been more promising improved. The mortality and morbidity rates as a 
result of ESRD in children have dropped considerably. Therefore the question 
of quality of life in relation to psychological, social and societal functioning in 
the long-term, has become steadily more relevant. Since 1988, a number of 
large-scale studies have been performed in the USA and Europe. The results 
were encouraging, although there were many differences in emphasis between 
the American and European studies. In three publications in 1991, American 
research groups sketched an optimistic picture of the psychosocial and societal 
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rehabilitation of patients who underwent dialysis and transplantation in child­
hood: in studies with respectively 118, 57, and 37 patients the large majority 
received an adequate education, albeit with some amount of delay (135-137). 
Physical condition was considered to be good or normal in 66.7%, 91%, and 
100%, respectively. Also social contacts, work, and family life were satisfactory 
after a successful transplant. 
Recent unpublished research at Dutch and Belgian centres showed that nearly 
all of the 43 kidney patients completed primary education; a large proportion 
completed secondary education, but only a small percentage completed voca­
tional training [138]. Delay of an average of two to three years was also 
observed, as a result of having to repeat classes and/or school years. These 
percentages are more favourable than those reported in comparable studies 
performed in Manchester and Germany [98,94]. In Manchester, two thirds of 
the - by then - adult renal patients (n=45) had obtained a school diploma as 
opposed to 90% in the healthy control group [98]. In the German study on a 
large sample of patients (n=276), 74% had not completed (secondary) voca­
tional training (Hauptschule). The dialysis patients were at a disadvantage 
compared to the transplanted patients: 95% versus 58% had not completed their 
education. The data provided by the EDTA were even less favourable: 41% (of 
617 young adults) had never been to secondary school or had not completed 
secondary education [94]. Comparison is difficult, because in this situation not 
only West European countries were included, but also South European coun­
tries. In the German study, the number of students who had received a special 
form of education (owing to mental, physical, and sensory handicaps) was five 
times higher than in the total German population [93]. 
These data show that although the education situation in the Netherlands 
seems to be slightly more favourable than in neighbouring countries, children 
with renal failure are clearly at a disadvantage compared to their healthy peers 
and that a deficient education or delayed completion decrease the chance of 
social rehabilitation, especially in periods with high unemployment figures. 
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Summary 
Objective: medical technical advances in the development of far-reaching 
techniques, such as continuous ambulatory peritoneal dialysis (CAPD) and 
haemodialysis (HD), have made it possible to treat young children with chronic 
renal insufficiency. The aim of the study was to evaluate whether chronic renal 
disease has a detrimental effect on motor and cognitive development. 
Setting: paediatric Dialysis Centres at the University Hospitals in Nijmegen, 
Utrecht, and Rotterdam. 
Design: prospective study. 
Methods: 18 children (mean age 37 months) who had been suffering from 
chronic renal disease since the first months of life, and 18 healthy children 
(mean age 35 months) underwent tests to evaluate their cognitive development; 
during the tests their behaviour was also monitored. The motor development of 
9 children with renal disease was compared to that of a control group of 17 
children. 
Results: significant retardation (>1 SD) was found in the cognitive and motor 
development of the patients. Within this group, there was a considerable 
difference in cognitive development between the children being treated conser-
vatively (n=8; developmental index = 92.0) and the children on CAPD or HD 
treatment (n=10; developmental index = 72.4). 
Conclusion: dialysis patients have an increased risk of developmental retarda-
tion. Regular screening of the development of this vulnerable group and 
intensive counselling of the parents are strongly recommended. 
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4.1. Introduction 
In the Netherlands, 20 to 25 children per year become candidates for renal 
replacement therapy: haemodialysis (HD), continuous ambulatory peritoneal 
dialysis (CAPD) or continuous cycling peritoneal dialysis (CCPD), as a result of 
chronic renal failure. Before these treatments can be instigated, there is usually 
a short-term or long-term period of severe renal failure, which requires strict 
diet and medication regimens (so-called conservative treatment). Dialysis 
treatment in children should be regarded as a temporary solution, because a 
kidney transplantation is the ultimate goal. Owing to the increasing shortage of 
donor kidneys, HD or CAPD may have to be continued for many years -
precious years, in which stagnation in growth and development can have serious 
implications for the quality of life, as has been demonstrated by research over 
the past 10 years [1-7]. 
Young children (<5 years) and especially those who develop renal disease 
before the age of one year, are at the greatest risk of suffering severe conse-
quences [4,8-14]. During the phase of cerebral ripening, not only the toxic 
effects of uraemia, but also anaemia and a poor nutritional condition are likely 
to have a detrimental influence on neurological, motor, and later cognitive 
performance. Research has shown that a kidney transplantation has a favourable 
effect on motor and cognitive development [4,12,15-18]. Further studies have 
also been conducted on the influence of other treatment modalities on the 
development of children [11,19]. 
However, the findings were ambiguous. Data were obtained in retrospect, 
patient populations were heterogeneous (regarding age, size, and type of 
treatment), and various study designs were used. In addition, it was not always 
clearly specified whether the patients had been suffering from chronic renal 
disease since infancy (with the exception of a few studies [16-18]). 
Therefore a prospective study was conducted in cooperation with three 
Dutch paediatric dialysis centres. Over a period of three years, an inventory was 
made of the development of young children (<5 years) with severe renal failure 
(renal function <20%). This longitudinal study formed part of a prospective 
study and aimed particularly at evaluating the motor and cognitive development 
of play group/nursery school age children (1.6 to 4 years of age) with chronic 
renal failure, in comparison with healthy children of the same age. 
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Table 4.1. Population in a study on motor and cognitive development of young 
children with severe renal failure. 
Renal patients 
cognitive development 
total number 
boys 
girls 
conservative treatment 
CAPD 
HD 
mean age in months (range) 
motor development 
total number 
boys 
girls 
conservative treatment 
CAPD 
HD 
mean age in months (range) 
18 
10 
8 
8 
8 
2 
37 (21-35) 
9 
5 
4 
3 
6 
0 
38.6 (27-51) 
Control group 
18 
7 
11 
35 (27-45) 
17 
7 
10 
35 (28-45) 
We also investigated whether there was a difference in motor and cognitive 
functioning between the patients on conservative treatment and those on 
dialysis. Close observation was made of the children's behaviour during the 
tests. 
4.2. Patients and methods 
In the longitudinal study, there were 31 consecutive patients who met the 
selection criteria for age (0.4-5 years) and renal function (<20% of the normal 
value). To measure renal function, the endogenous creatinine clearance was 
used. A number of the patients were being treated conservatively, while the rest 
were on CAPD or HD. The paediatric dialysis centres in Nijmegen, Utrecht, 
and Rotterdam participated in the study. From the original group of 31 patients, 
18 were selected who were of "play group/nursery school" age (mean age 37 
months). The performance of these children was compared to that of 18 healthy 
play group/nursery school children (mean 35 months) of a similar age and 
socio-economic status (Table 4.1). 
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Table 4.2. Overview of the diagnoses in the group of 18 patients with severe renal 
failure. 
Diagnosis 
renal dysplasia 
polycystic kidneys 
urethral valves 
congenital nephrotic syndrome 
prune-belly syndrome 
branchio-otc-renal syndrome 
haemolytic-uraemic syndrome 
Banter's syndrome 
renal hypoperfusion 
number of patients 
4 
3 
3 
2 
2 
1 
1 
1 
1 
The age range in the control group was slightly wider than in the patient group. 
Evaluation of motor development was only conducted in Nijmegen; 9 of the 
patients participated, and there was a control group of 17 children. 
Table 4.2 shows an overview of the diagnoses of the renal patients. With the 
exception of one, all the children had been suffering from renal failure since 
birth. Mean treatment duration (CAPD or HD) was 21.4 months (range 9-35). 
The children in the control group were attending a play group in Nijmegen for 
several half days a week. The patients were tested at hospital after an outpatient 
follow-up visit, while the control children were tested at play group in a 
separate area. The same researcher administered the psychological tests to both 
groups of children and observed their behaviour. 
Motor development 
The Hoskins and Squires test was used for testing motor performance (revised 
by Jansen, Duyghuizen, and Worm) [20]. Motor development was expressed as 
a motor quotient (age on the basis of the result of the motor test divided by the 
calendar age of the child). To make separate assessments of fine and gross 
motor performance, the so-called Van Wiechen scheme was used [21]. During 
the tests, motor behaviour was observed, and any striking characteristics were 
recorded and evaluated in retrospect. 
Cognitive development 
For all the children younger than 2.6 years, Bayley's Developmental Scales was 
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used [22]. The children's performance was expressed as a mental development 
index (DI score, norm: mean = 100; SD = 16), which gave an indication of the 
mental development level in comparison with the norm group of age-matched 
controls. 
For all the children older than 2.6 years, the McCarthy Developmental Scales 
was used [23]. Performance on the McCarthy was expressed as a "general 
cognitive test score" (GCT score, norm: mean = 100; SD = 16). This test 
differentiates between various cognitive functions, represented by the following 
subscales: verbal understanding, perceptual-performai tasks, quantities (under­
standing of numbers), and memory. In our opinion, reliable comparisons could 
be made between the total scores obtained with the Bayley and McCarthy 
because in our longitudinal study, regular measurements on the same child as 
he/she grew older, did not reveal any influence of the cross-over from Bayley to 
McCarthy. 
Statistical analysis 
The effect of the factor "treatment" (CAPD/HD, conservative treatment, no 
treatment (control)) on cognitive development was tested with a non-parametric 
analysis of variance (according to Kruskall & Wallis). Differences between two 
groups were also tested with a non-parametric analysis, the Mann-Whitney U 
test; χ-square tests were used to analyze behaviour. Differences were considered 
to be significant at p<0.05. 
4.3. Results 
Motor development 
Table 4.3 shows that the motor quotient in the patient group was significantly 
lower than that in the control group (Mann-Whitney U value = 22; p<0.005). In 
addition, the gross motor function in the patient group was significantly lower 
than that in the control group, whereas no difference could be found between 
the two groups for fine motor function. 
In the observations of motor behaviour using the subscales "strength", 
"tonus", "walking", and "running", no anomalies were recorded for the control 
children, whereas there were deviations in the scores of the patients. 
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Table 4.3. Level of motor development in the children with severe renal failure. 
Average score (SD) in the U; p* 
motor quotient according to 
Hoskins & Squires 
gross motor (Van Wiechen schema) 
fine motor (Van Wiechen schema) 
patients 
(n=9) 
76.4(18.6) 
83.3(20.9) 
103.2(22.2) 
controls 
(n=17) 
99.7(11.9) 
127.8(14.5) 
108.0(17.4) 
22;<0.005 
9;<0.0005 
74;<0.05 
U = Mann-Whitney-value 
*p = value of patients compared to controls 
It was striking that only 2 out of the 9 children in the patient group crouched 
down spontaneously, whereas this was the case in 14 out of the 17 control 
children. Moreover, 8 out of the 9 patients displayed signs of pes valgus. In 5 
of them there was slight flat-foot, while in 3 the condition was more pro­
nounced. None of the children in the control group had clear signs of pes 
valgus or pes planus, but 6 of them had slight flat-foot and tilting in accordance 
with their age. 
Cognitive development 
Within the group of patients, a distinction was made between the children on 
conservative therapy and those on dialysis. Table 4.4 shows that the mean 
developmental indexes in both patient groups were significantly lower than the 
mean index in the control group. The difference between the two patient groups 
was significant in favour of the children on conservative treatment (U = 96.5; 
p<0.02). The difference in development between the children on conservative 
treatment and the control children was also significant (U = 30; p<0.01). There 
were significant differences between the three groups (χ2 = 19.25; df = 2; 
p<0.001). The groups were also compared on the various subtests of the 
McCarthy Scales which was administered to the children of older than 2.6 
years. On all four subtests, the patients had significantly lower scores than the 
controls (p<0.05). The test profile was harmonic for both groups. 
Analysis of the children's behaviour showed that the patients deviated 
negatively from the controls on a number of variables. 
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Table 4.4. Level of cognitive development of the children with severe renal failure. 
number of children 
mean cogn. developmental index 
Mann-Whitney U test 
conservative 
treatment 
8 
92.0 
13.7 
CAPD/HD 
treatment 
10 
72.4 
19.2 
controls 
18 
102.4 
7.2 
Significant differences (p<0.05) were found for the factors "concentration", 
"cooperation", and "contact" with the researcher; strongly significant differences 
(p<0.001) were found for the factors "task orientation", "testability", and 
"latéralisation". In relation to the item "latéralisation", it should be mentioned 
that in the control group, significantly more preference was displayed for a 
particular hand, i.e., the hand used to perform the various tasks. 
4.4. Discussion 
The central question in this study was: to what extent do the motor and cogni-
tive performances of young (pre-school age) children with a chronic renal 
disease differ from those of a group of healthy age-matched controls? The 
results showed that in agreement with recent reports in the literature [8-14] 
young renal patients are at increased risk for cognitive and motor developmental 
delay or retardation. 
It was striking that the delay in motor development lay exclusively in the 
gross motor evaluations. These delays may be explained by the direct effects of 
renal disease: anaemia, poor nutritional condition, and uraemia. In addition, the 
dialysis fluid in the abdomen of the children on CAPD (6 out of the 9 patients) 
had a limiting effect on mobility, which may have also had a negative 
influence. 
Compared to the control group, there was a delay in the cognitive develop-
ment of the renal patients. The delay in the 10 dialysis patients was much larger 
than that in the 8 patients on conservative treatment (cognitive developmental 
indexes: 72.4 and 92, respectively). These findings partly confirm the results of 
other recent investigations in which slight developmental delay was reported in 
patients on conservative treatment [10,11,13,14]. 
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These literature data were often contradictory and offered little in the way of 
clear answers about the developmental chances of young patients on dialysis 
treatment. None of the studies confirmed our results that children on dialysis 
have significantly lower scores than children on conservative treatment. Salusky 
et al. mentioned that after the start of CAPD treatment, three out of the four 
patients were able to catch up some of their delay in development [19]. 
However, these measurements were performed on a very small number of 
patients. 
What can be the explanation for the differences observed between the 
patients on conservative treatment and those on dialysis? The not inconsiderable 
delay in development in the dialysis patients can partly be explained by the fact 
that four out of the ten patients in our group also had multiple congenital 
anomalies, which had a negative influence on the total score. All four patients 
scored >2 SD below the norm average. When these scores were omitted from 
the analysis, the dialysis group had a higher mean developmental index (83 
instead of 72), but it remained lower (non-significant) than the score of the 
conservative treatment group (92). Moreover, it is possible that the remaining 
renal function in the patients on conservative treatment had a positive effect on 
their cerebral functions. 
The results of our observations also suggest that behavioural factors may 
have had an influence on the retardation or delay in development of the total 
patient group. The parents of these patients and particularly the parents of the 
dialysis patients (10 out of the 18 patients) were carrying a great deal of 
responsibility for the medical condition of their child, because they were 
performing the treatment themselves. It is known that fixation on the disease, 
concern, and anxiety can lead to overprotection and pedagogical deprivation 
[2,3,7,18]. 
4.5. Conclusion 
Young children with chronic renal failure are at increased risk for development-
al retardation. Children on conservative treatment seem to run less risk of 
developmental retardation than dialysis patients. The delay in motor and 
cognitive development of young dialysis patients can be attributed to an 
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interaction between direct effects of renal failure and behavioural factors. 
In children of younger than 5 years of age with chronic renal failure, it is 
recommended to conduct systematic tests on the motor and cognitive develop­
ment. The early detection of developmental delay or disorders, offers the 
opportunity to apply a specific approach or treatment. In addition, structured 
counselling should be offered to the parents of young children who are partici­
pating in a dialysis programme, which not only provides information, but also 
pays attention to pedagogical aspects. 
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Summary 
Chronic renal failure in young children is associated with impaired cognitive 
development, but recent studies present a more optimistic perspective. An 
important question is whether the earlier initiation of renal replacement therapy 
(RRT) might prevent the reported developmental retardation. The cognitive 
development of 31 patients (age <5 years with a serum creatinine clearance of 
<20% of normal) undergoing different treatment modalities was monitored by 
repeated measurements during a prospective 3-year study. Fifteen patients 
received conservative treatment and 16 patients were on dialysis treatment at 
the start of the project. We were able to evaluate the effect of the onset of RRT 
on 12 patients who were transferred from conservative treatment to dialysis. At 
the beginning of the study, the cognitive development of the total group was 
significantly delayed (mean developmental index = 78.5, SD = 19.5) compared 
with a normal population. Patients undergoing conservative treatment scored 
significantly higher (p<0.01) than those on dialysis. The effect of starting 
dialysis treatment appeared to be positive, but only a significant short-term 
improvement was observed. Follow-up evaluation of 7 patients on conservative 
treatment and of 9 dialysis patients over a 2-year period did not show any 
significant change in a positive or negative direction. 
The present study revealed that pre-school dialysis patients are at risk with 
respect to their cognitive development. This is particularly true for the group 
with concomitant disorders. Less severe disease in the group on conservative 
treatment may be assumed to be a positive contributing factor to the more 
normal performance of these patients. No evidence was found to support the 
hypothesis that the earlier initiation of dialysis treatment will have a beneficial 
effect on development. 
Key words: Chronic renal failure - conservative treatment - dialysis treatment -
cognitive development - children 
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5.1. Introduction 
During the past decade, a number of reports have been published on the 
neurological, motor, and cognitive development of infants and young children 
with chronic renal disease (CRF). The results of these largely retrospective 
studies are heterogeneous and sometimes contradictory, but generally lead to the 
conclusion that young children with CRF are seriously retarded in their devel-
opment [1-9]. However, recent studies have presented a more optimistic view in 
terms of improvement in developmental progress due to better medication and 
nutrition, treatment modality (conservative versus dialysis), or early trans-
plantation [6-8,10-14]. Geary and Haka-Ikse [11] concluded that generally the 
developmental prospects of young renal patients are better than was previously 
assumed, but others stated that very young children in a critical period of 
cerebral growth may suffer more from the toxic effects of uraemia, anaemia, 
and a poor nutritional state [8]. Early transplantation in young children may 
reverse these effects [7,12-14], but these findings are still controversial 
[11,15,16]. 
Therefore, an important question is: what is the optimal time to start renal 
replacement therapy (RRT), or in other words: will the course of development 
of young renal patients benefit from starting dialysis treatment at an early 
stage? The best approach to find answers to these questions is to monitor 
prospectively the developmental course of infants and young children with 
advanced renal failure who are undergoing either conservative treatment or 
dialysis, and to investigate the effects of dialysis on children who were 
previously treated conservatively. 
The present study reports the results of a longitudinal project which investi-
gated the neurological, motor, and cognitive status and development of 31 
young renal patients under 5 years of age, whose renal function was <20% of 
normal. A group of patients on conservative treatment was followed as well as 
a group of dialysis patients. The effect of changing from conservative treatment 
to dialysis was assessed in 12 patients. In addition, the developmental scores 
were related to factors which are known to be associated with a negative 
outcome, such as biochemical parameters, presence of multiple congenital 
diseases, and psychosocial variables. 
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Table 5.1. Primary renal disease in all 31 patients. 
Diagnosis 
Dysplasia/hypoplasia 
Urethral valves 
Congenital nephrotic syndrome 
Renal hypoperfusion 
Polycystic kidneys 
Glomerulosclerosis 
Prune-belly syndrome 
Unknown 
Branchio-oto-renal syndrome 
Haemolytic uraemic syndrome 
Banter syndrome 
No. of patients 
7 
7 
3 
3 
2 
2 
2 
2 
1 
1 
1 
5.2. Patients and methods 
Patients 
Thirty-five patients treated at three Dutch paediatric nephrology units participa-
ted in the project between 1988 and 1991. Inclusion criteria were defined by 
age (<5 years) and by creatinine clearance, calculated from serum creatinine 
(<20% of normal renal function for age). During the project, new patients were 
admitted, and patients over 5 years of age and patients who received a kidney 
transplant dropped-out after a limited follow-up assessment. The mean duration 
of follow-up was 25.8 months (range 6-41 months). The data on 4 patients 
could not be used in the analysis (2 patients underwent only one assessment, 1 
patient did not co-operate in any session and 1 patient proved to have central 
nervous system disturbances as a result of serious cerebral complications 
(spastic tetraplegia and mental retardation after septic shock) and was unable to 
be examined by the appropriate method. The head circumference of all children 
except 3 (missing values) was lower than the 50th percentile. Nutritional status 
was generally satisfactory; in the youngest age group forced tube-feeding was 
necessary in most patients. Aluminium-containing phosphate-binding agents had 
been used in 5 children. Parathyroid hormone was normal at the time of study 
in all children. 
The study group comprised 31 patients (13 girls, 18 boys) aged 0.3-5.0 (mean 
2.5) years at the first assessment. Their primary renal diseases are listed in 
Table 5.1. 
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Table 5.2. Concomitant disorders in 10 patients. 
Pat. 
0 0 
2 
8 
10 
14 
22 
26 
29 
31 
32 
35 
Primary disease 
branchio-oto-renal syndrome 
dysplasia 
haemolytic uraemic syndrome 
dysplasia 
Prune-belly 
congenital nephrotic syndrome 
glomerulosclerosis 
unknown 
renal hypoperfusion 
renal hypoperfusion 
Develop­
mental 
disorder 
X 
X 
X 
X 
X 
X 
X 
Cerebral 
com­
plication 
X" 
х
ь> 
X" 
Visual 
disorder 
X 
Deaf­
ness 
X 
Cong. 
heart 
disease 
X 
a) Varicella encephalitis 
b) Cerebral hypoperfusion during artificial ventilation for septicaemia 
c) Meningoencephalitis 
All but 5 patients had been suffering from chronic renal insufficiency from 
infancy. Ten patients proved to have multiple (congenital) diseases or concomi­
tant disorders (Table 5.2). 
Of these 10 patients, 7 had an "early developmental disorder" at the time they 
were admitted to the paediatric nephrology unit. These developmental disorders, 
which included serious developmental delay, were diagnosed by a paediatrician 
as not being the result of their renal insufficiency, but due to either an event 
resulting in cerebral and renal complications or to unexplained cerebral impair­
ment. Five children had started receiving RRT during infancy; in 16 children 
RRT was initiated after the 1st year of life. 
For the dialysis patients, the duration of dialysis was calculated from the 
onset until the first assessment: mean 30.1 months, range 4.4-54.4 months. 
The research population of 31 patients was divided into two groups: patients 
treated conservatively, i.e., they were receiving standard medical management 
for CRF (n=15, mean age 29.2 months, SD = 19.0) and patients who were on 
dialysis (n=16, mean age 31.0 months, SD = 17.8). Twelve patients changed 
from conservative treatment to dialysis during the project because of end-stage 
renal disease (creatinine clearance <5-10ml/min per 1.73 m2) (Figure 5.1). 
There were only small differences in socio-economic class according to the 
occupation of both parents (6 categories). The majority of children were living 
in a rural area. 
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Total group 
η = 31 
Sart of project 
I 
I 
I 
I 
I 
I 
I 
I 
I 
End of project 
Figure 5.1. Distribution of patients between conservative treatment and renal replace­
ment therapy throughout the project. 
All the children over 2.5 years were attending a (sometimes specialised) day 
nursery or school. The study was approved by the ethics committees of the 
University Hospitals. Informed consent was obtained from the parents. The 
treatment in the three centres was essentially similar. 
Methods 
The cognitive development of the 16 children under 2.6 years and the 15 
children over 2.6 years was assessed by the Bayley Developmental Scales 
(mental scale only) [17] and the McCarthy Developmental Scales (verbal 
perceptual-performance and quantitative scales, respectively) [18]. These scales 
provided respectively a developmental index and a general cognitive index, 
based on raw scores, corrected for chronological age. Therefore in the repeated 
measurement design that was used, time effects such as maturation could be 
controlled. The mean score in the normal population is 100, with a SD of 16. 
The effect of the transition from one method (Bayley) to the other (McCarthy) 
was assessed: no significant differences were observed between the Bayley 
scales and the McCarthy scales during the course of the project (paired t-test, 
p=0.96). Behavioural observations and interviews with the parents about the 
child's condition, child-rearing practices, and special circumstances complemen­
ted the assessments. The children were examined once every 6 months. The 
test/retest reliabilities of the two methods were 76.4 (percentage of agreement 
Conservative 
η =15 
n = 12 
Renal 
Replacemant 
Therapy 
n = 16 
Conservative 
n = 3 
Renal 
Replacemant 
Therapy 
η = 28 
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[17] and 0.91, respectively [18]. The examinations, including medical screening, 
were carried out by the same health care professionals at each follow-up visit at 
the outpatient clinic. Blood urea, creatinine, and haemoglobin concentrations 
were determined each time, as well as height, weight, and head circumference. 
Statistical analysis 
The influence of the presence or absence of multiple disorders on the develop-
mental index was assessed by Student's t-test. Fisher's exact test (two-tailed) 
was used to test the difference in the proportions of children with multiple 
disease in the two treatment groups. Two-way analysis of variance (ANOVA) 
was used to analyze differences in the developmental index between the two 
treatment groups and between the patients with and without multiple diseases. 
The developmental course over a 2-year period of the two treatment groups 
(conservative versus dialysis) was analyzed by repeated measurement ANOVAs. 
The effect of the change from conservative treatment to dialysis on the patients 
who were transferred was analyzed using a paired Student's t-test. Pearson's 
correlation coefficient was used to examine the correlation between the develop-
ment index and the various medical, biochemical, and psychological parameters. 
Because age at initiation of treatment is critical, this factor was entered as a 
covariate in the ANOVAs to examine if there was an age/treatment interaction. 
5.3. Results 
Overall developmental level 
The cognitive development of the total patient group was delayed (Table 5.3). 
The mean developmental index based on the original values of each patient was 
significantly lower (mean = 78.5, SD = 19.5) than that of the normal 
population. 
Only 2 patients (6.5%) scored above the mean of the normal population 
(normal distribution 50%), while the scores of 29% were more than 2 SDs 
lower (normal distribution 2.3%). The low mean score in the total group might 
have been caused by the patients with concomitant disorders (10/31), most of 
whom had an early developmental disorder. 
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Table 5.3. Cognitive development of patients undergoing different treatment modalities 
with and without multiple diseases' 
.:.' 4 Patients with and without multiple diseases (total) 
1N 
Total 1 31 
Conserva- 15 
tive 
CAPD/HD | 16 
Mean 
78.5 
90.3 
67.6 
SD 
19.5 
14.3 
17.3 
Patients without multiple 
diseases 
N 
21 
12 
9 
Mean 
86.7 
93.3 
77.9 
Patients with multiple Τ | diseases 
SD N 
15.5 1 10 
13.2 1 3 
14.5 | 7 
Mean 
61.4 
78.0 
54.3 
SD 
15.6 
14.0 
10.1 
CAPD, Continuous ambulatory peritoneal dialysis; HD, haemodialysis 
* Two way analysis of variance: treatment (p=0.001), multiple diseases (p=0.001) and 
interaction between treatment and multiple diseases, as well as interaction between 
treatment and age at initiation of treatment 
Therefore, the influence of the presence of multiple disorders on the cognitive 
score of the total group was tested and proved to be significant (p<0.0001). 
There were also differences in the mean developmental index of the patients in 
the two treatment groups. A significant difference was found between the 
developmental index and the treatment modality (p=0.001) and between the 
developmental index and multiple diseases (p=0.001). No interaction was found 
between the treatment modality and multiple diseases, which meant that the 
difference in the developmental index between the two treatment groups was 
not significant for the patients with and without multiple diseases. The propor­
tion of patients with multiple diseases in the dialysis group was however larger, 
but not significantly so. 
Developmental course during treatment for CRF 
A complicated methodological problem in this longitudinal project was the 
uncontrolled selection of the study sample, as a result of the clinical need to 
transfer patients from conservative treatment to dialysis. Consequently, the 
treatment groups did not remain stable over a period of 3 years. However, it did 
prove possible to compare the treatment groups with regard to progression or 
retardation in development by monitoring the developmental course of 16 of the 
31 patients over a period of 24 months, with a minimum of five measurements. 
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Figure 5.2a. Cognitive development over time (mean +/- SEM) of a group of 7 
patients treated conservatively and of a group of 9 patients treated by 
continuous ambulatory peritoneal dialysis/haemodialysis. 
The remaining 15 patients were excluded from the analysis over a longer period 
because of a kidney transplant or a change from one treatment group to the 
other within the 2-year study period. Figure 5.2a presents the developmental 
course of the group of 7 patients who received only conservative treatment and 
of the group of 9 patients who were only treated with dialysis over a 2-year 
period. Figure 5.2b shows on an individual basis an increase or decrease in 
developmental quotients between the initial and last evaluation. Apparently, the 
significant difference between the two treatment groups was maintained over 
time (repeated measurement ANOVAs). 
The effect of starting dialysis treatment 
The effect of initiating dialysis treatment could be investigated in 12 children, 
all of whom transferred from conservative to continuous ambulatory peritoneal 
dialysis (CAPD) treatment. These changes occurred at random in the 6-month 
interval between successive measurements. Therefore, we could not measure 
short-term (2-6 months) and long-term (8-16 months) effects on all 12 patients. 
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Figure 5.2b. Cognitive development over time of 7 individual patients treated conser­
vatively and of 9 individual patients treated with CAPD/HD. 
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Figure 5.3. Short-term and long-term effects of the initiation of dialysis treatment on 
the cognitive development of 6 patients. 
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All the patients had a pre-dialysis score (<2 months before starting dialysis); for 
6 patients there were both short-term and long-term measurements (Figure 5.3); 
2 others only had short-term scores, while 4 other patients only had long-term 
scores. The short-term effect of dialysis treatment, which could be assessed in 8 
patients, was significant (p=0.029). In Figure 5.3, which is based on the 6 
patients for whom both short-term and long-term scores were available, a 
significant improvement was noticed after 2-6 months (p=0.017). At a later 
phase, after 8-16 months, the developmental index had deteriorated slightly, but 
the overall improvement remained significant (p=0.026). However, the long-
term effect assessed in all 10 patients with long-term scores was not significant 
(p=0.29). 
The contribution of biochemical and psychosocial variables to cognitive 
development. 
A relationship between changes in renal function (blood urea, creatinine 
clearance, and haemoglobin) and improvement or deterioration in cognitive 
functioning was anticipated, but no significant correlations could be established. 
The effect of erythropoietin treatment was evaluated on 11 dialysis patients 
after 2-7 months, but no influence could be demonstrated. Age (under or over 
2.5 years), CRF since birth, onset of dialysis treatment during infancy, age at 
initiation of treatment, duration of dialysis treatment, and medical complications 
(frequency and duration of admissions to hospital) did not contribute signifi-
cantly to the developmental indices. There was no relationship with socio-
economic class or with attending day nursery or school. 
5.4. Discussion 
This study longitudinally assessed the developmental progress of young children 
with severe CRF who were undergoing different treatment modalities. Consis-
tent with other studies [1-9], our data supported the conclusion that the 
cognitive development of infants and young children with CRF is impaired. 
This statement is an oversimplification, because there were two groups: a group 
treated conservatively, who scored at a nearly normal developmental level, and 
a group on dialysis treatment, who scored slightly more than 2 SDs below 
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average. These findings are in partial agreement with the results of some studies 
[2-4,11], but contradict others [1,8,10,19]. Comparison was difficult, however, 
because age, sample, methods, renal function, and inclusion criteria were 
different. In only one study young renal patients were investigated prospectively 
[11]. In addition, our sample was not assigned at random to different treatment 
conditions, because clinical indications for one modality or another precluded 
the use of a strictly experimental design. The potential impact of using non-
random assignment would not be easy to assess, but in any case involves the 
uncontrolled selection of treatment groups and as a consequence, unpredictable 
effects. Nevertheless the striking difference in cognitive functioning between the 
conservatively treated group and the dialysis group in our study cannot be 
explained purely by the effects of selection. 
In studies on the implications of various modes of therapy on the develop-
mental progress of children, adolescents, and adults, impaired cognitive 
functioning was found to be particularly associated with severe renal 
insufficiency and the need for RRT [10,11,20-22]. It has also been stated that 
children on dialysis treatment have lower performance levels for cognitive tasks. 
Some authors have emphasised the benefit of relieving uraemia [10], which 
suggests that changing from conservative treatment to dialysis might improve 
the cognitive functioning of advanced renal failure patients [20,21]. In the 
present study, the expected benefit of a lower blood urea level was not 
demonstrated. This is in contrast to the study of Geary and Haka-Ikse [11] in 
which the glomerular filtration rate was 31 (± 29) at the initiation and 29 (± 30) 
at the final evaluation. In our study all patients had a renal function of <20%. 
Consequently, differences were too small to reach statistical significance. 
Possibly, the less-severe nature of the disease and residual renal function were 
favourable contributing factors to the better cognitive performance of patients 
undergoing conservative management. 
Other relevant variables which might be related to developmental delay were 
also investigated. No evidence was found for significant correlations with age 
and the presence of CRF since birth. These findings are at variance with the 
results of other studies [1-9], but it should be borne in mind that our sample 
consisted of patients under 5 years of age and that all but 5 patients had had 
CRF since birth. There was very little variance in factors such as the onset of 
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dialysis treatment during infancy and the duration of dialysis treatment. Also 
expected hospitalisation effects [2], (medical complications as well as the 
frequency and duration of admissions to hospital) were lacking. Surprisingly, 
we did not find that erythropoietin had a positive effect as was found in recent 
studies on cognitive functioning and neuropsychological tests in adults and 
children [23-27], perhaps because the long-term effects could not be measured 
in the present study. The relatively young age of our subjects may have contrib­
uted to the inconsistency between our results and those reported in the literature 
[23-27]. In this age group cognitive functioning and intelligence are relatively 
unstable, but increasing stability can be expected over time at school age [10, 
38]. No evidence was found for a relationship between the developmental index 
and psychosocial factors such as socio-economic class, attending a day-nursery 
or school, and admissions to hospital; this was probably due to the small 
variance in our sample. 
It is noteworthy that there was a large number of patients with multiple 
diseases or concomitant disorders in our sample, particularly in the dialysis 
group, and these patients were not excluded, as in other studies [9,20,29], 
because they account for one-third of a paediatric renal sample, and the 32% in 
our study was consistent with other studies [10,30]. Although the scores of 
these patients had a negative influence on the mean developmental index of the 
total group, the difference between the two treatment groups remained signifi­
cant even after they had been excluded. Additional evidence of a difference 
between the two treatment groups can probably be found in the interaction of 
psychological factors with biochemical and clinical factors. Fixation on the 
disease and overprotection, resulting in educational and social deprivation, 
particularly in the dialysis group, might have had a negative influence on the 
cognitive development of the young, mainly С APD patients [2,31-34]. 
The hypothesis that initiating dialysis treatment at an earlier stage will 
improve a child's developmental course was not confirmed, although the mean 
developmental index of 6 of 12 patients advanced significantly after starting 
CAPD, particularly in the period shortly afterwards. There was probably a 
short-term catching-up effect which disappeared later. An explanation might be 
that the start of dialysis treatment was strongly indicated because of biochemi­
cal findings and the clinical condition of the patient. The amelioration of this 
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state may temporarily improve cognitive functioning, whereas the long-term 
effects of uraemia remain. This outcome was also consistent with another 
interesting finding, and in accordance with Geary and Haka-Ikse [11], that 
patients treated conservatively over a 2-year period and patients on dialysis over 
a similar period maintained their developmental level, as no significant differen-
ces were found between the first and the last measurements (Figure 5.2a). These 
results emphasise the need for longitudinal studies in young patients. It is clear 
that we need to gain greater insight into the developmental course from sensori-
motor functioning to more differentiated cognitive functioning on a higher 
cortical level [10,29]. Moreover, any misleading short-term effect of changing 
the mode of therapy can then be put into proper perspective in relation to 
development over a longer period of time. 
It might be argued that the striking differences between the group treated 
conservatively and the dialysis patients existed right from the start. This might 
mean that the children who need RRT at a very early age and over a long 
period (>2.5 years) are more vulnerable not only with respect to their renal 
function but also to neurodevelopmental variables [29]. Fennell et al. [20,29] 
investigated neuropsychological functioning in patients aged 6-18 years, but 
excluded children who were clinically retarded or had overt neurological 
disease, hence a comparison with the present study can hardly be made. 
However, their hypothesis that impaired development of renal patients is a trait-
like effect, which is probably caused by as yet unidentified congenital factors, 
rather than a state mainly determined by compromised renal function, might be 
valid for the neurodevelopmental course of young patients. Prospective research 
into this issue is required, with the ultimate goal of preventing cognitive 
retardation. Possible promoting features might include systematic developmental 
screening of this vulnerable patient group and the implementation of appropriate 
therapeutic interventions, such as sensorimotor training, speech therapy, 
advising the parents on educational matters and, if necessary, referral to a 
specialised day-nursery. 
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Summary 
Children with chronic renal failure (CRF) show developmental intellectual and 
motor disturbances. It is questionable if an early start of renal replacement therapy 
may prevent or delay these disturbances. We studied the neurological and intellec-
tual development of children <5 years suffering from CRF (creati-nine clearance 
<20% of normal) prospectively, over a period of 3 years. As part of the neurol-
ogical study brainstem auditory evoked potentials (BAEP) and somatosensory 
evoked potentials (SSEP) were recorded. Measurements were performed in a group 
of 22 children every 6 months. In 18 of these children CRF was present from 
birth. Sufficient data were available for analysis in 19 (BAEP) and 22 (SSEP), 
respectively. A delay of peak I of BAEP gave indications for peripheral conduction 
disturbances, possibly due to cochlear dysfunction. Brainstem conduction was 
normal. There were no differences between the children treated conservatively 
(n=9) and those treated with continuous ambulatory peritoneal dialysis (CAPD) 
(n=10). In children <2.5 years SSEPs showed a delayed thalamocortical conduc-
tion, which was not observed in older children. This might indicate a delayed 
myelination in young children with CRF. No differences were found between the 
children treated conservatively (n=10) and those treated with CAPD (n=12). 
Keywords: Chronic renal failure - Continuous ambulatory peritoneal dialysis -
Evoked potentials 
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6.1. Introduction 
It has long been recognised that end-stage renal failure in adults is associated with 
neurological complications [1,2]. Developmental disturbances and encephalopathy 
have also been reported in children with chronic renal failure (CRF) [3-6]. Intel-
lectual and motor development of young children with CRF is delayed compared 
with healthy children [7-11]. The investigation of cerebrospinal fluid has also 
shown abnormalities in purine/pyrimidine metabolism [12]. The young, maturing 
central nervous system seems to be affected in children suffering from CRF. It 
may be hypothesised that an early start of renal replacement therapy may prevent 
these disturbances. 
The neurological and cognitive development of children <5 years suffering 
from CRF (creatinine clearance <20% of normal) was studied prospectively, over 
a period of 3 years. As part of the evaluation of the neurological status of these 
patients, brainstem auditory evoked potentials (BAEP) and somatosensory evoked 
potentials (SSEP) were measured. Since peripheral nerve conduction may be 
delayed in uraemia, decreased latencies in evoked potentials can be expected. 
6.2. Patients and methods 
BAEP and SSEP were measured every six months in a group of 22 children (8 
girls, 14 boys). All children were <5 years and had a creatinine clearance <20% 
of normal, calculated with the serum creatinine using the Schwartz formula [13]. 
The children were divided in two subgroups. Group I was treated conservatively 
(n=9 for BAEP, n=12 for SSEP), group II with continuous ambulatory peritoneal 
dialysis (CAPD) (n=10 for both investigations). The mean creatinine clearance was 
15ml/min per 1.73m2 (range 6-20). Renal replacement therapy was started at a 
creatinine clearance <5-10ml/min per 1.73m2. 
In 18 children CRF was present from birth. The aetiology of CRF is given in 
Table 6.1; 8 patients had disorders affecting the nervous system (mental retardation 
(n=6), deafness (n=2), and motor retardation (n=l)). The BAEP of the two deaf 
children were excluded from the study. 
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Table 6.1. Aetiology of chronic renal failure (CRF) in the study group. 
Urethral valves 
Renal dysplasia 
Polycystic kidney disease 
Focal glomerulosclerosis 
Branchio-oto-renal syndrome 
Congenital nephrotic syndrome 
Haemolytic-uraemic syndrome 
Jeune syndrome 
Bartter syndrome 
Unknown 
7 
5 
2 
2 
2 
In group I the last recording before the start of dialysis was evaluated, in group II 
a recording at least 6 months after the start of dialysis. No recordings from the 
same patients were compared. For group I the mean age at performance of BAEP 
was 37 months and SSEP 40 months. In group II these ages were 43 and 36 
months, respectively. 
Potentially ototoxic drugs had been taken previously by some children: 3 were 
treated with frusemide, and 5 (CAPD) patients had been treated with aminogly­
cosides for a short period for peritonitis. Aluminium-containing phosphate-binding 
agents had been taken by 5 children in the past. The parathyroid hormone level 
was normal at the time of investigation in all children. All evoked potential 
recordings were obtained with a standard evoked potential device (Nicolet CA 
1000). The children were in the supine position. Sedation or anaesthetics were not 
used. 
Brainstem auditory evoked potentials 
Tin electrodes were attached to the prepared skin of the skull according to the 
international 10-20 system [14]. First the right and then the left ear was stimulated. 
Each test was performed twice in order to establish reproducibility. Each test was 
performed by delivering at least 1000 rarefaction clicks (0.1ms duration), at a 
regular rate of 11.1/sec and an intensity of 80dB. The results were analyzed, using 
a Nicolet Pathfinder П. The BAEP components were determined by visual analysis. 
Latencies of waves I, II, III, and V ipsilateral to stimulation and Пс, Шс, and Ve 
contralateral to stimulation were measured. Furthermore the interpeak latencies I-
III, I-V, Ш- , Пс- с, and IIIc-Vc were calculated. All values were compared with 
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nonnative values published by Thivierge and Cote [15]. 
Somatosensory evoked potentials 
The right median nerve was stimulated at the wrist at a regular stimulus rate of 
3.3/sec, with the stimulus intensity adjusted to produce a minimal thumb twitch. 
Each average contained between 100 and 1000 artefact-free sweeps, and the test 
was performed twice in order to establish reproducibility. At the spinous process 
of the seventh cervical vertebra (C7) the cervical responses, N13 and P16, were 
measured. From the contralateral somatosensory cortex (C3') peak PI5 and the 
cortical responses N20, P22, P27, and P45 were determined. P15 is the first 
consistent wave form observed in scalp recordings. It is generated between the 
medulla and the thalamus in the medial lemniscus or in the ventroposterolateral 
nucleus of the thalamus [16,17]. N20 is a cortical response generated in the 
posterior wall of the central sulcus, and P22 is also cortical, generated in the crown 
of the posterior central sulcus [16,18]. Interpeak latencies N13-P16, N13-P15, N13-
N20, and N20-P22 were then derived from their corresponding peak latencies. Our 
data were compared with normative values published by Taylor and Fagan [18]. 
Statistical analysis 
Because there were no latency differences in BAEP dependent on the side of 
stimulation we used the mean value of the measurements obtained on the right and 
left ears. The two-tailed probability test of Wilcoxon (Kruskal-Wallis) was used 
for the comparison of the CAPD and the conservatively treated group. A p-value 
<0.05 was considered to be statistically significant. After comparing peaks and 
interpeak latencies with the normal range, the significance of the number of 
children having a delayed peak or interpeak latency was assessed by binominal 
testing. For SSEP a t-test was applied at a significance level of p<0.05. 
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Table 6.2. Brainstem auditory evoked potentials (BAEP) peak latencies and inter peak 
latencies (IPL) in children treated with CAPD (n=10) and those treated 
conservatively (n=9). 
Peak/IPL 
I 
Π 
III 
V 
I-III 
I-V 
ПІ-
IIc-Vc 
IIIc-Vc 
CAPD u=10 
Mean (ms) 
1.93 
2.90 
3.99 
5.88 
2.06 
3.95 
1.89 
3.05 
2.17 
SD 
0.20 
0.29 
0.25 
0.35 
0.19 
0.31 
0.18 
0 29 
0.21 
Conservatively n=9 
Mean (ms) 
1.91 
2.82 
3.98 
5.78 
2.09 
3.89 
1.80 
3.04 
2.16 
SD 
0.27 
0.27 
0.26 
0.34 
0.22 
0.24 
0.14 
0.36 
0.15 
Normal tange 18] 
1st - 99th 
percentile 
1.40- 1.96 
2.36 - 3.26 
3.28-4.12 
5.00 - 6.16 
1.68 - 2.48 
3.28 - 4.68 
1.41 - 2.34 
6.3. Results 
Brainstem auditory evoked potentials 
The BAEP latencies were not different between children treated with CAPD and 
those treated conservatively (Table 6.2). 
In 9 of 19 patients peak I was significantly delayed, although the mean value 
of peak I latency was in the normal range. Of these 9 children, 4 were treated 
conservatively and 5 received CAPD. No age difference was found between 
children with normal peak I latency and those with delayed peak I latency. The 
latencies of peak Π were delayed in 3 children, peak ΙΠ in 7 children, and peak V 
in 8 children. There was no correlation between the use of potentially ototoxic 
drugs and these delayed latencies. Interpeak latencies were all within normal limits. 
This indicates a normal central conduction time (IPL I-V), from the acoustic nerve 
across the brainstem to the inferior colliculus. 
Somatosensory evoked potentials 
In view of the age dependency of SSEP latencies, we divided our group into 
children <2.5 years of age (n=10) and those between 2.5 and 5 years (n=12). In 
both age groups there were no significant differences between the conservatively 
treated children and those who were treated with CAPD (Table 6.3). 
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Table 6.3. Somatosensory evoked potentials latencies/IPL in the children on CAPD and 
treated conservatively subdivided into < and > than 2.5 years. 
^ 
Peak/IPL 
N13 
P16 
N13-N16 
P15 
N20 
P22 
P27 
P45 
N13-P15 
N13-N20 
N20-P22 
Age 
(months) 
Children <£5 years 
CAPD n=4 
Mean 
(ms) 
8.2 
12.1 
3.9 
12.0 
17.1 
21.5 
24.7 
40.0 
3.8 
8.9 
4.4 
22 
SD 
0.6 
1.0 
1.0 
1.4 
1.1 
1.9 
1.9 
6.2 
1.3 
1.1 
1.4 
5 
Cons. n=6 
Mean 
(ms) 
7.9 
11.6 
3.7 
11.1 
16.4 
22.5 
26.8 
42.1 
3.2 
8.5 
6.1 
18 
SD 
0.7 
0.6 
1.1 
1.0 
1.8 
1.5 
1.0 
4.7 
0.3 
0.7 
1.7 
9 
Chitaren >2JS years 
CAPD n=6 
Mean 
(ms) 
8.1 
12.8 
4.7 
10.5 
15.4 
20.9 
26.2 
41.6 
2.4 
7.0 
5.5 
50 
SD 
1.1 
1.0 
1.1 
1.1 
1.3 
2.7 
3.9 
4.2 
0.4 
0.8 
2.7 
8 
Cons. n=6 
Mean 
(ms) 
9.0 
13.0 
4.0 
11.2 
16.1 
22.5 
27.2 
41.3 
2.2 
7.1 
6.4 
54 
SD 
0.6 
1.3 
1.2 
0.4 
0.5 
1.7 
2.8 
7.9 
0.3 
0.8 
1.6 
12 
Therefore, further analyses were performed on the total group of 22 children. The 
latencies of components P15, N20, and P22 were delayed compared with 
normative values for children <2.5 years, and interpeak latency N13-N20 was 
significantly increased (Table 6.4). The latency of peak N13, a post-synaptic 
response in the dorsal column/cuneate nucleus, was not delayed. This implies that 
the conduction between the cervical myelum via the medial lemniscus and the 
thalamus to the somatosensory cortex is delayed in these young children. In the 
children between 2.5 and 5 years only P22 and N20-P22 were delayed. The central 
conduction between the cervical myelum and the cortex (N13-N20) was not 
delayed. 
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Table 6.4. Comparison of the SSEP data of the whole group of children with CRF with 
normal values [11]. 
'"-
РеакЛРЬ 
N13 
P15 
N20 
P22 
N13-N20 
N20-P22 
CnQdrea 
CRFn= 
Mean 
(ms) 
8.1 
11.6 
16.8 
21.9 
8 8 
5.1 
>Z5 
12 
SO 
0.6 
1.3' 
i.r 
1.8" 
0.9' 
1 7 
jeare *· 
Normal n= 
Mean 
(ms) 
7.8 
10.1 
15.4 
20 4 
7.8 
4.7 
A 
11 
SD 
0.3 
0.5 
0.6 
0.9 
0.4 
0.7 
Children >%S '' 
CRF n=12 
Mean 
(ms) 
8.5 
10.8 
15.7 
21.7 
7.0 
5.9 
SD 
1.0 
0.9 
10 
2.3" 
0.8 
2.1' 
years 
Normal η 
Mean 
(ms) 
8.6 
10.8 
15.3 
19.1 
6.7 
3.9 
•v '< 
=16 
SD 
0.5 
0.5 
0.6 
0.6 
0.5 
0.7 
• = [XO.OI 
* * = JKO.05 
6.4. Discussion 
In adults with end-stage renal disease polyneuropathy, demonstrated by the delay 
of peripheral conduction velocity, is frequently present [19-22]. The central 
conduction is also decreased, as measured by BAEP [23-25] and SSEP [22,24]. 
However, reports are rather scarce in children. De Beaufort et al. found normal 
peroneal nerve conduction in 12 children (mean age 11, range 5-17 years) treated 
with haemodialysis [26]. More recently, Suppiej et al. measured median nerve 
SSEP in 10 children (median age 14, range 9-19 years) treated by haemodialysis 
and reported no abnormalities [27]. Since the children in their group were signifi­
cantly growth retarded, they corrected their data for arm length and found a 
significantly delayed peripheral conduction. These children were considerably older 
than those in the present study. No evoked potentials are available for children 
with CRF from infancy. In 18 of the 23 children we investigated, CRF was present 
from birth. In our study, the delayed peak I latency of the BAEP in a large number 
of patients suggests the presence of a hearing disorder. Wave I represents activity 
of the acoustic nerve [28]. Stimulus intensity has significant effects on the latency 
of auditory brainstem potentials. A decrease in stimulus intensity is accompanied 
by an increase in BAEP latencies. The delayed latency of peak I may be the result 
of inner ear dysfunction, either anatomical or functional; a hair cell loss in Corti's 
organ has been supposed in a study of adult patients [28,29]. Using a click 
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stimulus, our study is not designed to detect frequency dependent dysfunctions. 
None of the children had clinically evident middle ear effusions during the 
investigation. It is known that drugs such as aminoglycosides and frusemide are 
potentially ototoxic [30-33]. Many children with renal failure have been treated 
with frusemide in the pre-terminal phase. Aminoglycosides were only used in some 
of the children treated with CAPD, and always for a short period, in the case of 
a peritonitis episode. Ototoxicity, although unlikely, can not be ruled out as an 
additional etiological factor of the disturbances observed in these children. Routine 
audiographies showed no abnormalities in our patients, in contrast to recently 
published data [33]. This study reported no abnormalities in BAEP. In our patient 
group ultra-high pure-tone testing was not performed. The normal interpeak laten-
cies indicate that brainstem conduction in the auditory pathway was normal in both 
groups. There were no differences between the children who were treated 
conservatively and those who were treated with CAPD. 
No differences between children treated conservatively and children treated with 
CAPD were observed for SSEP or BAEP. This suggests that the start of CAPD has 
no influence on the SSEP of young children suffering from CRF. We should, 
however, take into account the fact that the start of CAPD could have prevented 
a deterioration of SSEP and BAEP; this cannot be tested. The significantly 
increased interpeak latency N13-N20 in the younger age group indicates a delayed 
thalamocortical conduction in these children. There was no relationship between 
the abnormalities in SSEP and in BAEP in individual patients. This delayed 
conduction was not observed in the older age group. This may be due to a delayed 
myelination and/or synaptogenesis in the somatosensory pathway in young children 
with CRF. Of the sensory systems, the somatosensory is the most immature at 
birth. During growth and development there are variations in the rates of maturati-
on of different aspects of neural pathways [16,34-36]. Pathological conditions 
occurring in the maturing human brain may cause retarded maturation of myelin 
sheath. CRF might be such a pathological condition. 
BAEP and SSEP were not different between children treated conservatively and 
those treated with CAPD. Short latency evoked potentials do not measure cognition 
and motor control function. In the same patient group investigations on the motor 
and cognitive development showed significant differences between the con-
servatively treated children and the children in whom CAPD treatment was 
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established. The children who were treated with CAPD proved to be more at risk 
of impaired motor and cognitive development (Chapter 5, this dissertation). 
In conclusion, the study of BAEP and SSEP offers no arguments for an early 
start of renal replacement therapy in young children with CRF, although it cannot 
be excluded that evoked potentials would have deteriorated as start of dialysis 
would be postponed. The somewhat better renal function in the group treated 
conservatively should be considered in the interpretation of the data. 
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Summary 
Cognitive functioning of 20 children (aged 4-14 years) with end stage renal 
disease (ESRD) was assessed before and after a kidney transplantation using an 
intelligence test (WISC-R or WPPSI). Research questions were: 1. Do the test 
scores of children with ESRD obtained before transplantation deviate signifi-
cantly from those of the norm group? 2. Do the test scores of children with 
ESRD increase significantly from pre- to post-transplantation? 3. After trans-
plantation, do the test scores of children with ESRD deviate significantly from 
those of the norm group? 
The pre-transplantation scores showed that the performance of children with 
ESRD was significantly poorer than that of the norm group on the verbal part 
of the WISC-R. After transplantation, significant progress was observed in their 
general cognitive functioning, which was primarily due to a significant improve-
ment in performance on the verbal part of the test. However, kidney transplan-
tation did not lead to complete recovery of cognitive functioning: after trans-
plantation, the ESRD children still showed significantly lower scores for several 
of the tests (e.g., tasks involving concentration) than the children in the norm 
group. 
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7.1. Introduction 
Children with end stage renal disease (ESRD) form a small proportion of the 
total population of children with chronic diseases. In the Netherlands, 20 to 25 
children per year develop ESRD. After renal function has dropped to about 5%, 
it is necessary to start therapy to replace the function of the kidneys. Continu-
ous ambulatory peritoneal dialysis (CAPD) or haemodialysis are suitable 
treatment modalities until a kidney transplantation can be performed. Owing to 
the fact that the chances of survival of children with ESRD have increased, the 
question of quality of life is being raised more and more often. Studies on this 
topic have usually led to the same conclusion: chronic renal failure can form a 
serious threat to the cognitive and socio-emotional development of the child [1-
7]. 
Since 1979, several reports have appeared in the literature about the effects 
of end stage renal disease on the cognitive functioning of children. The results 
were heterogeneous. In various studies, the performance of the children with 
ESRD who were being treated with dialysis did not differ significantly from 
that of healthy children [8,9]. On the basis of these results, the authors conclu-
ded that the toxic effects of uraemia on cognitive functioning can be kept to a 
minimum by performing haemodialysis regularly. However, other studies on 
children undergoing dialysis treatment have shown a detrimental effect on a 
number of cognitive skills. These children obtained significantly lower scores 
for total IQ, i.e., on both the verbal and performal tasks of an intelligence test 
(Wechsler intelligence scale for children-revised (WISC-R)). More specifically, 
this applied to their problem-solving capacity, arithmetic skills, memory, 
abstract reasoning, visual-motor coordination and concentration [10-13]. 
In addition, several factors were found to be related to possible differences 
in cognitive functioning between children with ESRD. The age at onset of 
ESRD appeared to influence the course of mental development of the child. 
Early onset (i.e., before the age of 1 year) of chronic renal failure was found to 
have a permanent and significant detrimental effect on cognitive performance 
[3,14-16]. The level of cognitive functioning also appeared to be related to 
whether or not the child was on dialysis (improvement in functioning after 
treatment was started) [17], the age at which dialysis became imperative (better 
functioning if treatment could be started later in life) [13], and the duration of 
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renal disease (more damaging effects with longer duration) [3]. Various medical 
parameters were also mentioned (positive correlation between performance on 
neuro-psychological tasks and blood pressure) [10]. Psychosocial factors which 
can have a negative influence on cognitive functioning include social isolation 
from children of the same age, depression, attitude of family members towards 
the child (including overprotection), decrease in feeling of general well-being, 
and an increase in school absenteeism. It is not uncommon for the parents and 
the medical team to concentrate (too) strongly on the physical condition of the 
child, with the risk that too little attention is paid to cognitive development. 
Contrary to the research findings regarding the cognitive functioning of 
children with ESRD, the study results on the effects of a kidney transplantation 
on intellectual development are unequivocal [2,3,12]. A kidney transplantation 
was generally found to lead to significant improvement in cognitive functioning. 
This improvement was specific for a number of nonverbal tasks measured with 
the performal subtests of the WISC-R. 
Up till now, no research has been performed in the Netherlands into the 
effects of a kidney transplantation on the cognitive functioning of children. In 
this study, the first inventory was made of the problems encountered in children 
with ESRD at a Dutch university hospital clinic. The aim was to perform a 
longitudinal study on the cognitive functioning of children before and after a 
kidney transplantation. It was considered to be of great clinical relevance not 
only to follow individual children during the treatment so that problems could 
be detected at an early stage and solved if necessary, but also to be able to 
attempt to prevent problems from occurring on the basis of the data obtained. 
In this study, the three central questions were: 
1. Do the intelligence test scores of children with ESRD obtained at the start 
of dialysis treatment deviate significantly from those of the norm group? 
2. After a kidney transplantation, do the children obtain higher scores on an 
intelligence test than they did at the start of dialysis treatment? 
3. Does a kidney transplantation compensate for a possible delay in develop-
ment at the start of dialysis so that the functioning of the transplanted child 
becomes adequate for his/her age? 
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Table 7.1. Overview of the diagnoses of the patient population. 
Diagnosis 
Renal hypoplasia/dysplasia 
Reflux uropathy/nephropathy 
Congenital hydronephrosis 
Nephrotic syndrome 
Glomerulosclerosis 
Glomerulonephritis 
Alport's syndrome 
Haemolytic uraemic syndrome 
Nephronophtisis 
No. of patients 
5 
4 
2 
4 
2 
2 
1 
1 
1 
7.2. Patients and methods 
The study population comprised 20 children with ESRD (10 boys and 10 girls) 
who were being treated by CAPD or haemodialysis. They formed part of a total 
group of 29 children (17 boys and 12 girls) who, in the period 1979 to 1987, 
had undergone psycho-diagnostic investigation before and after renal transplan-
tation. A prospective study design was used. The data obtained from nine 
children could not be used in the analyses. These children had not completed 
the tests, or there were no comparable test instruments available for use in their 
case. There were various reasons for this, such as the use of a non-verbal test 
for allochtonous or hearing impaired patients and noncompletion owing to 
fatigue or time factors. Any possible effects of selection were probably exclu-
ded in this way. At the start of the study, the age of the patients varied between 
4.3 and 14.7 years. Table 7.1 shows an overview of the diagnoses of the study 
population. 
Three children also had other disorders, which comprised hearing impair-
ment, orthopaedic abnormalities, and hydrocephalus, respectively. The renal 
function of all the children was less than 5%, so they had to rely on CAPD 
(n=5) or haemodialysis (n=15) prior to transplantation. 
To establish the intelligence quotient of each child, the Wechsler preschool 
and primary scale (WPPSI) [18] was used for the children younger than 6 years 
at the time of testing, whereas the Wechsler intelligence scale for children 
(revised version, W1SC-R) [19] was used for the children older than 6 years at 
the time of testing. The two intelligence tests were designed with the same scale 
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construction, which enabled reliable comparison of the different IQ scores. Both 
tests could be used to obtain a total IQ score and two separate scores for the 
verbal and performal tasks (mean = 100, SD = 15 for each age group). On the 
basis of the raw score, it was also possible to calculate a standard score for 
each subtest (mean = 10, SD = 3) [20]. These standard scores could be used to 
calculated a score for seven combinations of tasks (each measuring a specific 
skill): concept formation, spatial ability, sequencing, perceptual organisation, 
concentration, verbal understanding, and visual-motor coordination (mean = 10, 
SD = 3) [21]. 
The intelligence tests were administered to the patients at two different times. 
The first measurement took place before or shortly after commencement of 
CAPD or haemodialysis treatment (mean 4 weeks before starting; range 7 
months before to 13 weeks after). Particularly medical factors caused the 
variations in time. During the first measurement, the age of the children varied 
from 4.3 years to 14.7 years (mean 9.5 years). 
The second measurement took place as soon as the child was sufficiently 
recuperated and in a stable medical condition after the kidney transplantation 
(mean 1.7 years after transplantation; range 5 to 47 months). During the second 
measurement, the age of the children varied from 8.2 to 17.6 years (mean 12.6 
years). There was wide variation in the intervals between the first and second 
measurements, ranging from 8 months to 68 months (mean 3 years). The length 
of the interval depended on various factors, such as the amount of time that a 
patient had to wait for a donor kidney, the number of unsuccessful transplanta-
tions (e.g., because of rejection), and the duration of recovery after a successful 
transplantation. 
7.3. Results 
The data were analyzed using an univariate analysis of variance (SPSS-X 
programme M ANO VA). 
Cognitive performance at the start of haemodialysis treatment 
The mean IQ scores of the children with ESRD during the first measurement 
were 97 (SD = 16.6) for the total test, 90 (SD = 16.4) for the verbal tasks and 
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Table 7.2. Average scores and standard deviations of children with ESRD before and 
after transplantation" 
Total IQ 
Verbal IQ 
general knowledge 
similarities 
arithmetic 
vocabulary 
comprehension 
digit span 
Performal IQ 
picture completion 
pict. arrangement 
block design 
object assembly 
codes 
mazes 
Comprehension 
Sequencing 
Spatial ability 
Perceptual organisation 
Concentration 
Verbal comprehension 
Visual-motor coord. 
Before transplantation 
X 
96.65 
90.35' 
7.85β β 
8 . 1 5 " 
9.55 
7.70 
9.30 
η \2" 
103.70 
9.70 
11.00 
11.65 
10.18 
9.40 
11.11 
8.29e 
8.33e 
10.26 
10.74 
8 . 1 2 " 
8.07e 
10.18 
SD 
16.65 
16.43 
3.13 
2.50 
3.50 
3.54 
3.51 
2.09 
15.89 
2.70 
3.02 
3.53 
2.43 
3.02 
2.96 
2.89 
2.29 
2.42 
2.71 
2.44 
2.81 
2.32 
After transpl 
X 
101.90 
96.85 
8.70' 
8.40' 
11.15 
9.25 
9.50 
6 .60" 
108.35 
9.95 
11.75 
12.25 
11.95 
10.15 
10.95 
9.05 
9.30 
11.38 
12.10 
8.88e 
8.96 
11.45 
antation 
SD 
16.46 
15.68 
2.68 
3.03 
3.28 
3.19 
3.25 
2.06 
17.71 
3.14 
3.37 
2.63 
3.22 
4.15 
3.20 
2.93 
2.41 
2.52 
2.62 
2.11 
2.50 
2.81 
F-value of 
the differen­
ce 
7.85' 
12.79" 
2.90 
0.31 
6.8 Γ 
7.31' 
0.14 
2.72 
2.51 
0.17 
1.13 
1.50 
12.72" 
0.80 
0.03 
1.79 
6.77' 
6.11' 
8.13' 
6.52' 
7.20' 
8.61" 
# n=20, owing to incompletion of a number of subtests of the WPPSI, n=17 for 
the first measurement and for the difference scores for "digit span", "picture 
arrangement", "object assembly", and all the factors. 
* significant difference before and after transplantation (p<0.05) 
** significant difference before and after transplantation (p<0.01) 
@ significant difference from the norm group (p<0.05) 
@@ significant difference from the norm group (p<0.01) 
104 (SD = 15.0) for the performal tasks. Comparison of these scores to the 
norm scores showed that the total IQ score did not deviate significantly, 
whereas the scores of the ESRD patients for the verbal part of the test were 
significantly lower than those of the norm group (p<0.05) (see Table 7.2). 
This applied particularly to the following subtests of the verbal tasks: general 
knowledge, similarities (verbal reasoning), vocabulary, and digit span (short-
term memory, concentration). The scores of the ESRD children for the perfor-
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mal tasks were very similar to those of healthy children. 
The scores obtained by the children with ESRD for the factors related to 
"concept formation", "sequencing", "concentration", and "verbal comprehen-
sion", were below average for their age. Nearly all of these factors consisted of 
verbal subtests, which contributed to this significant discrepancy. 
Analyses were also performed on the data obtained at the first measurement 
to evaluate whether there were any significant differences between the cognitive 
performance of: 
- children who developed renal failure before the age of 2 years (n=6) and 
children who developed ESRD after the age of 2 years (n=14); 
- children who were already having dialysis treatment at the time of the first 
measurement (n=10) and children who had not yet started treatment (n=10); 
- children in whom it had been imperative to start dialysis at a young age 
(<12.0 years) (n=14) and children who had started dialysis later in life (n=6); 
There were no significant differences between the scores obtained at the first 
measurement for any of these three variables. 
Differences between cognitive performance before and after transplantation 
The scores for total IQ on the Wechsler scale increased significantly after 
kidney transplantation. This increase was mainly due to a significant increase in 
the scores for the verbal tasks (Table 7.2). Significant improvement in perform-
ance was observed for the verbal subtests "arithmetic" and "vocabulary" and for 
the performal subtest "object assembly". No significant differences were found 
for any of the other tasks between the first and second measurements. 
After renal transplantation, there was a significant improvement in perfor-
mance for the tasks which involved "sequencing", "spatial ability", "perceptual 
organisation", "concentration", "verbal comprehension", and "visual-motor 
coordination". However, there was no improvement for "concept formation". 
Cognitive performance after the transplantation 
After transplantation, the children obtained the following scores for the TIQ, 
VIQ, and PIQ: 102 (SD = 16.5), 97 (SD = 15.7), and 108 (SD = 17.7) and were 
therefore functioning at an average intelligence level. The retardation observed 
during the first measurement for the verbal IQ, the subtest "vocabulary" and the 
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factors "concept formation", "sequencing", and "verbal comprehension" were no 
longer visible after the transplantation. The transplanted children were therefore 
functioning adequately for their age on these (parts of the) tests, contrary to the 
situation prior to transplantation. 
However, the children obtained significantly lower scores than those of the 
norm group for the subtests "similarities", "digit span", and the factor concentra-
tion even after transplantation (Table 7.2). 
7.4. Discussion 
The main objective of this study was to evaluate the effect of a kidney trans-
plantation on the cognitive functioning of children with chronic renal insuffi-
ciency. For this purpose, comparisons were made between pretransplantation 
and posttransplantation scores. We also investigated whether the cognitive 
performance of the ESRD children before and after transplantation was signifi-
cantly different from that of age-matched children in the norm group. 
During the first measurement, the performance of the children with chronic 
renal insufficiency was significantly poorer than that of age-matched children in 
the norm group for the verbal parts of the test (VIQ) and for the tasks which 
involved concept formation, sequencing, and concentration. Poor performance 
on the verbal tasks was mainly due to scores which were significantly below 
average for a number of subtests of the WISC-R: "general knowledge", "simila-
rities", "vocabulary", and "digit span". This verbal retardation can be explained 
to a large extent by repeated absenteeism from school; poor physical condition, 
fatigue, and little motivation, hindered the children from following a normal 
education programme. Another explanation was that if the children had emotio-
nal problems, these were very likely to influence verbal functioning [23]. It may 
be assumed that these children will have been carrying a heavy emotional 
burden just before starting dialysis treatment or during the early stages of 
treatment. It was in this period that we performed the first measurement. 
When the scores of the first and second measurements were compared, it 
appeared that the general cognitive functioning of the children with ESRD 
improved significantly after renal transplantation. This finding is in agreement 
with other research results [2,3,12]. The increase in total IQ was mainly caused 
by a significant improvement in performance on the verbal parts of the tests, 
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particularly for the subtests "vocabulary" and "arithmetic". The strong increase 
in the scores for "general knowledge" was probably due to less absenteeism 
from school; during haemodialysis treatment, the children received individual 
tuition from the hospital school. After transplantation, they were able to resume 
their normal education programme. On the basis of the above-mentioned 
assumption that emotional problems can influence verbal functioning, the 
improvement in verbal skills can be explained by a decrease in the emotional 
burden after transplantation. 
At the first measurement, there was no significant retardation in performal 
IQ, which was probably why there was no significant improvement in perfor-
mance on these parts of the tests after transplantation. However, there was one 
exception: the subtest "object assembly". This subtest is more strongly affected 
by test-retest bias than any of the other subtests; familiarity with the puzzles 
which the child had to complete, will have increased his or her chances of 
being successful at a second measurement. 
The findings related to the seven factors which each measured a specific 
skill, contributed little to the interpretation of the test results. 
In this study, we also investigated whether the performance of the children at 
the first measurement was influenced by three independent variables: "age of 
onset of renal function disorder", "treatment already started during the first 
measurement", and "age at which dialysis was started". None of these variables 
had any major effect. 
It is of importance to find out whether ESRD has a permanent and deleteri-
ous effect on a number of specific cognitive functions. As mentioned above, the 
study results showed that part of the retardation which the children displayed 
before transplantation, in comparison with the age-matched norm group, was 
neutralized after the transplantation. However, the scores of the ESRD children 
for the subtests "general knowledge", "similarities", "digit span", and the factor 
concentration, were significantly lower than average for their age. These 
findings indicate that children with ESRD are more likely to obtain significantly 
lower scores before and after transplantation for tasks which involve memory 
and concentration than the normal peer group. 
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7.5. Conclusions 
Part of the retardation (compared to the normal peer group) encountered in the 
ESRD children at the start of dialysis could be caught up after transplantation. 
This was partly thanks to directed coaching (including schooling). 
Further longitudinal research is strongly recommended to evaluate the 
cognitive development of children with ESRD, in which attention is paid to 
factors which might have a detrimental effect (e.g., social-emotional problems). 
Moreover it is imperative to follow the course of development of children 
with chronic renal disease so that retardation can be detected at an early stage 
and possibly even prevented. 
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Chapter 8 
A RETROSPECTIVE STUDY ON 
DIALYSIS TREATMENT IN CHILDREN AND 
THE BURDEN FOR THE FAMILY: 
-design of a family stress questionnaire-. 
8.1. A retrospective study 
Introduction 
This chapter is divided in two parts. The first one describes a retrospective 
study focused on the assessment of the burden placed on a family with a child 
on CAPD or HD. The underlying question was how parents experience the 
disease and the treatment of their child. Since no disease-specific methods were 
available two preliminary questionnaires were designed: one for parents with a 
child on CAPD treatment and one for parents with a child on HD treatment. 
The contents of these checklists were based on interviews and clinical experien-
ces with parents of renal patients, as well as on literature on the impact of 
chronic diseases on the family (see Chapter 3.3). The preliminary results, 
conclusions, and a comparison between the two modes of therapy are reported 
in this first part. 
The second part of this chapter presents a methodological account for the 
construction of the final questionnaire, which is designed for prospective 
investigations and for repeated measurements. The ultimate goal of the use of 
this method is a systematic monitoring of possible stressing factors during the 
dialysis treatment of a child in order to prevent so-called "parent-fatigue" or 
bum out [1,2]. 
Patients and methods 
Table 8.1 presents data of patients and parents who participated in the retro-
spective study. 
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Table 8.1. Demographic data of 17 CAPD patients and 21 HD patients and their 
parents. 
CAPD - HD 
patients 
n=17 boys n=ll 
girls n= 6 
age: <5 yrs old n=13 
>5 yrs old n= 4 
mean age: 6.2 years 
range: 1.2 - 11.1 
n=21 
age: 
boys n=14 
girls n= 7 
<5 yrs old n= 0 
>5 yrs old n=21 
mean age: 15.4 years 
range: 9.4-21.1 
parents 
n=32 
15 pairs of parents 
1 father only 
1 mother only 
refused participation: n=2 
n=39 
refused 
18 pairs of parents 
3 mothers only 
participation n=l 
All parents of patients who were treated during the last 5 years with renal 
replacement therapy at the paediatric dialysis unit of the Nijmegen University 
Hospital were asked to enter the study. In the CAPD study two couples of 
parents refused participation and in the HD study one pair of parents. After 
written information and a short introductory talk with the parents in which the 
aim of the study was explained, they were asked to answer a questionnaire 
consisting of two parts: a checklist of 27 (CAPD) or 30 (HD) items related to 
the medical and psychological aspects of the treatment. The question "which of 
the following factors do you find difficult or cause a great burden" could be 
answered by yes or no; comments were encouraged (see Appendix 8.1 and 8.2). 
These yes/no questions were followed by 8 open questions relating to the 
subjective feelings of the parents towards CAPD or HD treatment of their child. 
Examples of these questions are: "what was the most difficult or most stressful 
experience", "what turned out better or worse than you expected", "who gave 
you support". 
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Figure 8.1. Frequency distribution of percentage of yes-answers on Questionnaires 
Family Stress HD- and CAPD treatment. 
The final question encouraged the parents to give their own comments. 
Statistical analysis: the difference between the mean percentages of the 
amount of experienced stress in CAPD-parents and HD-parents and between 
fathers and mothers in the total sample, as well as in the treatment groups 
separately, was tested by a Mann-Whitney U-test. Spearman correlation 
coefficients were calculated in order to assess the agreement between fathers 
and mothers, as well as to test the relation between the stress-score and a 
number of variables: sex and age of the patient, socio-economic status of the 
family, geographic distance home-hospital, episodes of peritonitis, duration of 
hospitalization (in days), other complications, and duration of the dialysis 
treatment (in months). The results were considered to be statistically significant 
if p<0.05. 
Results 
Figure 8.1 presents the frequency distribution of the percentage of yes-answers 
on the checklist, averaged over both parents of children on CAPD (black bars) 
or HD (white bars). This figure shows clearly that parents differ in the way in 
which they experience the treatment of their child as stressful. Table 8.2 shows 
the mean percentages of yes-answers on both checklists (CAPD/HD) of the 
mothers, the fathers, and of the total group. No significant differences were 
noticed between fathers and mothers in both groups. 
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Table 8.2. Mean percentages of yes-answers on two Questionnaires on CAPD 
treatment and HD treatment. 
CAPD 
HD 
fathers 
37.5 
50.6 
mothers 
43.1 
43.2 
total 
38.3 
45.7 
Table 8.3. Questionnaire on CAPD treatment and Family Stress. The items are 
presented in order of percentage of yes-answers. 
> 
1. Admissions to hospital 
2. Eating problems 
3. Hygienic limitations 
4. Diet or medication rules 
S. Fear of peritonitis 
6. Distance home-hospital 
7. Family recreation 
8. Uncertainty about transplantation 
9. No prospect of transplantation 
10. Changing rules, habits 
11. Lack of social contacts parents 
12. Lack of contact with peers 
13. Late dialysis at 23:00 
14. Frequency of changing the dialysate 
IS. Financial problems 
16. Fixation on the disease 
17. Drain into the abdomen 
18. Household problems 
19. Sustaining the treatment 
20. Behavioural problems due to the treatment 
21. Responsibility for the treatment 
22. Baby-sitting arrangements 
23. CAPD check-ups 
24. Problems with the sibling 
25. Absenteeism (work) 
26. Talks with the doctor 
27. Care of the exit site 
Total % 
69 
59 
59 
56 
56 
56 
53 
50 
44 
44 
44 
41 
41 
38 
38 
37 
31 
31 
28 
25 
25 
25 
22 
22 
19 
19 
9 
Mother 
69 
69 
69 
63 
56 
56 
56 
56 
50 
44 
44 
38 
38 
38 
38 
50 
31 
38 
50 
31 
31 
31 
25 
25 
0 
25 
19 
Father 
69 
50 
50 
50 
56 
56 
50 
44 
38 
44 
44 
44 
44 
38 
38 
25 
31 
25 
19 
19 
19 
19 
19 
19 
38 
13 
0 
The correlation between fathers and mothers was 0.80. It was hypothesised that 
the CAPD-parents would score higher on the list than the HD group, because of 
the considerable practical burden and the medical responsibility related to 
CAPD-treatment. There was, however, no significant difference between both 
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CAPD-treatment. There was, however, no significant difference between both 
groups. Also the mean stress-scores of CAPD-parents and HD-parents on the 18 
items, that were non-specific for the treatment and therefore similar in both 
questionnaires, were not significantly different. No significant correlations were 
found, within each of the two treatment groups, between the amount of the 
experienced stress and sex, age of the patient, socio-economic status of the 
family, distance to and from the hospital, episodes of peritonitis, days of 
hospitalization, and the duration of the treatment. The last factor reached a 
borderline significance in the CAPD-group (p=0.05). 
Table 8.3 shows the 27 items of the first part of the CAPD-questionnaire 
ordered on the total percentage of yes-answers. Not the practical aspects directly 
related to the execution of the treatment (e.g., changing the dialysate, check-
ups) were experienced as a burden, but the - unexpected - complications like 
peritonitis and admissions at hospital. Together with a number of factors related 
to the medical responsibility (e.g., eating problems, diet, and medication) this 
can induce feelings of uncertainty resulting in an increase of psychological 
stress. 
Table 8.4 presents the 30 items of the HD-questionnaire. Remarkable is that 
the psychological aspects, more than the medical aspects, were rated most 
frequently, especially 'concern about the future', developmental aspects (e.g., 
growth, school, and social contacts), and 'uncertainty about transplantation'. 
A few striking differences between the responses of fathers and mothers on 
the items of the separate checklists were demonstrated: CAPD-fathers scored 
higher than mothers on only 3 items and HD-fathers on more than 18 items. 
This finding reveals that the mothers of the CAPD patients were burdened with 
the practical execution of the treatment, whereas the fathers of the HD patients 
were involved and stressed by the psychological, financial, and employment 
consequences. 
A synopsis of the content of the responses on the 8 open questions of the 
CAPD-parents and HD-parents is outlined in Table 8.5. The answers showed a 
wide diversity, and many parents mentioned more than one aspect. Only 
responses that were given by more than 10% of the parents are included in 
Table 8.5. 
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Table 8.4. Questionnaire on HD treatment and Family stress. The items are presented 
in order of percentage of yes-answers. 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
13. 
14. 
15. 
16. 
17. 
18. 
19. 
20. 
21. 
22. 
23. 
24. 
25. 
26. 
27. 
28. 
29. 
30. 
Concern about the future 
Feeling ill during dialysis 
Growth problems 
School absenteeism 
Lack of social contacts peers 
Fixation on the disease 
Uncertainty transplantation time 
Being connected to the dialyser 
Admissions to hospital 
Family recreation 
Being dependant on the dialyser 
Distance home-hospital 
Administering diet and medication 
Behavioural problems 
Fistula/shunt operation 
Problems with siblings 
Sustaining the treatment 
Eating/feeding problems 
Immobility during dialysis 
Responsibility diet and medication 
Transport to and from hospital 
Work absenteeism 
Outpatients' clinic visits 
Financial problems 
Social isolation 
Changing rules/habits 
Talks with the doctor 
Baby-sitting arrangements 
Problems householding activities 
Care of fistula/shunt 
Total % 
90 
74 
69 
67 
67 
67 
64 
62 
59 
59 
56 
54 
54 
51 
49 
49 
49 
44 
41 
33 
31 
31 
28 
28 
28 
26 
18 
15 
10 
8 
Mother 
86 
71 
67 
67 
67 
67 
62 
57 
48 
52 
62 
48 
48 
52 
52 
43 
48 
48 
43 
33 
38 
19 
19 
29 
24 
24 
24 
14 
10 
5 
Father 
94 
78 
72 
67 
67 
67 
67 
67 
72 
67 
50 . 
61 
61 
50 
44 
56 
50 
39 
39 
33 
22 
44 
39 
28 
33 
28 
11 
17 
11 
11 
A few answers were very detailed, sometimes several pages long, which 
provided insight into the specific problems of each treatment modality and 
which contributed considerably to the clinical experience of the team members 
of the dialysis unit. The responses of the CAPD-parents indicated that those 
aspects of the treatment which made explicit demands on the feeling of respon-
sibility were experienced as most stressful (e.g., eating problems, diet, and drug 
therapy including home treatment of peritonitis). 
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Table 8.5. Responses in percentages of parents on 8 open questions of the 
Questionnaires on CAPD and HD treatment and Family Stress. 
I. What was (is) most difficult for you? 
Eating problems 
Diet/Medicine/fluid limitations 
Frequency of changing the dialysate 
Peritonitis 
Uncertainty/stress about transplantation 
Lack of child's capacity to cope with medical problems 
Lack of child's capacity to cope with psychological problems 
Uncertainty 
2. What did you fear the most when the treatment started? 
Changing the dialysate: carrying out the procedure 
Uncertainty 
Child's capacity to cope 
Everything 
Distance home - hospital 
3. What is/has been the most difficult/stressful for your child? 
Admissions to hospital 
CAPD check-ups 
Hygienic limitations (no baths/swimming) 
Diel/medicine 
Lack of contact with peers 
Medical complications due to transplantation 
Psychological stress 
4. What turned out worse than you had expected? 
Admissions to hospital 
Peritonitis 
Eating problems 
Diet/medicine/fluid limitations 
Complications 
Nothing 
Complications due to transplantation 
5. What turned out better than you expected? 
The child's capacity to cope 
CAPD: carrying out the procedure 
Support from hospital 
Waiting time kidney 
6. What do you think of this mode of treatment? 
Good 
Reasonable, but difficult if complications arise 
Stressful 
7. Are you able to sustain the treatment? 
Yes, without help 
Yes, with help 
Very difficult, no 
No choice 
8. Who gave you support? 
Partner/family 
Friends/neighbours 
Hospital/G.P7district nurse 
CAPD 
22% 
19% 
16% 
13% 
19% 
19% 
19% 
13% 
22% 
19% 
19% 
16% 
13% 
19% 
19% 
13% 
13% 
13% 
13% 
19% 
13% 
50% 
16% 
13% 
50% 
38% 
6% 
66% 
16% 
29% 
HD 
28% 
26% 
21% 
13% 
23% 
46% 
18% 
38% 
13% 
18% 
18% 
13% 
8% 
21% 
28% 
18% 
10% 
18% 
18% 
25% 
26% 
13% 
13% 
26% 
49% 
21% 
38% 
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Some parents made a distinction between what was seen as a burden to them-
selves and what they perceived as stress for the child (hospitalizations, blood 
drawing). Six parents felt that their child was able to cope better with the 
CAPD-situation than expected. Half of the parents considered CAPD an 
acceptable form of treatment notwithstanding the stress involved. Fifty percent 
was able to continue CAPD treatment without support and 38% indicated to 
need support. The question "who gave you support" elicited in 82% of the cases 
that support came from family and friends, and in particular from the grandpar-
ents. The medical sector scored rather low with 29%. One parent commented 
"from nobody". 
Table 8.5 reveals that the responses of the HD-parents were also very diverse, 
but the content differed considerably from the responses of the CAPD-parents. 
Most stressing for these parents was the uncertainty regarding several aspects of 
transplantation and the lack of the child's capacity to cope with the medical and 
psychological aspects of the treatment (54%). However, other parents (28%) 
commented that the child's stress tolerance turned out better than expected. 
Discussion 
The data gathered in this retrospective survey provide insight into the specific 
problems with which parents have to cope when their child is on dialysis 
treatment. The following tentative conclusions and recommendations can be 
made: 
- parents in both treatment groups differ extremely in the way they experience 
the therapy of their child as stressful. Particularly in the HD-group, these 
differences can be attributed more to psychological than to medical factors, 
which has obviously to do with the age (mean 15.4 years) of the patients. 
Concern about the future and feelings of uncertainty regarding transplantation, 
as well as the child's inability to cope with the treatment, were frequently 
mentioned as stressing in this group. Feeding problems and medication rules, 
as well as the responsibility for the treatment, contribute considerably to the 
stress experienced by the CAPD-parents. If parents are unable to cope with 
eating problems serious disturbances in the parent-child relationship may 
result, leading to negative feelings in parents and child. The consequences for 
the functioning of the whole family, e.g., with regard to the siblings, recre-
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ational activities and the need to change habits and rules, were mentioned 
very often and therefore the risk of fixation on the disease is considerable [3]. 
Attention needs to be paid to preventive measures by the paediatric renal 
team early in the course of the treatment. 
- mothers and fathers in both treatment groups differ very little in the stress 
they experience. This is probably due to the fact that both parents are drawn 
into the treatment schedule right from the start and were advised to take turns. 
The mothers however were particularly stressed by problems related to the 
direct daily care, whereas the fathers were concerned about the influence of 
the disease on their job situation [4] (see Table 8.4). 
- social support, especially by family and friends, proved to be a positive 
factor, which is in accordance with the literature on stress and coping [5-7]. 
- no significant correlation was found between the stress scores of the parents 
and a number of demographic and clinical parameters. Only the length of 
CAPD seemed to have some influence. Repeated measurements during the 
course of the treatment may offer more insight into the influence of the 
duration of the therapy on family stress. 
- the hypothesis that the parents of CAPD patients would be more burdened 
than HD-parents, because of their medical responsibility and the time consu-
ming daily care, was not confirmed. No significant differences were 
established between the two treatment groups. 
These conclusions have to be interpreted with caution, since the two samples of 
patients and parents were different on a number of variables which affected the 
results. 
- The data of the HD-group were more retrospective than those of the CAPD-
group since some patients were transplanted a few years before, which might 
have distorted the results. 
- Another factor, which was already mentioned, was the difference in age in the 
two samples: the mean age of the CAPD patients was 6.2 years and the mean 
age of the HD patients was 15.4 years. Parents of young children encounter 
other problems than parents of schoolchildren and adolescents who are more 
confronted with the long-term consequences of the disease. Therefore a 
reliable comparison between family stress related to CAPD- or HD treatment 
itself can not be made on these data. 
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- The HD-parents frequently reported their concern about transplantation, which 
was not the case in the CAPD-group. Because the majority of the CAPD 
patients was under 5 years of age and transplantation was possible at a 
minimum weight of 12 kg (see Chapter 2), this topic was less relevant for 
these parents. 
Notwithstanding the different samples, these results give insight into the specific 
problems of each treatment modality. 
In conclusion it can be stated that prospective research, with repeated evalu-
ations of the same questionnaires with a treatment specific part, is needed in 
order to follow and improve patient care with more efficient and goal oriented 
interventions. 
8.2. Design of the revised version of the Family Stress Questionnaire 
In order to assess family stress due to dialysis treatment in a child, two separate 
questionnaires were developed: one focusing on CAPD and one on HD. The 
items were based on the literature on this topic [1-4,8,9] and on clinical 
interviews with all parents by the psychologist and social worker who were 
involved in the psychosocial care of paediatric renal patients in the University 
Hospital Nijmegen. The CAPD-scale consisted of a checklist of 27 yes/no 
(dichotomized) questions and 8 open questions. The HD-scale contained 30 
dichotomized items, partly different from the CAPD-list, and the same 8 open 
questions (see Appendix 8.1 and 8.2). By means of a retrospective investigation 
in CAPD-parents as well as HD-parents the construction of a treatment specific 
questionnaire was pursued, applicable in the two dialysis groups and suitable for 
repeated measurements during the course of the treatment. 
In order to compare modalities of dialysis treatment in families with a renal 
patient, an instrument designed specifically for these families is necessary, since 
the practical and psychosocial stress is quite different from those with other 
diseases or with other problems. The advantage of disease specific methods is 
that the responsiveness to changes due to e.g., alterations in modes of therapy is 
higher than that of global measures. They also are better accepted by patients 
who perceive them to be relevant to their particular problems [10,11]. Further-
more the questionnaire should meet criteria as brevity, ease of understanding by 
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parents, simplicity of administration, and amenability to statistical analysis [10]. 
The initial versions, those used in the study described in the first part of this 
chapter are given in Appendix 8.1 and 8.2; the revised versions are presented in 
Appendix 8.3 and 8.4. 
Scale construction 
Thirty-two fathers and mothers of 17 С APD patients and 39 fathers and 
mothers of 21 HD patients filled in the questionnaires (see par. 8.1). 
Missing responses - only 3.7% in the CAPD-group and 2.6% in the HD 
group - were found in nearly all items and in fathers and mothers as well. 
Relatively many missings in both scales were found in the items "asking days 
off from work" and "problems with siblings" (Appendix 8.1 and 8.2). Probably 
parents did not answer these questions because they were unemployed (the 
majority of the mothers) or they did not have other children. This finding 
resulted in an adapted instruction in which "no" has to be answered if a 
question does not apply. 
The internal consistency (homogeneity) of both scales was analyzed by the 
SPSSX program RELIABILITY. Cronbach's α [12] of the CAPD scale was 
0.87, which means that the internal consistency was high. The item-total 
correlations of 24 items were moderate to high-positive (= very good). The 
items 4, 11, and 19 (Appendix 8.1) were respectively negative and <0.10. After 
having omitted these items the α increased to 0.89. The internal consistency of 
the HD scale was also very good (a=0.89). The items 2, 20, and 22 (Appendix 
8.2) showed a low (<0.10) item-total correlation. After deletion of these items α 
increased to 0.90. 
The responses on the 8 open questions were rated by two psychologists, 
independent from each other, and, after interpreting the individual answers, 
classified into a number of question specific categories (see Table 8.5). Those 
answers which met a frequency >10% (more than 10% of the parents mentioned 
this topic) as well as an inter-rater agreement of 1.00, were added to the revised 
version of the checklist. 
The item-selection can be accounted for as follows (for item numbers see 
Appendix 8.1 and 8.2): cancelled due to low (<0.10) item-total correlation: 
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САРР 
4: care of the exit site 
15: no prospect of transplantation (does not longer apply since transplanta­
tion is also possible in younger children) 
19: baby sitting arrangements 
HP 
2: care of fistula or shunt 
20: baby sitting arrangements 
Maintained despite the low item-total correlation, but because of the high value 
in the other scale: 
CAPP 
11: outpatient's clinic visits and check-ups: see item 14 revised questionnaire 
HP 
22: financial problems: see item 24 revised questionnaire 
Added to revised CAPP-questionnaire because of high value in HP-scale or 
responses on open questions (Appendix 8.3 and 8.4): 
CAPP/HP 
10: responsibility diet and medication 
30: problems growth retardation 
31: school absenteeism 
32: concern about the future 
Added to final CAPP/HP questionnaire because of frequency (>10%) in open 
questions: 
CAPP/HP 
9: fluid restriction 
18: to be available for transplantation 
19: waiting period transplantation 
20: uncertainty result transplantation 
33: physical handicaps/limitations (fatigue) 
34: coming to terms/acceptance 
35: counselling and education 
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36: lack of information 
37: unexpected medical complications 
After item-analysis and the extension with new items based on responses on the 
open questions a revised questionnaire (see Appendix 8.3 and 8.4 and Chapter 
9, Table 9.2) was devised with: 
- unique items [1-6] for either the CAPD/CCPD-parents or the HD-parents 
- common items to compare family stress in both treatment groups [7-37]. 
The internal consistency of this revised checklist (see Chapter 9) was high 
(Cronbach's a=0.87). 
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Appendix 8.1. Questionnaire on CAPO treatment and Family stress 
Child's name: 
I. The statements below are associated with 's CAPD treatment. Which of them 
have you found difficult, or a burden? 
1. The regularity of changing the dialysate (4 times per 
day, every day) 
2. Late dialysis at 11 or 12 pm 
3. The catheter in 's abdomen 
4. Taking care of the exit site 
5. The diet/administering medication 
6. Possible eating disturbances related to the treatment 
7. Limitations related to hygiene (no baths, no swim-
ming) 
8. Possible behavioural problems associated with the 
treatment 
9. The responsibility you have for carrying out the 
treatment at home 
10. Anxiety /uncertainty about possible peritonitis 
11. The regular visits to hospital and check-ups 
12. The distance from home to the hospital 
13. The regular admissions to hospital 
14. Consultations with the doctor about 's condition 
15. No prospect of there being a transplant in the near 
future, because your child is still too young 
16. Uncertainty about when the transplant will take 
place 
17. Possible problems with brothers and sisters 
18. Possible problems with daily household activities 
19. Having to arrange a baby-sitter for the other children 
if you have to go to hospital 
20. Often having to ask for time off work 
Yes No Remarks 
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21. Possible financial problems resulting from the illness 
and treatment of 
22. Having to keep up the treatment 
23. Spending your family's leisure time (e.g. going on 
holiday, going out for the evening) 
24. Always being occupied with or talking about 's 
illness and/or treatment 
25. Rules and habits which had to be changed in your 
family because of 's treatment 
26. Missing contact with friends of the same age as 
27. Becoming isolated/missing contact with your family 
and friends 
Yes No Remarks 
II. 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
What has been the most difficult or the heaviest burden in 's treatment 
up to now? 
What did you dread the most when the treatment was started? 
What has turned out worse than you expected? 
What has turned out better than you expected? 
What do you think about the treatment now? 
Are you able to keep up the treatment? 
With help 
Without help 
Who gives you a great deal of support? 
In your opinion, what is the most difficult or the greatest burden for ? 
Do you wish to make any further comments? 
Appendix 8.2. Questionnaire on Haemodialysis treatment and Family stress 
Child's name: 
I. The statements below are associated with 's haemodialysis treatment. Which 
of them have you found difficult, or a burden? 
1. Creating the fistula/shunt in 's arm 
2. Taking care of the fistula/shunt 
3. The distance from home to the hospital 
4. Travelling (alone) in the taxi to and from 
haemodialysis 
5. Being connected up to the machine (vena puncture) 
6. Having to be connected to the machine and being 
dependent on it 
7. Having to lie still for several hours 
8. The idea that has to keep up the treatment 
9. The diet/administenng medication 
10. The responsibility of having to administer the medi-
cation and stick to the strict diet 
11. Possible eating problems associated with the treat-
ment 
12. If does not feel well on dialysis day (e.g., head-
aches, nausea) or after treatment 
13. Possible behavioural problems associated with the 
treatment 
14. The regular visits to hospital and check-ups 
15. The regular admissions to the hospital 
16. Consultations with the doctor about 's condition 
17. Uncertainty about when the transplant will take 
place 
18. Possible problems with brothers and sisters 
19. Possible problems with daily household activities 
20. Having to arrange a baby-sitter for the other children 
if you have to go to the hospital 
Yes No Remarks 
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21. Often having to ask for time off work 
22. Possible financial problems resulting from the illness 
and treatment of 
23. Spending your family's leisure time (e.g. going on 
holiday, going out for the evening) 
24. Always being occupied with or talking about 's 
illness and/or treatment 
25. Rules and habits which had to be changed in your 
family because of 's treatment 
26. Missing contact with friends of the same age as 
27. Becoming isolated/missing contact with your family 
and friends 
Yes No Remarks 
II. 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
What has been the most difficult or the heaviest burden in 's treatment 
up to now? 
What did you dread the most when the treatment was started? 
What has turned out worse than you expected? 
What has turned out better than you expected? 
What do you think about the treatment now? 
Are you able to keep up the treatment? 
With help 
Without help 
Who gives you a great deal of support? 
In your opinion, what is the most difficult or the greatest burden for ? 
Do you wish to make any further comments? 
Appendix 8.3. Questionnaire on С APD treatment and Family stress 
(revised version) 
Date: 
Concerning: mother/father of: 
This questionnaire comprises a number of issues associated with the CAPD treatment 
of Please indicate which of these issues you find difficult, or a burden for 
yourself or your child. The questions should be answered with yes or no. Give only 
one answer per question. If an issue is sometimes stressing and sometimes not, choose 
the answer which describes the situation which occurs most frequently. It is very 
important that you answer all of the questions with yes or no. If an issue does not 
apply to you or your child, answer with no. 
1. The regularity of changing the dialysate (4 times 
per day, every day) 
2. Late dialysis at 11 or 12 pm 
3. The catheter in ,,, 's abdomen 
4. Limitations related to hygiene (no baths, no swim­
ming) 
5. Carrying the responsibility for the dialysis, being 
afraid of doing it wrong 
6. Anxiety/uncertainty about possible peritonitis 
6a. If applicable, administering growth hormone 
7. Possible eating disorders related to the treatment 
8. The diet/administering medication 
9. Limiting the quantity of fluid may drink 
10. The responsibility of administering the medication 
and keeping to the strict diet 
11. Distance from home to the hospital 
12. Keeping up the treatment 
13. Possible behavioural problems associated with the 
treatment 
14. The (regular) hospital visits and check-ups 
15. The regular admissions to hospital 
Yes No Remarks 
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16. Consultations with the doctor about ,, 's condi­
tion 
17. Uncertainty about when the transplant will take 
place 
18. Always having to make sure that you can be rea­
ched because of the transplant 
19. Being on the waiting-list for a transplant for too 
long 
20. Uncertainty about the outcome of the transplant 
21. Possible problems with 's brothers and sisters 
22. Possible problems with daily household activities 
23. Often having to ask for time off work 
24. Possible financial problems resulting from the 
illness and treatment of 
25. Spending your family's leisure time (e.g. going on 
holiday, going out for the evening) 
26. Always being occupied with or talking about 
's illness and/or treatment 
27. Rules and habits which had to be changed in your 
family because of 's treatment 
28. Becoming isolated/missing contact with your fami­
ly and friends 
29. Missing contact with friends of the same age as 
30 *s possible growth problems 
31 's regular absenteeism from school 
32. Anxiety about 's future in relation to: 
a. medical condition 
b. education 
с social contacts with boy/girl friends 
d. choice of career 
33. 's tiredness of physical limitations 
Yes No Remarks 
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34 's coping and acceptation of the treatment 
35. Counselling and taking care of 
36. Lack of adequate information and counselling 
about the illness and treatment 
37. Extra interventions, unexpected admissions to 
hospital and other treatment complications 
Yes No Remarks 
Appendix 8.4. Questionnaire on Haemodialysis treatment and Family stress 
(revised version) 
Date: 
Concerning: mother/father of: 
This questionnaire comprises a number of issues associated with the CAPD treatment 
of Please indicate which of these issues you find difficult, or a burden for 
yourself or your child. The questions should be answered with yes or no. Give only 
one answer per question. If an issue is sometimes a burden and sometimes not, choose 
the answer which describes the situation which occurs most frequently. It is very 
important that you answer all of the questions with y_es or no. If an issue does not 
apply to you or your child, answer with no. 
1. Creating the fistula/shunt in 's arm 
2. If does not feel well on dialysis day (e.g. head-
aches, nausea) or after treatment 
3. Travelling alone in the taxi to and from 
haemodialysis 
4. Being connected up to the machine (vena puncture) 
5. Having to be connected to the machine and being 
dependent on it 
6. Having to lie still for several hours 
6a. If applicable, administering growth hormone 
7. Possible eating disorders related to the treatment 
8. The diet/administering medication 
9. Limiting the quantity of fluid may drink 
10. The responsibility of administering the medication 
and keeping to the strict diet 
11. Distance from home to hospital 
12. Keeping up the treatment 
13. Possible behavioural problems associated with the 
treatment 
14. The (regular) hospital visits and check-ups 
15. The regular admissions to hospital 
16. Consultations with the doctor about 's condition 
Yes No Remarks 
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17. Uncertainty about when the transplant will take place 
18. Always having to make sure that you can be reached 
because of the transplant 
19. Being on the waiting-list for a transplant for too long 
20. Uncertainty about the outcome of the transplant 
21. Possible problems with 's brothers and sisters 
22. Possible problems with daily household activities 
23. Often having to ask for time off work 
24. Possible financial problems resulting from the illness 
and treatment of 
25. Spending your family's leisure time (e.g. going on 
holiday, going out for the evening) 
26. Always being occupied with or talking about 's 
illness and/or treatment 
27. Rules and habits which had to be changed in your 
family because of 's treatment 
28. Becoming isolated/missing contact with your family 
and friends 
29. Missing contact with friends of the same age as 
30 's possible growth problems 
31 's regular absenteeism from school 
32. Anxiety about 's future in relation to: 
a. medical condition 
b. education 
с social contacts with boy/girl friends 
d. choice of career 
33 's tiredness of physical limitations 
34. ,, 's coping and acceptation of the treatment 
35. Counselling and taking care of 
Yes No Remarks 
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36. Lack of adequate information and counselling about 
the illness and treatment 
37. Extra interventions, unexpected admissions to hospi-
tal and other treatment complications 
Yes No Remarks 
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Summary 
The burden placed on the parents of a child in dialysis treatment can induce 
negative effects on the medical treatment and on the psychological development 
of the child. To identify which families are at risk, both parents of 14 out of 16 
eligible patients in continuous ambulatory peritoneal dialysis (CAPD) answered 
an extensive questionnaire three times during one year. Large differences were 
found between the families with regard to the amount of stress experienced. 
Parents of older children (>5 years) (and particular parents of children with a 
failed transplantation) experienced significantly more stress. The nature of the 
stress was determined more by the psychological aspects than by the medical 
aspects of the treatment. Concern about the future contributed most to the stress 
experienced. Therefore, emotional support as well as practical help for families 
at risk is recommended. 
Keywords: Chronic renal disease - Children - Peritoneal dialysis - Family 
stress. 
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9.1. Introduction 
Children with end-stage renal disease (ESRD) can be treated by hemodialysis 
(HD) or by continuous ambulatory peritoneal dialysis (CAPD) and continuous 
cyclic peritoneal dialysis (CCPD) until a kidney is available for transplantation. 
HD usually takes place in hospital, whereas CAPD and CCPD are carried out at 
home by the parents. Both methods have advantages and disadvantages, and it 
may be assumed that medical factors alone are not decisive for successful 
treatment. 
Children with a chronic disease requiring intensive medical treatment such 
as dialysis, are more vulnerable than adults to the negative impact of the 
disease, because a child is still developing and is strongly dependent on his 
family, both physically and psychologically [1]. Parental coping behaviour is of 
great influence, not only on the course of the medical treatment, but also on the 
psychological development of the child [2]. 
Previous reports on hospital versus home HD and on CAPD treatment have 
shown that the burden of responsibility for the physical well-being of their child 
is very stressful for the parents. A possible consequence is an ambivalent 
attitude: being both doctor and parent. In this respect "parent-fatigue" is a well-
known phenomenon [3-7]. Problems, such as concern about growth, medical 
prognosis, other siblings at home, finances, and risk of marital breakdown are 
reported frequently [8-10]. 
In order to obtain a balanced view of the psychological impact of CAPD-
treatment, we have performed a study on the specific burden placed on the 
family, i.e., on the parents of a CAPD patient. The initial purpose of the present 
study was to determine the amount of stress that parents experienced as a result 
of their child's treatment and if this stress increased or decreased during the 
course of treatment. Second, we were interested in the differences between 
fathers and mothers, and the influence of factors such as age of the patient, 
failed transplantation, duration of the illness and dialysis treatment, patients' 
school attendance and socio-economic class, on the amount of stress. The third 
issue was the specific nature of stress due to the treatment (what is stressful and 
what is not?). 
In order to evaluate and to measure the parental stress due to CAPD treat-
ment, it was necessary to develop a specific method for investigation. This 
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method had to be appropriate for prospective goals and for repeated measure-
ments in order to monitor the process of coming to terms with the treatment, 
management of the disease, and to highlight potential burn out. A questionnaire 
based on the material of a previous retrospective study [7] was therefore 
designed. 
9.2. Patients and methods 
Patients 
Both parents (n=28) of 14 of the 19 CAPD patients in the paediatric dialysis 
unit at the Nijmegen University Hospital were included in the study. Two sets 
of parents refused cooperation, and 3 couples were unable to cooperate: 2 
couples were too stressed because of major complications due to encephalitis 
following transplantation in 1 child and a long-term period of artificial ventila-
tion in the other. In 1 family, cooperation was not possible because of serious 
psychological problems unrelated to the treatment (child abuse). No single-
parent families participated in the study, which is not normal for the Dutch 
population in general, but is probably related to the fact that the majority of the 
families were living in rural, non-urbanized areas. At the start of the study, 4 
out of 14 patients had undergone a failed transplantation; none was less than 5 
years of age. The mean age of the patients was 5.6 years (range 0.8-14.0 years). 
Mean duration of the underlying illness was 4.5 years (range 0.8-13.8 years). 
Mean duration of CAPD treatment was computed from the onset of CAPD until 
the first measurement: mean 1.8 years (range 0.2-7.0 years). During the study 
period, 1 child was successfully transplanted and 1 child was transferred from 
CAPD to conservative treatment. 
Methods 
After receiving written information and an introduction explaining the aim of 
the study, each parent was asked to answer a standardized questionnaire three 
times during 1 year. Parents of patients who changed from dialysis to conserva-
tive management, or who underwent a kidney transplant were followed-up by 
one measurement after 4 months. The items of the questionnaire were based on 
findings in the literature [1,3-5,8-10] and on extensive previous interviews, 
Peritoneal dialysis treatment in children and parental stress 171 
which were held as part of the normal routine at the start of dialysis treatment 
with the parents of patients with renal disorders. By means of "yes" and "no" 
answers to the question: "which of the following aspects of the dialysis treat­
ment of your child do you find difficult or causes you great burden?" the 
parents could report what was stressful during the preceding period. The method 
was based on the results and item analysis of a previous, retrospective study on 
32 parents of 17 children [7]. Short descriptions of the items are given in Table 
9.2. The first item "concern about the future", was subdivided into "concern of 
medical, social, educational, or occupational nature". 
The questionnaire consisted of 37 items. The internal consistency (homoge­
neity) of the checklist was high. (Cronbach's α = 0.87) [11]. 
Statistical analyses 
The amount of family stress experienced by a particular family was expressed 
as the total percentage of yes answers on the questionnaires at all three assess­
ments. A mean score was computed for the total study population, for the 
fathers and the mothers separately, and for the successive assessments. 
Wilcoxon matched-pairs signed ranks test was used to test differences in 
amount of stress between the successive assessments and between fathers and 
mothers. Spearman correlation coefficients were calculated in order to assess the 
agreement between fathers and mothers. Mann-Whitney U-tests were used to 
test differences in amount of stress due to the following variables: transplanta­
tion (not versus failed), age (<5 years versus >5 years), duration of illness (<5 
years versus >5 years), duration of CAPD treatment (<1 year versus >1 year), 
socio-economic class (working class versus middle/upper class), and school 
attendance of the patient (yes versus no). The results were considered to be 
statistically significant if p<0.05. A conservative level of significance (p<0.01) 
is elected for testing the differences at the item level concerning the nature of 
stress between parents with children <5 yrs and >5 yrs by Mann-Whitney U-test 
as well. 
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Table 9.1. The amount of stress averaged over 3 measurements during 1 year, 
influenced by 6 factors. 
Transplantation (Tx) 
without 
failed 
Age 
<5 years 
>5 years 
(without Tx) 
(failed Tx) 
Duration Illness 
<5 years 
>5 years 
Duration CAPD treatment 
<1 year 
>1 year 
Socio-economic status 
working 
middle/upper 
School attendance 
yes 
no 
И 
10 
4 
7 
7 
(3) 
(4) 
8 
6 
5 
9 
7 
63) 
11 
3 
Amount of 
stress 
27.4 
45.5 
23.2 " 
42.1 
(37.5)1)2) 
(45.5)2) 
24.8 
42.9 
28.2 
35.0 
36.4 
22.5 
33.6 
28.2 
Mann-Whitney 
Ü 
4.0 
7.0 
7.0 
ρ - value 
0.0003 
0.026 
0.029 
ns 
ns 
ns 
0
 Significantly different (U=2, n=7,3, p=0.033). 
2)
 Not significantly different (U=3, n=3,4, p=0.20). 
3)
 One missing. 
9.3. Results 
Amount of stress experienced 
Considerable differences in the stress experienced were found between individ­
ual families, ranging from 5.4% to 67.6%. The average amount of stress over 
the three assessments for the total research population was 32.6% (31.7-
33.3%). In order to monitor the amount of stress during the research period of 1 
year, comparisons were made between the scores of assessment 1 with assess­
ment 2 and 3, respectively. No significant differences were found between these 
assessments: the amount of stress neither increased nor decreased essentially 
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during the period studied. 
No significant differences were found in the amount of stress experienced 
between fathers and mothers on any of the three measurements; the mean of the 
amount of stress experienced over these assessments was 33.8% for mothers 
and 31.8% for fathers; the mean Spearman correlation coefficient was 0.72 
(p<0.002) and therefore the following analyses were executed on so-called 
family scores, i.e., the average of the two parents. 
It was hypothesized that according to the literature and clinical experience, a 
number of variables could influence the amount of stress experienced. Table 9.1 
presents the results and obviously only age (>5 years versus >5 years), and 
related to age, a failed transplantation and duration of the illness (>5 years) 
show significant differences in amount of stress. 
Nature of the stress experienced 
Table 9.2 presents the frequency distribution of the items in the questionnaire, 
ordered according to the percentage of yes answers. The first column shows the 
total percentage, averaged for fathers and mothers together, over three assess-
ments, since no significant differences were found between fathers and mothers 
and between the three assessments with regard to the overall amount of stress. 
At item level, however, comparisons between fathers and mothers concerning 
the nature of the stress revealed that mothers felt a significantly greater burden 
than fathers due to the behavioural problems of their child (p=0.028). The items 
"requesting time off work" and "drain in the abdomen" were significantly more 
stressful for the fathers (p=0.008 and p=0.043, respectively). The majority of 
both parents were stressed by "concern about the future", particularly with 
regard to the medical and educational prognosis. 
The most striking differences at item level with regard to the nature of the 
stress were found between parents of an older child (>5 years) and parents of a 
younger child (<5 years) (Table 9.2). A remarkable finding was that 5 out of 
the 6 significant items were concerned with the psychological (particularly with 
uncertainty about transplantation) and not with the medical aspects of treatment, 
although both categories were equally represented in the total scale. 
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Table 9.2. Frequency distribution of the Questionnaire Family Stress CAPD Treat­
ment for the total group, and split up between parents with childeren <5 
years and >5 years. P-values for the differences between these two sub­
groups are given. The items are rank ordered according to the percentage 
of yes answers of the total group. 
Items .. 
,' 
4 
Concern about the future' 
Unexpected medical complications 
Distance home-hospital 
Family recreation 
Eating/feeding problems 
Admissions to hospital 
Uncertainty result transplantation 
Hygienic limitations 
Problems growth retardation 
Physical handicaps/limitations 
Uncertainty transplantation time 
Fear of peritonitis 
Visits outpatient clinic 
Late dialysis at 23 00 
Financial problems 
School absenteeism 
Waiting period transplantation 
To be available for transplantation 
Social isolation 
Frequency of changing the dialysate 
Behavioural problems 
Fixation on the disease 
Work absenteeism 
Changing rules, habits 
Problems with siblings 
Sustaining the treatment 
Lack of social contacts peers 
Problems household activities 
Coming to terms, acceptance 
Administering diet and medication 
Counselling and education 
Fluid restriction 
Drain into the abdomen 
Talks with the doctor 
Lack of information 
Responsibility for the treatment 
Responsibility diet and medication 
* Concern about the future 
- medical 
- educational 
- social 
- occupational 
Total 
group 
u=I4 
73 1 
66.1 
65.5 
60.1 
54 8 
54 2 
51.2 
47.6 
45 8 
45.2 
44.0 
417 
417 
37.8 
37.5 
34.5 
33.9 
32.7 
30.4 
28.2 
28.0 
25.6 
22.6 
21.4 
20.2 
19.0 
17.9 
17.9 
16.7 
16.1 
16.1 
13.7 
11.3 
7.1 
7.1 
7.1 
4.2 
66.7 
42.9 
25.6 
24.4 
<5yeam 
BW7 
50.0 
48 8 
619 
45.2 
60.7 
46 4 
9 5 
48.8 
167 
26 2 
17.9 
26.2 
47 6 
41.7 
26.2 
7.1 
0.0 
0 0 
26.2 
26.2 
25.5 
16.7 
25.0 
20.2 
14.3 
8.3 
11.9 
23.8 
11.9 
16.7 
7.1 
0.0 
11.9 
0.0 
0.0 
9.5 
2.4 
41.7 
167 
20.8 
0.0 
>5 years 
n=7 
92.9 
83 3 
69 0 
75 0 
48 8 
619 
92 9 
46.4 
75 0 
64.3 
70.2 
57.1 
35 7 
33.3 
48 8 
61.9 
67.9 
65.5 
34.5 
30.6 
31.0 
34.5 
20.2 
22 6 
26.2 
29.8 
23 8 
11.9 
21.4 
15.5 
25.0 
27.4 
10.7 
14.3 
14.3 
4.8 
6.0 
88.1 
65.5 
29.8 
45.2 
Ρ values 
• 
0001 
0004 
0.002 
0 003 
0.003 
0014 
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Discussion 
Parents of dialysis patients differed greatly in the degree to which they expe-
rienced their child's treatment as a burden. A previous study of parents of 
CAPD-patients [7] produced similar findings, but the process of dealing with 
the treatment over a longer period was not investigated. The results of the 
present study showed that the amount of stress did not increase or decrease over 
a 1-year period of treatment, either at an individual level or in the total group. 
Nor did the duration of treatment (prior to the period studied) influence the 
amount of stress experienced. It might have been more convincing if the 
questionnaire had been administered from the start of the dialysis treatment. 
Nevertheless, it may be concluded that parental burn-out is not simply deter-
mined by being obliged to sustain the treatment, which is frequently assumed in 
clinical practice. Maybe the process of adaptation, the practical routine of 
dialysis treatment, and the personal control and involvement [10] offer a kind of 
structure and clarity in the daily Ufe of a family with a chronically ill child 
[1,9,12,13]. 
The effect of the duration of the illness must be interpreted with caution, 
because all but three children had renal disease from the time of birth. Conse-
quently, age and duration of illness are highly interrelated variables. 
No differences were found in the amount of stress between fathers and 
mothers, except for some specific items; this is probably due to the fact that at 
the start of renal replacement therapy, both fathers and mothers were equally 
involved and instructed in the management of the treatment. 
The parents of the older children (>5 years) experienced more stress than the 
parents of the younger ones, which seems to be the main explanation for the 
great variety in parental stress. It was hypothesized that families of younger 
renal patients were, in particular, more at risk of bum-out [5,7] because of the 
practical burden, the higher incidence of medical complications and the specific 
vulnerability of young children to developmental delay and emotional disorders 
[5,13,14]. With older children, however, parents are confronted with problems 
at school (absenteeism), growth retardation, and concern about medical, 
educational, and occupational perspectives, all of which are considered to be 
obstacles, impeding the normal development of the child, because of the risk of 
feelings of dependency and lack of self esteem and autonomy, especially during 
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adolescence. This finding of higher stress in the parents of older children is in 
accord with the study of Reynolds et al. [9] in which over half of the children 
were of secondary school age. 
Another major factor contributing to the amount of experienced stress in 
parents is failed transplantation. In our population however this factor was 
related with age, since all four children who had a failed transplantation were 
older than 5 years. Nevertheless, the parents of children not yet transplanted in 
both age groups were able to deal with the disease and treatment with the 
comforting cognition that all problems and stress would be solved by a success-
ful transplantation. Although they know that transplantation can fail and that 
many medical complications can arise, selective perception and even distortion 
of reality are part of adequate coping behaviour which was oriented towards a 
healthy future and a positive prospect for their child [12,15,16]. After a failed 
transplantation, however, the shattered positive expectations, the re-initiation of 
the straining treatment and the confrontation with a probably longer waiting 
time caused a higher level of stress in the family. 
Socio-economic class, which can influence the cognitive and medical 
management of the treatment, did not appear to contribute essentially to the 
amount of stress experienced. This finding is in accordance with the outcome of 
other studies [7,10]. The expectation that the patients' day nursery or school 
attendance could reduce the parents' practical burden of everyday life was not 
confirmed, since no significant effect was found. These findings have to be 
interpreted with care, however, since the sample size was rather small. 
In the present study, the nature of the stress experienced differed partly from 
that in previous studies [5,7,8]. The results of these studies revealed a strong 
fixation on the medical and practical aspects of treatment (complications, 
household activities, feeding problems, frequency of changing the dialysate). In 
contrast, the present study made it clear that parents were strained mainly by 
psychological aspects. In particular, uncertainty and lack of confidence in the 
future were prominent contributing factors to the stress experienced. 
An explanation for the shift from medical to psychological aspects of 
treatment may be found in the fact that, since CAPD-treatment is widely 
accepted and has improved technically, and since experience with this treatment 
modality has increased, the medical staff places less emphasis on strict rules 
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concerning hygiene and practical management. As a result, parents are less 
focused on their medical responsibility and are more open-minded to the 
psychosocial implications of their childs' disease. 
From a psychological point of view, it has to be considered positive that 
parental stress is not only determined by medical and practical care, which 
includes the risk of fixation and overprotection resulting in impairment of the 
childs' development [13]. Concern about the psychological impact implies 
coming to terms with, as well as accepting, the disease and considering the 
consequences for the future [1,12,17,18]. 
In conclusion, this study revealed that parents of children of school age and 
parents of children who have undergone a failed transplantation are particularly 
at risk. Chronic illness in a child challenges the family at three levels: cogni-
tive, emotional, and the behavioural [1]. Medical and psychosocial care in a 
paediatric dialysis unit is usually oriented towards practical and behavioural 
support. Particularly for the above-mentioned families at risk, not only should 
adequate and repeated information be available, but also structural emotional 
support in order to help them to deal with the undermining and stressing 
feelings of uncertainty. 
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Chapter 10 
GENERAL DISCUSSION 
10.1. Cognitive development 
The first part of this thesis describes research which focused on the cognitive 
development of children with chronic renal disease. The main topics of interest 
were the neurological, motor, and cognitive development of young children (<5 
years) with serious renal function disorders (<20%). The hypothesis that starting 
renal replacement therapy at an early stage would improve a child's develop-
mental chances, could not be confirmed on the basis of neurological (Chapter 6) 
or developmental psychological parameters (Chapter 5). Nevertheless longitudi-
nal research revealed several important findings. It was expected that especially 
the children on conservative treatment with poor (or rapidly deteriorating) renal 
function whose motor and cognitive development were at risk. Contrary to this 
assumption, however, the dialysis patients scored more than one standard 
deviation below the average score of the norm group. Moreover the longitudinal 
design of the study made it possible to demonstrate that the effect of starting 
dialysis treatment was only temporary and did not lead to any long-term 
improvement. 
These results seem to contradict those reported in an important study by 
Geary et al. on the same subject and with a similar number of patients [1]. 
However, it was not possible to make any direct comparisons between the 
results, because the methods used by Geary et al. differed considerably from 
ours, in particular regarding the test method (Revised Yale Developmental 
Schedule), a less differentiated method, and the calculation of the level of the 
renal function (in Geary et al. the mean GFR was 31 ± 29, without the usual 
correction for age). 
The explanation of the striking discrepancy between the patients on conser-
vative treatment and those on dialysis, should not only be sought in the positive 
effects of the remaining renal function on a child's cognitive capacity (as 
described in Chapters 4 and 5), but also in other, as yet undetermined, factors 
as well [5,6]. 
So-called uraemic toxins are a group of poorly-defined substances, which 
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have not all been fully identified. It is unlikely that a single substance can be 
incriminated. Over one hundred solutes have been distinguished that accumulate 
in higher than normal levels in the body fluids of patients with advanced renal 
failure [7]. The best-known of these is urea. Many investigators have shown 
that urea has little toxicity at the concentrations commonly found in the body 
fluids of uraemic patients, especially in dialysis patients [8]. Similarly, the 
infusion of large concentrations of creatinine into dogs has not been found to 
produce any neurological symptoms [9]. Several guanidines have been impli-
cated as causal elements of the uraemic syndrome. However, due to nonspecific 
measurement methods, this has not been proven yet [10]. 
The brain's metabolism of amino acids is altered in uraemia and this may 
also produce neurotransmitter imbalance. It has been demonstrated that the 
transport of most amino acids is impaired at the level of neurons and/or glial 
cells [11]. A high gamma-amino-butyric acid level is thought to indicate a 
specific disturbance of glutamine/glutamate metabolism and to lead to the 
delivery of abnormal substrates to brain cells [11]. Studies on purine and 
pyrimidine metabolism in young children with chronic renal failure have shown 
a marked increase in pseudouridine and cytidine in cerebrospinal fluid, as well 
as the presence of a high concentration of a compound which has not yet been 
identified [12]. 
The neurotoxic potential of parathyroid hormone has been evaluated exten-
sively and it is the only substance which has been causally related to clinical 
findings [13]. However, hyperparathyrodism can be carefully and effectively 
prevented by the administration of active vitamin D components; this was the 
case in our patients as well as in most other study groups. 
The above-mentioned findings may be closely related to the high percentage 
of comorbidity, not only in our sample, but also in other study populations of 
children with renal failure [14]. The fact that the number of children with 
multiple disorders (n=10) was over-represented in our sample of dialysis 
patients, should not be considered a coincidence. 
In this study, we did not evaluate the extent to which the efficacy of dialysis 
played a role in the difference in cognitive functioning between the two 
treatment groups and why this difference did not manifest itself in the neuro-
physiologies parameters (Chapter 6). 
General discussion 183 
To judge the adequacy of dialysis, urea kinetics can be used. Within the 
limitations of the correlation between the blood urea concentration and the 
uraemic syndrome, the quantity of urea removed from the body by dialysis can 
be used as a means to measure the adequacy and efficiency of treatment. The 
concept of KT/V was developed for this purpose; К is the dialyser clearance, Τ 
the time of dialysis and V the patient's distribution volume of urea [15]. A 
positive correlation was found between the KT/V urea concentration and 
mortality and morbidity in adult haemodialysis patients [16,17]. Surveys have 
also been performed on adult peritoneal dialysis patients [18-20], and a small 
number of studies are presently available on paediatric peritoneal dialysis [21-
23]. Further and more extensive studies are needed. 
In this study insufficient proof has been found for the conjecture that psychol­
ogical factors influenced the difference between the two treatment groups. 
However, significant differences were found on a number of behavioural 
variables between the group of kidney patients (n=18) and a group of healthy 
controls (n=18) (see Chapter 4). The method used (behavioural observations 
during testing sessions according to a structured checklist, partially derived from 
В ay ley [24]) and performed by the same researcher) was insufficiently standard­
ized and therefore not reliable enough. In this part of the study, no significant 
difference was found in behavioural factors between the patients on conserva­
tive treatment (n=8) and those on dialysis (n=10), but the samples were too 
small to draw reliable conclusions. However, evidence has been found by other 
researchers [14,25-28] who have recently performed studies on the psychosocial 
adaptation, schooling and rehabilitation of chronic renal patients (including 
CAPD/HD patients) and transplanted patients. The results showed that the 
psychosocial adaptation and psychological well-being of (particularly) the 
children on dialysis and of their parents, differed in a negative sense from the 
predialysis and transplanted patients. Earlier reports in the literature have also 
demonstrated that psychosocial factors, such as social isolation from peers, 
depression, the attitude of the parents and an increase in school absenteeism, 
may have a negative influence on cognitive functioning. In addition, the parents 
and the medical team as well can be strongly fixated on the physical condition 
of the child, particularly during the dialysis phase, which carries the risk that 
too little attention is paid to cognitive development [29,32]. In the introductory 
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chapter on the psychosocial consequences of chronic renal disease in children 
(Chapter 3), these aspects are dealt with extensively (see Sections 3.2, 3.3, and 
3.4). 
The research results described in Chapter 7 show that: 
- a group of 20 children with ESRD aged 4 to 14 years at the start of dialysis 
treatment (an average of 4 weeks before) had significantly lower scores on 
the verbal part of an intelligence test than their normal peers, but that the 
total IQ was not significantly different from the norm group; 
- after a successful transplantation, the total IQ showed a significant increase. 
However, the scores for general knowledge, similarities and concentration, 
were significantly lower than those of the norm group, both before and after 
transplantation. 
These findings are in general agreement with those of other studies [33-35], but 
seem to disagree with the conclusion drawn in the studies described in Chapters 
4 and 5: cognitive development, particularly in dialysis patients, was retarded 
by more than one standard deviation below the norm mean. This gives rise to 
the question of whether or not the cognitive functioning of young dialysis 
patients is at risk in the long-term, i.e., as they grow older and/or have a 
transplant. In the approach to this question, it is important to incorporate 
various methods, namely developmental tests versus intelligence tests. 
Recent Dutch research [35] has revealed that the Bayley scale, when applied 
to children of 2 years, can make a predictive distinction between low risk and 
high risk for developmental disorders at the age of 5 years. In addition, devel-
opmental tests used at a young age have proven their worth in intra-individual 
longitudinal research, for example to evaluate the effect of starting a particular 
treatment. Predictions about intellectual functioning made on the basis of 
developmental research, measured by intelligence tests which call upon higher 
cortical functions, can only provide a global indication, or aim at the detection 
of risks [36,37]. 
In the light of these remarks, the discrepancy between the outcomes of the 
studies described in Chapters 4 and 5 and the relatively positive results reported 
in Chapter 7, can be explained as follows: 
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1. None of the patients who participated in the study on the effects of trans-
plantation on cognitive functioning (Chapter 7), except for one (4.3 years), 
reached the stage of ESRD before the age of 5 years. This sample cannot be 
considered to belong to the risk group of renal patients who need to start 
dialysis treatment at a very young age (Chapters 4 and 5). 
2. Although, particularly after transplantation, the general cognitive status of 
the patients in this group hardly differed from the norm mean, these 
children had a number of irreversible function disorders (on e.g., memory 
and concentration tasks), which was also demonstrated by Fennell et al. 
[34,38] in a longitudinal study. This explains why renal patients, despite 
having mental capacities which seem normal, often have problems at school 
or have difficulty completing their education [14,39]. 
3. The effects of transplantation on cognitive functioning could not be evalu-
ated sufficiently in a number of young patients during the study period, 
because they had not yet reached the target weight for a transplant. There-
fore the question whether the developmental potential of this group is 
permanently reduced, could not be answered. 
Evaluation of the described research into the neurological, motor, and cognitive 
development of children with severe renal disease, leads to the following 
recommendations: 
1. Further studies on the pathogenesis of uraemic encephalopathy are necessary 
to gain more insight into a possible relationship between congenital renal 
disease and early developmental disorders. 
2. Longitudinal screening of motor and cognitive development has turned out 
to be worthwhile, because treatment interventions and counselling of the 
parents can be initiated at an early stage, in order to compensate for any 
further delay or retardation. For reliable motor screening, more standardised 
screening methods are required than those applied in this study. We are 
currently pursuing new designs. 
3. The influence of psychological factors on the difference between the conser-
vative treatment group and the dialysis patients (Chapters 4 and 5) deserves 
further attention, with more objective observation methods and a controlled 
design. 
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4. In view of the specific failure of cognitive functions, even after a successful 
transplantation in children of school age, further neuropsychological diag-
nostic assessment is indicated in this group, along with contiguous schooling 
focused on the individual and the specific problems. The results of (particu-
larly European) large-scale studies have shown that the schooling of (ex)-
renal patients is unsatisfactory and reduces the chance of social integration 
[14,27,39]. It is therefore fortunate that a multicentre project aimed at the 
schooling of dialysis patients has been started recently in the Netherlands. 
5. Finally, establishing guidelines for improving the adequacy of dialysis 
treatment is strongly recommended. 
10.2. Family stress 
The chapters in the second part of this thesis deal with the level and nature of 
the daily and psychological burden on the family, particularly the parents, 
resulting from their child's dialysis treatment. At the start of the study, there 
was the feeling that especially the parents of young CAPD patients would be 
heavily burdened by having to carry out their child's treatment. This assumption 
was based on experience of paediatricians, nurses, psychologists and social 
workers. At that time, little or no systematic research had been conducted into 
the family burden of dialysis treatment and in addition, no disease-specific 
instruments were available to measure the burden. Owing to the fact that the 
central question in the study on cognitive development was whether starting 
renal replacement therapy at an early stage would improve a young child's 
developmental chances, a second question arose, namely whether the parents 
would be able to keep up with the (long-term) treatment of their child. In other 
words: can the risk of burn-out be foreseen and prevented? It was therefore 
considered necessary to make an inventory of the parents experience of their 
child's treatment and how much of a burden dialysis treatment was in general 
and per family (Chapter 8). On the basis of this inventory, a disease-specific 
questionnaire was constructed, the Family Stress Questionnaire, which was 
applied in a prospective study on parental stress (Chapter 9). 
The hypothesis that the parents of young CAPD patients would be heavily 
burdened by the practical aspects of the treatment and by the delegated medical 
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responsibility, was confirmed in the retrospective study, whereas in the prospec-
tive study, we found that these aspects were of minor importance compared to 
the psychological burden of the treatment. Particularly the factors associated 
with uncertainty about the disease, treatment, transplantation and the child's 
future, were consistently mentioned by the parents as being a heavy burden. An 
explanation for the difference between the two studies may be found in the time 
factor, as described in Chapter 9: the retrospective study on CAPD patients was 
conducted in the early phase of CAPD in young children. The emphasis at that 
time was lying on meticulousness, hygiene, the lack of aids (e.g., UV device), 
the risk of peritonitis and was inducing a certain amount of fixation on the 
medical aspects of the treatment to the parents. The prospective study, on the 
other hand, showed that the aspects of treatment that were within the parents' 
control, even if they required considerable time investment over a long period, 
were ultimately less of a burden than the aspects that were beyond their control. 
These findings are not only in agreement with current theories about stress and 
coping behaviour in relation to a chronic disease [40-43], but also with the 
results of recent studies in which the parents of CAPD patients experienced 
fewer psychological problems than the parents of haemodialysis patients 
[25,26,44]. 
Unfortunately, we could not demonstrate the difference in the degree of 
burden between CAPD parents and HD parents reliably, because only four HD 
patients and their parents participated in the study. The mean score for stress in 
this small, non-representative group was higher than that of the CAPD parents 
(60% versus 34%, respectively). 
The hypothesis that the parents of young children in particular, would be at 
risk for bum-out could not be confirmed. On the contrary, the results of the 
retrospective and prospective studies showed that the parents of children of 
school age experienced the heaviest burden. Concern about their child's future 
played a major role. 
The fact that an unsuccessful transplant made a considerable contribution to the 
severity of the burden, was not a surprise in itself. The long waiting time until a 
kidney becomes available for a re-transplant and a structural shortage of donor 
kidneys emphasizes the importance of societal activities and of government 
intervention for providing more information about organ donation and donor 
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recruitment. 
The level and the nature of stress resulting from the dialysis treatment of a 
child are not determined by the duration of the disease or treatment, nor by the 
socio-economic status, nor by whether or not the child attends (nursery) school 
which gives the family a break, but by a number of the above-mentioned factors 
and by the way in which a family copes with the disease and the treatment 
(Chapter 3, Sections 3.1 and 3.3). 
A start was made with a study, expected to be important, to evaluate the 
coping behaviour of the parents and specific family characteristics. For this 
purpose, a disease-specific method (Family Characteristics Checklist) [45] was 
developed to enable paediatricians to detect risk factors resulting from ini. I-
equate coping behaviour and negative family characteristics. However, this 
method requires further validation, with criteria such as non-compliance of the 
child and parents, and the frequency and nature of the requests for help. 
Recommendations which arise from the results of these studies on family stress, 
focus on: 
1. Further research to determine risk factors for inadequate disease manage­
ment and for parental burn-out by means of validation of the measurement 
methods. 
2. Systematic and serial application of both methods at the paediatric dialysis 
centres in order to identify problems in the treatment and symptoms of 
potential burn-out, so that practical support and, if necessary, therapeutic 
help can be offered. 
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SUMMARY 
Recent progress in the medical treatment of children with chronic renal failure 
has led to a longer life expectancy and, in many respects, also to a better 
quality of life. Studies have shown, however, that radical replacement therapies, 
such as haemodialysis, peritoneal dialysis, and transplantation, have serious 
consequences on a child's development - particularly on that of young 
children - and on the psychological functioning of the child and its family. This 
thesis describes the psychological consequences of end-stage renal disease in 
children in the light of a number of studies. These studies focused on the 
question of whether the neurological, motor, and cognitive developmental 
disorders and retardation, as reported in the literature published in the nineteen 
eighties, could be prevented by the early initiation of renal replacement therapy. 
An integral part of this question was also to evaluate whether and how much a 
family and especially the parents were burdened by the treatment and by having 
to keep it up. 
Chapters 1, 2, and 3 form an introduction to the six studies we performed. They 
offer an overview of the medical and the psychological aspects of chronic renal 
disease and treatment in children, based on the literature. 
In Chapters 4, 5, 6, and 7, four studies are described that focused on the effects 
of chronic renal failure and transplantation on the neurological, motor, and 
cognitive development of young children. 
Chapter 4 describes a prospective study on 18 renal patients of preschool age 
and on 18 healthy peers. Motor and cognitive development were assessed by 
developmental screening methods and additionally the behaviour by means of 
observation. Significant retardation was found in motor and cognitive develop-
ment in the patient group. Moreover, there was a considerable difference in 
cognitive functioning between the patients on so-called conservative (pre-
dialysis) treatment and those on dialysis treatment. It was concluded that 
dialysis patients are at increased risk for developmental retardation. 
Chapter 5 deals with a multicentre study on the cognitive development of 31 
patients younger than 5 years who had a renal function of <20%. The study had 
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a duration of three years. At the start of the project, 15 children were on 
conservative treatment and 16 were on dialysis. In this study, the effect of 
starting dialysis treatment was evaluated in 12 patients. The cognitive develop-
ment of the total group at the start of the study was retarded (M = 78.5, SD = 
19.5). The patients on conservative treatment had significantly higher scores 
than the dialysis patients; particularly the children with multiple diseases were 
at risk. Starting dialysis treatment had a positive effect, but only for a short 
period. Follow-up evaluation of 7 children on conservative treatment and of 9 
dialysis patients over a period of two years did not reveal any significant 
amelioration or deterioration in the two groups. It was concluded (as in Chapter 
4) that dialysis patients are at risk for developmental retardation and that this is 
particularly the case in patients with comorbidity. The hypothesis that starting 
dialysis treatment at an early stage would improve the developmental chances 
of young children with ESRD was not confirmed. 
Chapter 6 presents a monograph of a longitudinal project aimed at the neurolo-
gical development of 23 young kidney patients younger than 5 years of age and 
with a creatinine clearance of <20% of the age-related norm. Brain stem 
auditory evoked potentials (BAEPs) showed delay of peak I of the BAEP, 
indicative of peripheral conduction disturbances, possibly resulting from 
cochlear dysfunction. In children younger than 2.5 years (but not in older 
children) disturbances were found in thalamocortical conduction on the basis of 
somatosensory evoked potentials (SSEPs). This finding is an indication of 
delayed myelination in young children with chronic renal failure. No differences 
were found between the children who received conservative treatment and those 
on dialysis. 
Chapter 7 describes a follow-up study on the effects of a kidney transplantation 
on 20 (predominantly) older patients of school age. Cognitive function was 
evaluated with intelligence tests before and after transplantation. The results 
showed that the performance of the renal patients on the verbal part of the test 
was significantly poorer than that of a norm group. However, after a successful 
transplantation, the patients showed great progress in their general cognitive 
functioning as a result of an improvement of the scores on the verbal subtests. 
The transplanted patients had significantly lower scores than normal children of 
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the same age, particularly on concentration tasks. It was concluded that this 
group of patients are still at risk of falling behind at school, also in the long-
term. 
Chapters 8 and 9 describe studies on family stress. For this purpose, question-
naires had to be developed because no disease-specific instruments were 
available, and very little research had been performed on the burden caused by 
dialysis treatment. It was our aim to design questionnaires which are easy to 
administer and suitable for serial measurements. The central theme was the 
stress as experienced by the parents of renal patients undergoing CAPD/CCPD 
and HD. Based on experience in the early years of PD, it was hypothesized that 
the parents of young CAPD patients would be the most heavily burdened and at 
the greatest risk of bum-out. 
Chapter 8 reports on a retrospective study on the parents of CAPD patients and 
of HD patients. The results provided a great deal of insight into the specific 
burden as experienced by these parents, and showed that the amount of stress 
varied considerably from one parent to another. The parents of the CAPD 
patients experienced eating problems as a particular burden, whereas the parents 
of the HD children expressed most concern about their child's future. The 
considerable difference in age between the two groups played a role in this 
finding. In totality, psychological factors were found to contribute more to the 
stress than medical and practical factors. Contrary to the hypothesis, no signifi-
cant differences were found in the amount of stress between the mothers and 
the fathers or between the CAPD parents and the HD parents. In the second 
part of Chapter 8, a methodological account is given of the construction of the 
final versions of the family stress questionnaires, which were developed for 
prospective research and for use at a paediatric dialysis centre. 
Chapter 9 describes a prospective study on the burden, as experienced by the 
parents of 14 CAPD patients. Three measurements were performed over a 
period of one year. Once again, considerable differences were found in the 
amount of stress reported by the parents. Contrary to the hypothesis, the parents 
of the older children (>5 years) felt more burdened than the parents of the 
younger patients. Especially the parents of the children who had undergone an 
unsuccessful transplantation reported a high degree of stress. There were no 
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significant increases or decreases in the amount of stress measured at the three 
intervals during the one-year study period. The nature of the stress was deter-
mined more by psychological factors than by the medical aspects of the 
treatment. Support was found for our previous findings that concern about the 
future and factors associated with uncertainty made the greatest contribution to 
the burden. Emotional support for those parents with the highest scores on the 
questionnaires was therefore recommended. 
Chapter 10 presents the General Discussion in which comparisons are made 
between the results in the above-mentioned studies and those of various other 
recent surveys and in which shortcomings of the research are discussed. A 
summary is given of the most important conclusions and recommendations are 
made for further research. 
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SAMENVATTING 
De recente vooruitgang in de medische behandeling van kinderen met een 
chronische nierinsufficiëntie heeft geleid tot een verlengd levensperspectief, en 
in velerlei opzicht ook tot een verbeterde kwaliteit van leven. Ingrijpende 
nierfunctievervangende technieken zoals hemodialyse, peritoneaal dialyse en 
transplantatie bleken echter ook ingrijpende gevolgen te hebben voor de ont-
wikkeling van met name jonge kinderen en voor het psychisch functioneren van 
kind en gezin. Dit proefschrift beschrijft de psychologische gevolgen van 
terminaal nierlijden bij kinderen aan de hand van een aantal studies. Deze 
onderzoeken waren gericht op de vraag of de, in de jaren '80 in de literatuur, 
geconstateerde stoornissen en retardatie in de neurologische, motorische en 
cognitieve ontwikkeling van jonge kinderen voorkomen zouden kunnen worden 
door vroegtijdig te starten met nierfunctievervangende therapie. Met deze vraag 
diende ook een afweging gemaakt te worden of en in hoeverre een gezin en 
vooral de ouders belast zouden worden met de uitvoering van de behandeling 
en of zij deze zouden kunnen volhouden. 
De hoofdstukken 1, 2 en 3 vormen een inleiding op de zes uitgevoerde studies 
en bieden een overzicht van zowel de medische als de psychologische aspecten 
van een chronische nierziekte en de behandeling daarvan bij kinderen, aan de 
hand van de literatuur. 
In de hoofdstukken 4, 5, 6 en 7 wordt een viertal studies beschreven die gericht 
waren op de effecten van een terminale nierinsufficiëntie en transplantatie op 
met name de cognitieve ontwikkeling. De studies waren prospectief en longitu-
dinaal van aard. 
In hoofdstuk 4 wordt een prospectief onderzoek beschreven bij 18 nierpati-
entjes in de peuter/kleuterleeftijd en bij 18 gezonde leeftijdsgenootjes. Onder-
zocht werden de motorische en cognitieve ontwikkeling, alsmede het gedrag aan 
de hand van observaties. Er werd een significante achterstand gevonden in 
zowel de motorische als cognitieve ontwikkeling van de patiëntengroep. 
Bovendien werd een groot verschil geconstateerd in het cognitieve functioneren 
tussen patientjes in zg. conservatieve behandeling en patientjes die in dialysebe-
handeling waren. Geconcludeerd werd dat dialysepatiëntjes een vergrote kans op 
een ontwikkelingsachterstand hebben. 
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Hoofdstuk 5 behandelt een multi-centre onderzoek naar de cognitieve ontwikke-
ling van 31 patientjes <5 jaar en met een nierfunctie van <20% gedurende een 
looptijd van drie jaar. Vijftien patientjes werden bij de start van het project 
conservatief behandeld en 16 patiënten waren in dialysebehandeling. In dit 
onderzoek werd het effect van de aanvang van dialysebehandeling geëvalueerd 
bij 12 patiënten. De cognitieve ontwikkeling van de totale groep bleek bij 
aanvang van de studie vertraagd (M = 78.5, SD = 19.5). Patientjes die conser-
vatief behandeld werden scoorden significant hoger dan de dialysepatiëntjes, 
waarbij met name de kinderen met multipele afwijkingen een verhoogd risico 
hadden. Het effect van starten met dialysebehandeling leek positief, echter 
alleen op korte termijn. Follow-up evaluatie van 7 conservatief behandelde en 9 
dialysepatiënten over een periode van twee jaar bracht geen significante 
verschillen aan het licht. Geconcludeerd werd dat, evenals in hoofdstuk 4, 
dialysepatiëntjes een risico hebben op ontwikkelingsretardatie en dat dit met 
name geldt voor de patiënten met comorbiditeit. De hypothese dat een vroegtij-
dige start van dialysebehandeling de ontwikkelingskansen van jonge patientjes 
met een terminale nierinsufficiëntie zou kunnen verbeteren, werd niet bevestigd. 
Hoofdstuk 6 beschrijft een deelstudie van een longitudinaal project gericht op 
de neurologische ontwikkeling van 23 nierpatiëntjes beneden de 5 jaar en met 
een creatinineklaring van <20% van de leeftijdsnorm. Brainstem auditory 
evoked potentials (BAEP) onderzoek liet een vertraging zien in peak I van de 
BAEP, hetgeen indicaties geeft voor perifere geleidingsstoomissen, mogelijk 
tengevolge van een cochleaire dysfunctie. Bij kinderen <2.5 jaar, maar niet bij 
oudere kinderen werden stoornissen in de thalamocorticale geleiding gevonden 
op basis van somatosensory evoked potentials (S SEP) onderzoek. Deze bevin-
ding biedt aanwijzingen voor een vertraagde myelinisatie bij jonge kinderen met 
een chronische nierinsufficiëntie. Er werden geen verschillen gevonden tussen 
de conservatief behandelde kinderen en de kinderen in dialysebehandeling. 
Hoofdstuk 7 beschrijft een follow-up studie naar de effecten van een niertrans-
plantatie bij 20, overwegend oudere, patiënten in de schoolleeftijd. Het cognitief 
functioneren werd onderzocht aan de hand van intelligentietests voor en na 
transplantatie. Uit de resultaten van het onderzoek bleek dat nierpatiëntjes in 
vergelijking met de normgroep op het verbale gedeelte van de test lager 
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presteerden, maar dat zij na een geslaagde niertransplantatie significant vooruit-
gingen in het algemeen cognitief functioneren als gevolg van een stijging in 
scores op de verbale subtests. De getransplanteerde patiënten echter scoorden 
significant lager dan normale leeftijdsgenoten op met name concentratietaken. 
De conclusie is dat deze groep patiënten ook op langere termijn een achterstand 
op school kan ontwikkelen. 
De hoofdstukken 8 en 9 zijn gericht op het onderzoek naar de gezinsbelasting. 
Omdat er geen ziekte- of behandelingsspecifieke methode voorhanden was en er 
nog nauwelijks onderzoek naar de belasting tengevolge van dialysebehandeling 
was verricht, werd er een vragenlijst ontwikkeld die gemakkelijk toepasbaar en 
voor herhaalde metingen geschikt moest zijn. Uitgangspunt was de belasting 
tengevolge van CAPD/CCPD en HD, zoals ouders deze zelf ervaarden. Op 
grond van ervaringen in de beginjaren van PD was de hypothese dat ouders van 
jonge CAPD-patiënten het meest belast zouden zijn en een verhoogd risico 
hadden voor bum-out. 
Hoofdstuk 8 behelst een verslag van een retrospectief onderzoek bij ouders van 
zowel CAPD-patiënten als HD-patiënten. De resultaten bieden een goed inzicht 
in de specifieke belasting die ouders ondervinden. Ouders verschilden aanzien-
lijk in de mate waarin zij de belasting ten gevolge van de behandeling van hun 
kind ervaarden. Voor de CAPD-ouders bleken vooral eetproblemen en proble-
men rond dieet en medicatie bij te dragen aan de ervaren belasting, terwijl dit 
voor de ouders van HD-kinderen vooral de zorgen voor de toekomst betrof. Het 
aanzienlijke leeftijdsverschil tussen beide groepen speelde hierbij een rol. In 
totaliteit bleken psychologische factoren meer bij te dragen aan de ervaren 
belasting dan medische en practische factoren. Er werden geen significante 
verschillen gevonden in de ervaren belasting tussen vaders en moeders en, dit in 
tegenstelling tot de hypothese, tussen de CAPD-ouders en de HD-ouders. De 
tweede paragraaf van hoofdstuk 8 geeft een methodologische verantwoording 
van de constructie van de definitieve Gezinsbelastings-vragenlijsten die voor 
prospectieve doeleinden en voor gebruik in het kinderdialysecentrum ontwikkeld 
werden. 
In hoofdstuk 9 wordt een prospectief onderzoek beschreven naar de belasting 
van ouders van 14 CAPD-patiënten gedurende een jaar, waarin drie metingen 
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werden verricht. Opnieuw werden er grote verschillen in de ervaren stress 
tussen ouders geconstateerd. De ouders van oudere kinderen (>5 jaar), voelden 
zich, ook weer in strijd met de hypothese, meer belast dan de ouders van de 
jongere kinderen. Van deze ouders rapporteerden vooral de ouders van kinderen 
die een mislukte transplantatie hadden ondergaan een hoge mate van stress. De 
belasting gemeten op drie tijdstippen gedurende een jaar nam wederom niet 
significant toe of af. De aard van de belasting werd meer bepaald door psycho-
logische factoren dan door de medische aspecten van de behandeling. Ook in 
deze studie bleken zorg over de toekomst, alsmede factoren die samenhingen 
met onzekerheid, het meest bij te dragen aan de ervaren belasting. Emotionele 
ondersteuning van ouders die hoog scoorden op de checklist werd dan ook 
aanbevolen. 
Hoofdstuk 10 tenslotte geeft een slotbeschouwing, waarin de uitkomsten van de 
verschillende studies worden vergeleken met recent verrichte andere onderzoe-
ken, waarin tekortkomingen van het onderzoek worden bediscussieerd en waarin 
een samenvatting wordt gegeven van de belangrijkste conclusies en aanbevelin-
gen voor verder onderzoek. 
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I. Uit een inventariserend onderzoek in het kader van het Onderwijsproject 
Kinderdialyse Nederland blijkt dat van de dialysepatiënten in de leeftijd van 
4 - 1 6 jaar meer dan 50% is aangewezen op het speciaal onderwijs. Voor de 
totale Nederlandse leerlingenpopulatie ligt dit percentage tussen 4 en 7.6%. De 
extra financiële inspanning die momenteel wordt opgebracht ten behoeve van 
het zojuist gestarte project kan dan ook allerminst als een luxe worden 
beschouwd. 
II. De bevinding dat vaders zich in gelijke mate belast voelen door de ziekte en de 
behandeling van hun kind als moeders lijkt zo vanzelfsprekend, dat in de 
literatuur hiervan niet eerder melding is gemaakt. 
(dit proefschrift) 
III. Thrombose van de donornier is de belangrijkste vroege complicatie van een 
niertransplantatie op de kinderleeftijd. Het is te hopen dat profylaxe met anti-
stolling deze complicatie zal doen verdwijnen. 
(AF van Lieburg et al, J Pediatr Surg 30:616-619, 1995) 
IV. De prevalentie van mentale retardatie onder patiënten met erfelijke diabetes 
insipidus is minder uitgesproken dan in de literatuur wordt gesuggereerd. 
(JA Hoekstra et al.. Human Genetics, in press) 
V. Gezien het algemeen publiek belang dient de bevordering van orgaandonatie niet 
alleen een zaak en een taak van particuliere instellingen te zijn, maar ook van 
de overheid, waarbij in voorlichtingscampagnes de psychologische, ethische en 
juridische aspecten belicht dienen te worden. 
VI. Psychologische contraindicaties bij een ouder-kind transplantatie dienen in een 
vroeg stadium van de besluitvorming met de ouders besproken en gewogen te 
worden. 
VII. Indien therapieontrouw wordt vermoed bij dialyse- en getransplanteerde 
patiënten in de adolescentiefase, is het van groot belang na te gaan of dit een 
symptoom is van (psychisch) gezond adolescentengedrag, dan wel van 
onderliggende psychische problematiek, zoals een (gemaskeerde) depressie met 
al dan niet bewuste suïcidale componenten. 
(dit proefschrift) 
VIII. Uitgangspunt bij de start van de nog steeds belastende behandeling van kinderen 
met groeihormoon dient te zijn dat méér centimeters zonder meerwaarde van 
geen waarde zijn. 
(BJ Ottert, MCWJ de Jong, GM Hulstijn-Dirkmaat) 
IX. De psychologische voorbereiding van kinderen op invasief onderzoek en 
operaties is alleen dan effectief indien deze is afgestemd op de specifieke 
ingreep en op het individuele leeftijds- en ontwikkelingsniveau van het kind. Bij 
een collectieve voorbereiding middels folders, boekjes en videofilms ontbreekt 
de mogelijkheid in te gaan op de emoties en (ir)reèle voorstellingen en 
fantasieën van het individuele kind. 
X. Bij de conservatieve of palliatieve behandeling van kinderen met een ernstige 
congenitale hartafwijking en een beperkte levensverwachting is de inbreng van 
een medisch psycholoog gewenst vanwege de vragen en problemen van ouders 
rond ontwikkeling en opvoeding die samenhangen met het begrensde perspectief 
van het kind. 
XI. Gezien het toenemende aantal allochtone patientjes dat een complexe 
behandeling ondergaat, verdient het aanbeveling om naast het inschakelen van 
tolken ook allochtone consulenten met een medische en/of verpleegkundige 
deskundigheid aan te stellen, ter voorkoming van andere dan alleen taalkundige 
communicatieproblemen. 
XII. Dat pijn nooit went, wordt in het professioneel enthousiasme over verbeterde 
behandelingsresultaten bij chronisch zieke kinderen nogal eens vergeten. 
XIII. Le voyage est une expérience, comme l'immobilité sur un coin de terre est une 
expérience, comme l'amitié, la contemplation, l'amour, le travail, la maladie, 
sinon le jardinage ou la cuisine, sont des expériences. Pourquoi discriminer entre 
elles? (Marguerite Yourcenar in "Les Yeux Ouverts") 
XIV. Die hele volmaakte wereld die er moet zijn - het volmaakt onvindbare antwoord 
op de vraag welke wereld dat is. 
(Rutger Kopland in "Voor het verdwijnt en daarna") 
Heumen, 20 oktober 1995 



